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Preface 
Abstract 
Alternative hosts for expressing heterologous proteins have recently gained an increased attention. 
Actinomycetes, and among these especially the Streptomycetes are considered promising candidates, since 
they through their saprophytic lifestyle are capable of excreting large amounts of proteins. Industrially this 
is very useful due to the reduction of downstream processing. Streptomycetes have long been studied, and 
a great amount of knowledge has been gained on genetic tools and metabolism. A most promising 
candidate as host among the Streptomycetes is S. lividans, since this strain exhibits an exceptionally low 
protease activity, ensuring good product stability. Despite the fact that S. lividans has already seen 
industrial application studies on quantitative physiology are still lacking. It will greatly benefit the use as a 
common host to elucidate how S. lividans behaves in submerged cultivations, as well as how it is affected 
by expressing a foreign protein. 
In this thesis methods have been established for the study of quantitative physiology and a method for 
screening large amounts of carbon/nitrogen/phosphorus sources have been tested. Further, parallel to the 
project that is the basis of the thesis is an EU project that has had to be supported with physiological data. 
Cultivations have been run across laboratory relevant scales. A strong physiology platform is required to 
obtain the most informative results from the advanced ‘omics’ analyses. Whether the biomass is harvested 
from batch or chemostat experiments, reproducibility is essential for comparing results under controlled 
conditions. 
Dansk Resumé 
Antallet af værter der med fordel kan bruges til heterolog protein produktion har været søgt forøget 
gennem mange år. Actinomyceterne, heriblandt særligt Streptomyceterne er lovende kandidater, da de 
gennem deres naturlige livsstil er i stand til at udskille store mængder proteiner. Dette søges udnyttet 
industrielt, da extracellulær secernering i høj grad minimerer mængden af oprensning, og dermed er 
omkostning minimerende. Som værter har Streptomyceterne været undersøgt gennem en årrække, og der 
er opnået stor viden indenfor genetiske værktøjer og metabolisme. En klar kandidat som vært blandt 
Streptomyceterne er S. lividans da denne har en exceptionelt lav extracellulær protease aktivitet, og 
hermed kan bedre produkt stabilitet sikres. På trods af at S. lividans har været brugt industrielt, mangler 
der dog stadig nogle studier om kvantitativ fysiologi, da det vil øge brugbarheden som vært at få klarlagt 
hvordan S. lividans opfører sig i kultiveringer, og at få estimeret hvordan cellen påvirkes af at udtrykke et 
fremmed protein. 
I denne afhandling er metoder blevet etableret, og dermed er fundamentet lagt for studier af den 
kvantitative fysiologi. Der er yderligere blevet testet en metode til screening af anvendelige 
kulstof/nitrogen/fosfat kilder. Ydermere har projektet der ligger til grund for afhandlingen været kørt 
parallelt med et EU projekt, og dette skulle også støttes med kvantitative studier. Der er blevet udført 
kultiveringer på tværs af laboratorierelevante skala. En stærk forståelse af fysiologi er nødvendig for at sikre 
de mest sigende resultater når de avancerede ’omics’ metoder benyttes. Uanset om biomassen bliver 
høstet fra batch eller chemostat forsøg er reproducerbarhed en forudsætning for at kunne sammenholde 
resultater der er opnået under kontrollerede forhold.  
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Chapter 1. Outline 
Actinomycetes are widely recognised as producers of antibiotics and secondary metabolites with a wide 
range of biological activities; further they have been investigated as producers of heterologous proteins. 
Though, the amount of published literature within this field is very limited compared to publications 
regarding secondary metabolites. For a host to be considered for heterologous production of protein, i.e. to 
be used as protein cell factory, some basic requirements have to be in place.  
 knowledge of the genomic sequence 
 access to genetic tools 
 knowledge about metabolism 
 knowledge about physiology across scales of production 
 know-how about scale-up 
 knowledge about regulation 
 the capacity to perform reproducibly in  cultivations, also related to kinetic parameters such as 
o growth rate 
o productivity 
o substrate uptake 
o lag-phase, and experiment duration 
Actinomycetes are considered promising hosts for heterologous proteins production because as a benefit of 
the thorough interest in secondary metabolites some of the cell factory pre-requisites have been met. A 
number of Actinomycetes have been full genome sequenced, and several more are in progress. The 
genetics have been thoroughly studied in a number of hosts, therefore metabolism has been described 
thoroughly, and general physiology is known, besides the developments of genetic tools. Actinomycetes 
also possess an inherent capacity to secrete large amounts of proteins (enzymes), as part of their 
saprophytic lifestyle, which has been one of the primary criteria for selecting them as potential good hosts. 
The importance of high secretion capacity is that exporting the product to the growth medium eases 
downstream processing and thereby reduces process costs. 
Streptomyces lividans, specifically, is one of the particularly promising Actinomycetes, since this organism 
already has been used in industrial scale for production of human proteins (Brawner, 1994). Further this 
soil bacterium is recognised to have a very low endogenous extracellular protease activity (Lussier, et al., 
2010) ensuring product stability, as well as improving the yield. 
S. lividans has been studied as a heterologous host for more than 20 years (Anné & Mellaert, 1993) 
(Brawner, 1994), and during that time a number of important developments have been made, including an 
efficient expression system, characterisation of a number of promoters and secretion-signal peptides, 
molecular characterisation of the export systems (SEC and TAT), creation of a wide range of cloning vectors, 
and establishment of protocols for genetic and molecular work. The amount of work available on 
quantitative physiology in bioreactors, relating to primary metabolism however is sparse, though as a host 
for heterologous secondary metabolites S. lividans has proved its worth.  
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The project that is the basis for this thesis has therefore sought to address exploiting the potential of S. 
lividans as a cell factory. The work described in this thesis has been closely tied to the EU framework 6 
project named STREPTOMICS that was focussed on developing S. lividans as a cell factory by studying the 
effect of heterologous protein production on the physiology of the organism, and possibly suggesting and 
implementing metabolic engineering optimisations to improve production. The members of the consortium 
included specialists in many fields, some familiar with, others experts in, Streptomyces, some were brought 
in for their expertise in a particular field, despite their lack of specific experience with Streptomycetes.  
 
Figure 1 adapted from the technical annex of the STREPTOMICS project. This figure gives an overview of the STREPTOMICS 
project, and also relates how interconnected all of the operations are. Identifying genes of interest and expressing these are only 
the first steps. Subsequently a great deal of fermentation experiments are required to gather the samples for the 
advanced ‘omics’ analyses, which will feedback data towards strain optimisation/engineering. Because 
Streptomyces are fairly uncharacterised, a number of bioinformatics tools need to be developed as well as help 
investigate the genome sequence, which should be sequenced as part of this project. 
STREPTOMICS took its starting point in a number of S. lividans strains that have already successfully 
expressed a number of proteins. These were to be characterised thoroughly, and samples should be taken 
for advanced ‘omics’ analyses, which the separate members in the consortium were proficient in analysing, 
and included among others proteomics which was to be performed by University of Greifswald, 
metabolomics that was to be performed by University of Manchester, and finally transcriptomics, as well as 
development of bioinformatics tools that were to be performed by BioXpr, Belgium. Two partners, KU 
Leuven (Belgium) and FORTH (Greece), were involved in characterising the secretion machinery. DTU was 
responsible for quantitative physiology, and flux analysis of strains, as well as obtaining samples from 
reproducible conditions in bioreactors, in order to more thoroughly be able to compare the results from 
the analyses. Genome sequencing as well as Bio-prospecting among Icelandic thermophiles for potential 
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products was to be performed by Matis ltd. an Icelandic Food and Biotech R&D institute. Further, a number 
of small and medium enterprises (SME’s) have been included in the project, with various roles, reflecting 
that the project has an industrial relevant angle.  
As depicted in Figure 2 the work in this thesis has been shaped to facilitate the overlying EU project, and it 
has been a great opportunity to collaborate with prime researchers in their respective fields. The Centre for 
Microbial Biotechnology has had a long experience with antibiotic and secondary metabolite production in 
the strains S. coelicolor and Amycolatopsis balhimycina, which meant that some infrastructure was in place, 
though adaptation and validation of methods had to be performed. The other project partners have 
primarily been utilising classical rich media, therefore a defined minimal medium had to be introduced to 
ease quantitative and ‘omics’ analyses, and ensure comparability of results between the groups.  
 
Figure 2 An overview of how the various parts of my project has evolved controlled by the needs of the EU project 
The quantitative physiology was primarily considered by DTU in the EU project, since the other members 
were interested in developing the analyses of their core competence. Where biomass had not yet been 
supplied, the partners performed experiments in shake flasks, which obviously caused a higher degree of 
variance caused by the imperfect control of mass transfer-, as well as physio-chemical -, parameters in 
shake flasks. 
The thesis is the result of work performed here at DTU, which has been of a developmental nature as little 
has been reported within this field. A lot of basic work had to be performed, both to establish working 
conditions, as well as to support the EU project. The limited number of published papers reflects the 
challenging nature of establishing a cell factory, which others hopefully can build on. 
The shape the thesis takes resembles the overall shape of the EU project, as depicted in Figure 2. Before 
delving into the work performed, a thorough introduction into Streptomyces lividans as a cell factory is 
needed, and will be presented in chapter 2. An overview will be given of cell factories and common hosts 
for protein production. The setup includes generating propagation procedures, as well as screening of 
carbon and nitrogen sources for effect on growth and product formation. These elements are included in 
the chapters 3 and 4, of which the latter is a paper submitted to Applied Microbiology and Biotechnology 
(AMB) (Rattleff, et al., 2013a). Physiology is also the core of the chapters 3, 4 and 5, where quantitative 
physiology was studied across laboratory relevant scales, from microtiter plates to 1L lab scale bioreactors. 
Further, in chapter 5 the effect of growth rate on product formation was studied in chemostats. The 
chemostats with their highly controlled conditions are useful for reproducibly sampling for the advanced 
EU-project 
Setup Physiology 'omics' 
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‘omics’ analyses, and thus support the EU project. Lastly, in chapter 6 an overview will be given of what 
‘omics’ analyses are available, what results have been obtained, and what perspectives are in the 
development and use of these analyses. This chapter is being supported by two papers that are appended 
as drafts, one is the preliminary flux analysis, to asses ED-pathway activity in a number of Actinomycetes 
(Rattleff, et al., 2013b), the other is a collaborative effort to develop an unstructured kinetic model to 
simulate the fermentation processes of S. lividans (Nandy, et al., 2013). Chapter 7 contains the concluding 
remarks, on the evaluation, and perspectives, of S. lividans as a cell factory for heterologous protein 
expression. 
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Chapter 2. Introduction 
Industrial biotechnology 
The power of microbes has been harnessed over the course of the centuries. Only in the more recent 
history has the human race become knowledgeable about the microbes, and have begun to investigate 
them more in-depth. Industrially, microorganisms have seen use in the brewing and baking industry almost 
since the dawn of time. The use of fermented food and drink go back a long way through history, not only 
to increase shelf life, but also as a means to increase nutritional value (Demain, 2010). There are indications 
that even in ancient Rome 100 BC there were 250 bakeries selling leavened bread (Demain, 2010). Brewing 
was originally something performed on an individual basis. In the mid-16th century industrialization took 
place, where monasteries and breweries took over the brewing, and sold their product to the local pubs. 
Biotechnology was a term first believed to be coined in 1919 by a Hungarian agricultural engineer Karl 
Ereky. Originally the term meant “all the lines of work by which products are produced from raw materials 
with the aid of living organisms” (Bud, 1989). Over the years the understanding of the term has changed, 
with the change in technology available, suffusing towards microbial biotechnology. 
Industrial microbiology became interesting with the need for glycerol for production of ammunition during 
World War one, and later with the advent of antibiotics large scale fermentation processes were developed 
rapidly (Vinci, 2003). Another pioneering microbial process was the Acetone-Butanol-(later also ethanol) 
fermentation by Clostridium which is considered the first non-food fermentation (Demain, 2010). 
Fermentation for production of food and industrial products has the pronounced advantage that variability 
in production is less, and the scaling of production to fit demand is easier than using crops or purification 
from these. For some processes the environmental impact is also reduced compared to e.g. petro-chemical 
applications. Reduced variability of product was especially seen for the production of citric acid that 
originally was extracted from lemons, though Currie patented a process in 1916, that was later developed 
to industrial scale in 1923, where he used Aspergillus niger (Demain, 2010). Potentially the environmental 
impact of using bioprocesses is reduced compared to classical production methods. The waste streams will 
contain fewer and less toxic components. 
Later, in an attempt to improve penicillin production, it was discovered that high concentrations of glucose 
had a detrimental effect on the production. An alternative was to use lactose that supported high 
productivity, but was inefficient as a growth medium. A mixed medium of glucose and lactose was a 
possibility, though the problem is that high glucose concentrations inhibit production of antibiotics, among 
other, and extending the batch by feeding small amounts of glucose, overcomes the problem of inhibition, 
while using a carbon source that supports growth very well, thus resulting in the invention of a fed-batch 
process in 1953, which is widely applied in industry today (Demain, 2010). One of the main benefits of the 
fed-batch is that incredibly high cell density can be obtained, and after the initial batch phase, the growth 
rate can be controlled by controlling the rate of addition of feed. Controlling the addition of glucose, allows 
e.g. to maintain an uninhibiting low concentration of glucose in the medium. This allows for a high 
productivity of products whether they are growth-related or -independent. 
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Figure 3 A schematic overview of the connection between available products, their complexity, and the complexity of the 
process producing them. Abbreviations are representative organisms in each category: LA (lactic acid bacteria), BS (Bacillus 
subtilis), EC (Escherichia coli), SC (Saccharomyces cerevisiae), AC (Actinomycetes), FF (filamentous fungi), MM (mammalian cells). 
 Figure 1 gives a schematic representation of the connection between the complexity of the process and 
the complexity of the product. The dashed line represents a trade-off consideration, which can be difficult 
to determine in reality. It is meant to suggest when it would be sensible choosing a different organism. The 
trade-off will be between with increasing complexity of the production and increasing complexity of the 
product. Some of the higher organisms allow producing more complex products, that are also higher value 
added, and here there is no problem with that decision. Alternatively, filamentous fungi are capable of 
producing high amounts of primary metabolites, though they are involved in relatively complex processes, 
thus the amount, and price, of the product have to be weighed accurately against the cost of running the 
process. 
Product complexity 
The complexity of the products is based on where they are derived in the metabolism, and what the 
requirements for using said products are. Simple products are primary metabolites, and with increasing 
complexity homologous proteins, secondary metabolites, simple heterologous proteins, modified 
secondary metabolites and lastly complex heterologous including those requiring glycosylation. More in 
line with choosing the organism to produce the product is the value of product in the market. Here 
products can be divided into bulk and high value added products. A classical high value added product 
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would belong in the pharmaceutical industry, with a market size estimated between 87 (2008) and 169 
(2014) billion US$, whereas the market size for heterologous (bulk industrial) proteins is estimated to be 
between 5.1 (2009) and 6.5 (2013) billion US$ (Mattanovich, et al., 2012) (Erickson, et al., 2012); despite 
the difference in relative market values, the physical volume is not addressed. The bulk enzymes are used 
in almost all areas of industry e.g. feed, food, detergents, and biofuels. The distinction between bulk and 
high value added products is of importance when designing the process, as it implies how much of the 
product obtained per substrate is required for the process to be successful. Optimising bulk products are 
mostly related to optimising Ysp, yield of product on substrate, since the cost of the substrate has a large 
impact on the final price of the product. In high value added products the optimization parameter is rp, 
specific rate of product formation (usually g product/ (g DW * h), since the price of the substrate is less 
important; it is more interesting how long the process will be, what by-products there are etc. The media 
for high value added products can become quite expensive because of the wish for a defined product 
spectrum, the requirements of the organism, and bureaucratic regulatory concerns depending on whether 
the product is pharmaceutical. 
Known primary metabolites are among others: vitamins, amino acids (food additives), organic acids, and 
solvents. Examples of the latter two could be citric acid, acetone, butanol, and ethanol. All of these are 
established bulk products (Makino, et al., 2011) (Adrio & Demain, 2006) (Soetaert & Vandamme, 2006). 
Secondary metabolites have biological activities, and are often of an ecologically adaptive nature (Bibb, 
2005). The activities include: antibiotics, antitumor, antimalarial, anthelmintic, and colours. One of the 
most famous secondary metabolites is penicillin, discovered by Alexander Fleming, and many antibiotics 
have since been discovered. Secondary metabolites are often found from hosts that inhabit selective 
niches, and have complex living requirements; while it is possible to develop each specific host for 
producing the compound of interest, the complex regulatory networks controlling secondary metabolites 
make them excellent subjects for heterologous expression. Estimated 60% of all antibiotics are produced by 
members of the order Actinomycetales, and heterologous expression of antibiotics in this order has long 
been an area of interest. 
Homologous proteins are, in terms of complexity, considered on-par with secondary metabolites in this 
representation, while actually belonging to the primary metabolism. These proteins are often sought 
because of specific activity, and are to be produced in bulk. Production of homologous proteins depends on 
amount and activity and very much on the capability of the natural producer, but a wide range of natural 
hosts are available, including bacteria and filamentous fungi. 
The more advanced products are mainly concerned with heterologous proteins which will be elucidated 
later, though this group can be subdivided depending on whether glycosylation is required, which shifts the 
process requirements towards higher complexity.  
Process/organism complexity 
Organism complexity and process complexity are closely related, since the increasing demands of the 
organisms reflect how complex the process is to handle. The bacteria and unicellular yeasts are relatively 
uncomplicated to use in bioprocesses, while mass and energy transfer issues are relevant to keep in mind 
for high density aerobic processes, their very simple morphology makes no restraints. Their product 
spectrum varies, but is concerned primarily with the simpler products, such as primary metabolites, 
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solvents (ethanol, butanol…), vitamins, amino acids, protein (single cell protein, homologous proteins, and 
simple heterologous proteins). Thus a vast range of processes are represented by this group of organisms. 
(Morello, et al., 2008) (Mattanovich, et al., 2012) (van Ooyen, et al., 2006) (Demain & Vaishnav, 2009). 
In the area of higher process complexity the product spectrum expands to include the very complex 
heterologous proteins with human glycosylation patterns. Filamentous fungi (FF) are represented in all 
avenues of production, from primary metabolites (organic acids), over homologous proteins, to 
heterologous proteins of even moderately complex character including proteins requiring correct 
glycosylation to function. The mammalian cells are because of their sensitivity, complex feeding 
requirements, the price of their media, and their growth rate primarily used for producing high value 
complex proteins which require correct glycosylation. They are difficult to handle, but due to their nature 
capable of producing human, or mammal, proteins quite efficiently.  
What lacks to be mentioned from figure 1 is that in the sweet spot, less complex than filamentous fungi, 
though with the capability for producing somewhat complicated products, are the actinomycetes. They 
have been investigated for many years as potential hosts for heterologous protein production due to their 
excellent innate ability to excrete proteins to their surroundings (Brawner, 1994) (Binnie, et al., 1997) 
(Anné, et al., 2012). 
Microbial cell factories 
The term “microbial cell factories” is relatively new, sprung from industrial biotechnology. It is the aim to 
convert a cell into a cell factory i.e. the cell should be able to produce the wanted compound, from a 
cheaper source of raw material. The biotransformation should preferably be competitive with alternative 
production methods, i.e. production should be carried out with high efficiency, a limited number and 
amount of by-products, and high selectivity (should the product be e.g. amino acids, or in another way 
stereoselective). Further, for an organism to come into consideration as microbial cell factory, genetic tools 
for modification should be available, the strain should be genetically stable, it is of great benefit if the 
genomic sequence is available, and the strain should be amenable to high cell density cultivations. 
These features are very important to establish a cell factory, and it is obvious that genetic stability and 
process reproducibility are key factors in an industrial setting. Further, choosing a production strain that 
produces no toxic compounds, or even carries a US-FDA GRAS (US food and drug administration, generally 
regarded as safe) status for food and/or feed processes, can be highly valuable in terms of easing 
governmental regulatory constraints. After having introduced the changes needed for obtaining the 
product, and preferably in high amount, it is important also that the process can run stably for an extended 
duration, without losing productivity. Reproducibility and ease of handling should allow the process to run 
reliably and preferably in a partly automated fashion. A further feature that is wanted is product stability. A 
high productivity is not worth much if the product is constantly being degraded, which is often the case for 
protein products, since many heterologous hosts produce proteases as well.  
Heterologous protein production 
In nature proteins (enzymes) can be found with very unique properties. In order to use these proteins they 
have to be produced in sufficient amounts that their price does not exceed their applicability. Many of the 
proteins with interesting activities are found in hosts that are unviable for industrial production, e.g. arctic 
phosphatase, thermo stable proteases, lipases, and cellulases. All of these proteins have been isolated from 
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extremophile hosts that either requires high growth temperatures (increasing the energy consumption, 
thus the price for the process, or have very low growth rates, making the process unbearably long. Thus the 
production of heterologous proteins is achieved by specific application of microbes with desirable 
properties to produce a, to the host, non-native protein. The first industrially produced heterologous 
protein was insulin produced in E. coli by Eli Lilly. So far, very few pharmaceutical heterologous protein 
products have actually been approved by the authorities, the number lies in the lower end of hundreds 
(Anné, et al., 2012) (Mattanovich, et al., 2012). 
Heterologous proteins can be divided into: 
Bulk: industrial proteins, e.g. proteases, xylanases, cellulases, phosphatases, lipases, 
amylases 
Specialised: e.g. restriction enzymes, polymerases 
Pharmaceutical: IFN-alpha2, TNF-alpha, antibodies, human proteins (EPO) 
Especially the bulk enzymes are often produced from endogenous hosts, since they already have a high 
capacity for expressing a given protein. There is also the possibility that this production can be further 
optimised, though there is a limitation, before regulatory processes become a problem.  Heterologous 
expression is most often chosen for the more specialized products, were purification from live tissue would 
be impractical or connected to risk, e.g. insulin, or  in cases where the natural titers are so low that it is 
vastly uneconomical to choose endogenous production. Further, heterologous production has the distinct 
advantage that a production strain can be chosen, for which there is well established fermentation know-
how. 
One major problem with heterologous protein production is that many of the known, and currently used, 
producers also have a high capacity to produce proteases. This reduces product stability, and yield. 
Especially the filamentous fungi, though also the gram positive Bacillus spp., are known for their proteases 
(van den Hombergh, et al., 1997) (Westers, et al., 2004) (Punt, et al., 2002). Different ways to reduce 
protease levels have been applied both knock outs of protease gene, morphological “engineering” (Wang, 
et al., 2005). Though often the residual activity is still high enough to cause substantial product loss, or the 
knock-out strain may be severely hampered in its growth. 
Endogenous vs. heterologous host 
Choosing if a protein should be produced in an endogenous or heterologous host relies much upon the 
characteristics outlined in the previous sections. Is it a bulk product, and is the endogenous host capable of 
producing sufficient amounts of the product, under conditions and with media components that will not 
cause regulatory concerns. If it is a homologous product, and it is already produced as one of the major 
products of the cell, then only culturing demands can bar the way for using the homologous strain. If 
however, the product is a minor product, or originally produced from a host, e.g. a plant that cannot easily 
be cultured to yield sufficient product, the choice of heterologous production is clear. 
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Well established heterologous hosts for protein production 
Bacterial hosts 
Escherichia coli is probably the most well-known host. It is very well studied, and a large repertoire of 
genetic tools is available. E. coli grows fast; under favourable conditions a generation time can be as low as 
20-30 min. It is easy to handle, and supports high cell density fermentation, up to 150 g/L dry weight 
(Schmidt, 2004). This in conjunction with the absence of secondary metabolites makes E. coli a good host. It 
is a gram negative, which means it has a cell wall, besides the cellular membrane. This has a very profound 
effect on this organism as a host for heterologous protein production. Many proteins are accumulated, 
either in the cytoplasm, or in the periplasmic space, as inclusion bodies. This is problematic, since the 
aggregates are inactive protein that needs to be refolded to obtain functional activity. Though proteins that 
require sulphide bonds can be accumulated in the periplasmic space, and subsequently released, after 
subjecting the culture to an osmostic shock (Terpe, 2006). Some researchers have also increased yield by 
co-expressing chaperones, to help fold the product correctly. There is mention in the literature of 
intracellular and periplasmic proteases, and subsequently protease deficient mutants, though E. coli is 
generally recognized as having low protease activity. Historically the first available commercial 
heterologous product was insulin produced in E. coli by Eli Lilly, and many products have followed. As much 
as 30% of the FDA approved products are produced in E. coli (Huang, et al., 2012). 
Bacillus spp. and Lactococcus lactis are gram positives and have high capacities for excreting active protein 
into the growth medium. This is favourable in terms of downstream processing, making purification easier. 
Bacillus subtilis is almost as well studied, and well known as E. coli. Bacillus is industrially a well-tested 
genus, and around 50-60% of industrial enzymes are produced in Bacillus spp (Schallmey, et al., 2004) 
(Westers, et al., 2004). The genomic sequences of a number of bacilli are available, as are a large number of 
genetic tools. Terpe claims it is more difficult to transform bacilli, since protoplastation is necessary (Terpe, 
2006), though compared to working with filamentous fungi this is likely a small encumbrance. 
Unfortunately many gram positives have an inherent capacity for producing proteases, which results in 
reduced product stability. Studies have been conducted to knock out the various proteases, with varying 
degree of success (Westers, et al., 2004), as well as using the less common relatives with an inherent lower 
protease activity. Yields (titers) in the range 3 g/L have been reported using B. subtilis as host, and reports 
have also mentioned that up to 30% of the soluble protein was heterologous (Terpe, 2006). 
Lactococcus lactis is one of the new contenders for heterologous expression. Industrially it is used in the 
dairy industry. It has a simple product spectrum mostly concerned with primary metabolites, such as lactic 
acid and there is only one extracellular protein at detectable levels. Recently some work has gone into 
presenting L. lactis as hosts for heterologous protein expression, and since it only has one extracellular 
protease that can be inactivated, seemingly without hampering growth (Morello, et al., 2008). Further, it is 
a well-studied organism with a simple metabolism that supports aerobic and anaerobic growth. L. lactis is 
considered GRAS, and therefore suitable for producing enzymes to be used in food and feed industries. 
Lactococcus is well known fermentation wise and large scale fermentations are in place. 
Yeast hosts  
The simplest eukaryotic cells are the yeasts, which while in essence fungi, have their own group in terms of 
production hosts, and their mostly unicellular lifestyle. They are also one of the most studied groups of 
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organisms, together with the bacteria; partly due to the ease of handling, and the fact that they are 
eukaryotic, so they can in some instances be used as simple models of higher organisms. The most common 
yeast hosts are Saccharomyces cerevisiae and Picchia pastoris. Of these, the latter is known for very high 
protein expression levels using the highly inductive methanol promoter system. The yeasts possess the post 
translational machinery of eukaryotes for e.g. glycosylation that bacteria lack; though the post translational 
activity is only somewhat successful. S. cerevisiae has been shown to hyper glycosylate heterologous 
proteins, and uses a non-mammalian mannose glycosylation pattern (Demain & Vaishnav, 2009). Work has 
gone into producing humanised-yeasts, with less aggressive glycosylation patterns (van Ooyen, et al., 
2006). Both of the model yeasts can be used in very high density fermentations, surpassing 200 g DW/L 
(Demain & Vaishnav, 2009). And they are very well studied, characterised and easy to handle both in a 
fermentation sense, but also genetically, e.g. Kluyveromyces lactis was the first yeast for which a 
transformation system was introduced (van Ooyen, et al., 2006). Many of the yeasts are considered GRAS, 
since they have been used throughout history (Juturu & Wu, 2012), among these K. lactis, which industrially 
has been used to produce both lactase and later bovine chymosin, the first higher eukaryotic protein 
expressed in a microorganism (van Ooyen, et al., 2006). Yeasts have a proven track record in terms of large 
scale industrial production, also of heterologous proteins, with the added benefit that for the most part, 
they are able to secrete fully folded protein. Protease activity is a known issue, and for Picchia protease 
knock-out mutants have been produced (Macauley-Patrick, et al., 2005). Unfortunately, the methylotrophic 
yeasts, including Picchia, that use the highly inductive methanol promoter system, require explosion proof 
fermentation equipment, which increases the capital investment when setting up the process (van Ooyen, 
et al., 2006). While yeasts are easy to handle in terms of physiology, they produce a lot of heat and CO2, 
and for aerobic processes need a high aeration, resulting in high energy consumption.  
In cases where the yeast is Crabtree positive, then the process will draw out, due to the production of 
ethanol at high growth rates, that later has to be taken up again, and metabolised, at a much slower 
growth rate. To prevent Crabtree effect in continuous or fed-batch processes the feeding rate has to be 
below the critical substrate uptake rate, thus growth has to be kept below 0.1 h-1 (Mattanovich, et al., 
2012), off-setting one the yeasts main benefits, a reasonably fast growth rate. 
Fungal hosts 
Fungi are recognized to have a very developed capacity for excreting active product, by merit of their 
saprophytic lifestyle. Homologous products are known in titers of 10-30 g/L e.g. proteases and amylases 
(Wang, et al., 2005) (Punt, et al., 2002), though heterologous products are nowhere near this scale yet; 
many fungi produce high amounts of secreted proteases reducing product yield (van den Hombergh, et al., 
1997). Much effort has gone into characterizing and minimizing the extracellular protease production, in 
heterologous protein fermentations. It has been found that pH, inoculum, medium composition and 
morphology are some of the features that affect protease production. One of the approaches to reduce 
extracellular protease production is to make genetic knock-outs. This approach, while somewhat successful 
(Punt, et al., 2002), also has caused the mutants to be debilitated to a degree that makes them undesirable 
for large scale production (Wang, et al., 2005). And still there is protease activity, even if only 1-2% of the 
parental strain, it is sufficient for degrading heterologous proteins (Mattern, et al., 1992). Even knock-outs 
of transcription factors controlling proteases show limited success (Punt, et al., 2008). 
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In the recent past much research focus has been put into creating genetic tools for expanding the toolbox 
of filamentous fungi. Despite the expanding toolbox, knowledge of the secretory pathway is lacking 
compared to bacterial systems (Wang, et al., 2005) (Mackenzie, et al., 1987). Due to some court cases, 
concerns over intellectual property matters regarding the use of fungi have increased the interest in 
expanding the range of available hosts; this is expansion is also with the consideration for what strains are 
recognized as GRAS in the food industry (Punt, et al., 2002). Two of the common genera of well-known 
production strains are Aspergillus and Trichoderma, known for their endogenous proteins such as proteases 
and cellulases and organic acid production. 
One thing that characterizes filamentous fungi is their hyphal growth, which can be both of merit and 
detriment during cultivation depending on the product. The hyphal growth results in highly viscous 
fermentation broths that, depending on the particular morphology, can have non-Newtonian properties. 
This causes problem with mass transfer, which in turn can affect product formation. Much effort has gone 
into describing and controlling morphology, and estimating the impact of morphology on product 
formation. It is a complex problem, since it can be difficult to discern whether the effect seen is caused by 
the physiological or morphological change. Some researchers have reported that it seems the variability in 
productivity is caused mainly by physiology, less by morphology, as long as the morphology does not impart 
mass transfer limitations (Wang, et al., 2005). The most used process when it comes to filamentous fungi is 
the submerged fermentation, and while great know-how is available, recent developments have given 
increased impetus to developing solid state fermentation, as the genetic regulation here is vastly different 
(Nevalainen, et al., 2005), and potentially novel products can be developed, that are unavailable or 
produced in low amounts in submerged fermentations (Oda, et al., 2006). Despite their great promise, so 
far no heterologous pharmaceutical products are produced by filamentous fungi (Wang, et al., 2005); 
though their presence in industrial fermentations is endemic. 
Streptomycetes – state of the art 
Streptomyces are gram positive soil bacteria, and have long been recognized for their plethora of secondary 
metabolites, which have been one of the main driving forces for developing the Streptomycete genetics. It 
is a very diverse group spanning many habitats, and many Streptomycetes can be found possessing very 
unique abilities, further increasing interest in studying them, both for their potential products, but also 
their capabilities as heterologous hosts for these secondary metabolites. Not only are they capable of 
producing interesting secondary metabolites, by virtue of their saprophytic lifestyle, Streptomycetes are 
specialised in degrading macro cellular substrates, and therefore both capable of producing proteins with 
unique abilities but also secreting high amounts of proteins. Industrially actinomycetes have been used to 
produce many secondary metabolites, including antibiotics, and a number of industrially relevant, and a 
few pharmaceutical, proteins. Specifically Leucotropin™ by Cangene is produced using S. lividans as host 
(Brawner, 1994) (Binnie, et al., 1997) (van Wezel, et al., 2006). What makes S. lividans a promising host for 
heterologous protein production, compared to some other actinomycetes, aside from high secretion 
efficiency is the surprisingly low extracellular protease activity (Strickler, et al., 1992) (Anné, et al., 2012). In 
terms of genetics, S. lividans is also favoured, since it has become the model for heterologous protein 
studies of Streptomycetes due to a very relaxed restriction system, and the fact that it does not methylate 
its own DNA, easing transformation. The close relative S. coelicolor A3(2) is on the other hand a favoured in 
studies of genetics and regulation due to the coloured antibiotics it produces (Kieser, et al., 2000). The two 
strains are so genetically closely related that expression arrays from S. coelicolor A3(2) has been used for S. 
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lividans (Jayapal, et al., 2007), and in the comparative genomics investigation it was found that S. lividans 
differs from S. coelicolor mainly in laterally acquired genetic elements (Lewis, et al., 2010) (Jayapal, et al., 
2007). S. colicolor A3(2) has been full genome sequenced (Bentley, et al., 2002), and while several 
sequencing initiatives have been performed, an annotated full genome sequence is still lacking for S. 
lividans, though the Broad institute has the partial genomic sequence (draft) of S. lividans among several 
actinomycetes1. Genomic sequence can therefore be considered accessible, if not completely known.  A 
host of genetic tools are available (Kieser, et al., 2000) (Brawner, 1994) (Vrancken, et al., 2010), and 
detailed knowledge about the metabolism is being gathered (Hodgson, 2000). S. lividans only has a limited 
spectrum of secondary metabolites, and the before mentioned low exogenous protease activity, making it 
a good choice for heterologous expression (Jayapal, et al., 2007) (Kieser, et al., 2000) (Anné & Mellaert, 
1993) (Vrancken & Anné, 2009).  
Using Streptomyces as heterologous hosts have been considered many times over the last few decades 
(Brawner, 1994) (Hong, et al., 2003) (Vrancken & Anné, 2009), and in the cases of (Brawner, 1994) 
(Vrancken, et al., 2007) (Schaerlaekens, et al., 2001) (Mellaert, et al., 1998) among others, effort has been 
made developing the molecular and genetic tools for using Streptomyces as heterologous hosts. An 
example of a molecular genetic tool used for large scale manipulation of the genome is based on the use of 
PCR-targeted substrates flanked by short direct repeats. The target sequences are created from a Supercos-
1 library, and the gene can be deleted, in-frame, by a double cross-over event (Gust, et al., 2003). The 
method represents establishing the use of technology moved between different organisms, as both E. coli 
and S. cerevisiae methodology is applied to improve speed and efficiency of genetic manipulations in 
Streptomyces.  
Despite the present knowledge of metabolism, most of the know-how of fermentation in larger scales is 
kept with companies, and precious little has been published. Brawner and Binnie are affiliated with 
Cangene, a company that uses S. lividans as a production host, and they have published some papers. 
Otherwise, the knowledge of handling S. lividans has been presented by Van Wezel, and very recently 
D’Huys (van Wezel, et al., 2006) (D'Huys, et al., 2011) (D'Huys, et al., 2012). Anné published a review in 
2012 (Anné, et al., 2012), where he outlined the state of S. lividans, and some of the tasks that should be 
performed, in order to gain sufficient understanding of the S. lividans biology to introduce S. lividans as a 
general heterologous production host next to the classical hosts, E. coli and Bacillus. Most of the features in 
this review are concerned with physiological knowledge, Flux, Metabolomics, Proteomics etc., and 
molecular knowledge of the protein transport systems, SEC and TAT. 
Very little has been published on the use of S. lividans in chemostats (Rossa, et al., 2002), aside from some 
very thorough genetic stability studies in the 80’s and 90’s. Concerning heterologous proteins a few studies 
can be found, which are mainly studying alternative limitations, PO4, Mg
2+ and carbon catabolite repression, 
more on this in chapter 4. 
Outline of this thesis 
The aim of this thesis has been to investigate the physiology of heterologous protein producing strains of S. 
lividans. 
                                                          
1
 http://www.broadinstitute.org/annotation/genome/streptomyces_group/GenomeStats.html accessed 16-03-2013 
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Despite much knowledge on the subject of general metabolism, we would like to know more specifically 
what the impact is of various carbon and nitrogen sources are on S. lividans as production host for 
heterologous protein production.  
Further, I wish to study the physiology of S. lividans in liquid fermentation in different laboratory related 
scales and establish chemostats, where the impact of the growth rate on the production of heterologous 
proteins is being estimated. 
Lastly, based on the physiological studies, the next step is to expand the knowledge, both to develop a 
model of S. lividans, that can predict growth and product formation, and verify this model with 
fermentation data; as well as we wish to be able to sample biomass for advanced ‘omics analyses, that can 
help deepen our understanding of the intracellular reaction networks and regulation of S. lividans. 
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Chapter 3. Screening and growth 
of streptomycetes 
Setting up a strain as a cell factory requires a great deal of knowledge of the strain and ability to control it, 
in terms of both reproducibility as well as genetic manipulation. One of the most basal requirements for 
successfully using a strain as a cell factory is that it should be predictable in the production environment; 
which also requires reproducible kinetic parameters. 
Requirements for a cellular factory includes: 
 knowledge of the genomic sequence 
 access to genetic tools 
 knowledge about metabolism 
 knowledge about physiology across scales of production 
 know-how about scale-up 
 knowledge about regulation 
 the capacity to perform reproducibly, also related to kinetic parameters 
o growth rate 
o productivity 
o substrate uptake 
o lag-phase, and experiment duration 
Historically most studies have been concerned with cultivating Streptomycetes either for producing 
antibiotics, or in smaller scales, e.g. shake flasks or on plates for genetic studies. There are a number of 
studies that relate to using S. lividans for protein production specifically in larger scales, 10L and up 
(Fornwald, et al., 1993) (Sianidis, et al., 2006) and (van Wezel, et al., 2006). Many more studies are available 
for antibiotics, and while antibiotic production may seem unrelated to heterologous protein expression 
there can be beneficial developments in tools and know-how that can easily be transferred. Many tools, 
such as genetic manipulation, cosmid libraries (Wohlleben, et al., 2009), promoter characterisation for 
heterologous expression (Hopwood, 1999), transformation techniques including protoplast formation 
(Kieser, et al., 2000), and thorough fermentation experience has become available because of this interest 
(Fazeli, et al., 1995) (Ives & Bushell, 1997) (Kirk, et al., 2000). When one wants to apply knowledge gained 
from these studies to protein production applications, it must be kept in mind that secondary metabolism 
usually is triggered by using stress-inducing limitations of e.g. phosphate (Bruheim, et al., 2002), and the 
effect of the limitation must be considered. However, important insight into the primary metabolism may 
still be gained from publications on antibiotic production. 
Much molecular work has been done, and a number of genetic tools are available (Kieser, et al., 2000) 
(Vrancken, et al., 2010); more is still to come, which in term will become beneficial. General metabolic 
knowledge is available, and constantly being improved upon (Kieser, et al., 2000) (Hodgson, 2000). 
Genomic sequences are slowly being published (Omura, et al., 2001) (Bentley, et al., 2002) (Barbe, et al., 
2011) (Grubbs, et al., 2011). Industrial know-how is present, but available literature on the subject is 
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limited. Brawner and Binnie are directly affiliated with Cangene, a company utilising S. lividans for 
production, and have been publishing some of their results and methods; otherwise the vast majority of 
the literature is academic. What is lacking the most is a series of physiological studies that are required to 
properly investigate the effects of the developed tools, and the effect on the strain of producing the 
products. 
Streptomyces lividans, like all Streptomycetes, are recognised by their complex developmental and 
extracellular biology (Flärdh & Buttner, 2009) (Chater, et al., 2010). Even more interest has been due to 
their wide array of secondary metabolites, which is particular pronounced among the members of the 
Streptomyces genus (Ventura, et al., 2007). The core group of Actinomycete specialists at the John Innes 
Center have over the years assembled several guides on how to handle actinomycetes, and how to study 
their genetics. The first manual was published as a “Genetic Manipulation of Streptomyces: a laboratory 
manual” in 1985, followed by the first edition of the “Practical Streptomyces genetics”, published in the 
year 2000 (Kieser, et al., 2000). This guide serves as a very good starting point, and a lot can be learned 
about the specific Streptomycete biology, and a collection of general laboratory manuals are included. A 
good foundation in the biology is required when establishing a cell factory, which entails all levels of 
handling, from establishing a cell bank, developing inoculation- and sporulation procedures, establishing 
media compositions and sample procedures. Many of these, often time-consuming, parameters are often 
overlooked when comparing work between known and less well characterised strains. 
 Streptomyces are characterized by their very intricate growth cycle. Initially the spore germinates, and a 
small germ tube is formed. This is the initial mycelium, which extends to form vegetative hyphae and begins 
to branch. The vegetative hyphae have few septations, and possess multi copies of the genome. In liquid 
culture no aerial mycelium is formed, and very few strains have the capacity to sporulate submerged. On 
solid culture, the vegetative mycelium, also called the substrate mycelium, extends through the substrate, 
and when nutrients have been mostly expended, aerial hyphae are formed (multi nucleated, reproductive 
mycelium (Manteca, et al., 2010)). The aerial hyphae extend upwards, begins to curl, which occurs at the 
same time as separation of the chromosomes occur, followed by septation, formation of the thick spore 
cell wall, and finally the rodlet layer that mediates hydrophobicity to the spores (Claessen, et al., 2002), 
which remain attached in chains. While submerged culture does not result in sporulation, the secondary 
metabolism can still be triggered, and ample antibiotics produced (Kirk, et al., 2000) (Borodina, et al., 
2005). The filamentous mode of growth, may in liquid culture result in pellet or clump formation (Whitaker, 
1991), which can create morphological conditioned mass transfer problems. Depending on the product, or 
purpose of the experiment, the complex morphology can introduce heterogeneity in the culture, and 
complicate sampling and data analysis. Morphology is an area of study for the Streptomycetes (Whitaker, 
1991), as well as for filamentous fungi, and some knowledge transfer can take place despite that the 
filamentous fungi are eukaryotic. 
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Figure 4 - a reproduction of figure 1 from (Flärdh and Buttner 2009). The developmental stages in the growth cycle of S. 
coelicolor. In liquid media most Streptomycetes do not sporulate, and therefore do not form aerial hyphae. The formation of 
aerial hyphae is the beginning of a complex regulatory shift of metabolism, and the visible change was prompting much of the 
early genetic research, characterizing the bald genes (bld, no aerial hyphae), white genes (whi, no grey spore pigment 
formation). It is also during this phase that the various coloured antibiotics are produced. 
To handle Streptomyces in liquid culture and obtain dispersed biomass, the classical methods are, for shake 
flask cultivations, to add physical objects to the medium that can create turbulence to increase oxygen 
transfer, and improve morphology. Of physical objects to have been used, steel springs (Kieser, et al., 
2000), and glass beads, 20-30 beads per shake flask (Sohoni, et al., 2012) can be mentioned. In the larger 
scales, where physical objects would damage the bioreactor, the medium can be supplemented by 
additives, like surfactants, which have proven to improve morphology. Other measures to control 
morphology in the larger scales are possible, and inoculation concentration does have a significant 
influence on the process (Wang, et al., 2005), as does the physical parameters used in the bioreactor, 
including pH and stirrer speed (Celler, et al., 2012) (van Wezel, et al., 2006) (Wang, et al., 2005). Some 
additives however can be consumed by the host or complicate sampling by disturbing OD or DW, which is 
likely undesirable in minimal media in the academic setting, where the characterisation of the strain often 
is what is sought. Despite this, antifoam can hardly be avoided, since the impact of excessive foam, 
including the risk of contamination, loss of medium and biomass, and mixing related mass transfer 
problems, will likely have a deleterious effect on the experiment. Morphological engineering is not entirely 
trivial, as many parameters influence the process, including inoculation procedure and inoculum 
concentration; therefore to establish an efficient and reproducible method of working with Streptomycetes 
with regards to heterologous protein production, the basic methods have to be established; the work I 
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have done in this regard will be the focus of the following sections. Further on a comparison between the 
strains grown in batch, and lastly, an example of a screening method for testing the effect of different 
carbon sources on protein production will be presented. 
Establishing a propagation procedure 
Having generated a spore stock, the next step is determining a robust and reproducible way of generating 
an inoculum. In the following the establishing of an inoculation procedure is described, and while 
generating a spore stock will not be mentioned in detail, it has been part of the preparatory experiments, 
and is time consuming. For storage of the strains, as well as for the stock from which the cultures will be 
started, two options are available. One is using spores, thus letting the strain expend the nutrients 
available, and complete the life cycle, producing spores, which are generally quite robust, and inert; spores 
can survive several freeze-thaw cycles, as long as they have not started to germinate. Creating a spore stock 
is time consuming, and because the spores have to germinate before they will grow, it also increases the 
time of the separate experiments. The other option is storing cells harvested in mid-exponential growth; 
this option is necessary if working with strains without sporulation capacity, but can be used by most 
strains. For filamentous organisms, an extra step is included in the protocol of crushing the cells in a 
mortar, to obtain the most dispersed stock. A frozen mycelium stock is more sensitive to storage, and 
failure of the same, as well as with the increased amount of handling steps, there is an increased risk of 
contamination. The frozen stock can be directly used as inoculum, which shortens the overall process time, 
though with the risk of variability in viable cell count. All of the strains I have worked with retain 
sporulation capacity, and therefore I have used the spore stock. 
One of the first things necessary when using spores is ensuring that they germinate, preferably as 
synchronised as possible. Secondly, using a relatively uniform amount of viable cells, or germinated spores, 
will improve reproducibility of the experiments. Studies have shown that the initial concentration of cells or 
germinated spores in the bioreactor very much affects the physiology in the batch experiments; (Wang, et 
al., 2005) and (Papagianni, 2004) report that the inoculum concentration affects morphology, and 
morphology affects the amount of protease activity in the end of the experiment for Aspergillus spp. 
Therefore establishing a germination and inoculation procedure is necessary. Lynne Dobson suggests that a 
spore concentration of 1*107-9 spores/L gives smaller pellets; from 1*108 spores/L the major amount of the 
pellets is less than 0.5mm in size ( (Dobson, 2008), figure 3.7). (Whitaker, 1991) relays that for S. coelicolor 
antibiotic production only takes place at initial spore concentrations higher than 1*108 spores/L, and that in 
a range 3.7*107–8.7*108 spores/L the biomass yield is proportional to the spore concentration. I made a 
qualitative test on the length of the lag-phase using spore concentrations 1*106,7,8, and 9, and found that 
1*108 spores/L gave a short lag phase, and good growth. Pellets were visible at all concentrations tested, 
and the amount of the working stock required to obtain that spore concentration was balanced in terms of 
the concentration of the spore stock. The inoculum of 1*108 spores/L results in an initial OD600 
measurement of approx. 0.01-0.03.  Subsequently it was necessary to determine if a special germination 
medium is required, or if it is possible to inoculate with spores directly in the minimal medium. 
Germination 
In-house there is experience with filamentous fungi, which can be germinated in the minimal medium in 
the bioreactor, starting with a low pH and keeping stirrer speed and gas flow low, to prevent the 
hydrophobic spores from being bubbled out of the medium and causing wall growth. Germination methods 
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of Streptomyces spores, according to (Kieser, et al., 2000), include heat shock or nutrient dependent 
germination. Nutrient dependent germination should be understood as subjecting the spores to 
germination inducing nutrients, often found in rich media; in the following I used the nutrient method, 
germinating the spores in the rich 2YT medium for a specified amount of time before transferring them to 
the actual growth medium. 
To test whether it was possible to efficiently germinate the spores directly in a minimal medium, a 
comparison was performed in square deepwell microtiter plates, from EnzyScreen, with 3mL working 
volume, according to the method of (Sohoni, et al., 2012). The minimal medium ‘germination’ step (direct 
inoculation) was performed directly in the plates in the growth medium, setting the shaking table at a slow 
rotation speed (100 RPM with 20mm throw), for the same duration as the separate germination step in the 
rich medium. After the germination step, the directly inoculated plates were transferred to another shaker 
with the rotational speed turned up to growth conditions, 150 rpm with 50mm throw; the plate with the 
separately germinated spores was placed in the same shaker.  The separate germination step took place in 
50mL of the rich 2YT medium in shake flasks with 20-30 4mm glass beads. When the germination time had 
passed, the rich medium was transferred, without the glass beads, to 50mL Falcon tubes, and was 
centrifuged at 4000g for 8 min at room temperature. The supernatant was discarded, and the spores were 
resuspended in 5 mL sterile water, and all spores were added to the growth medium. Thereafter the 
growth medium was dispensed into the plate, which was then placed in the shaker at 30°C and 150 rpm 
with 50mm throw. The specific germination time used was 6 hours, as determined below. The spore 
concentration was obtained by using a specified amount of spore stock, which had previously had the spore 
concentration determined by CFU counting several dilutions. 
In Figure 5 the two compared conditions, i.e. direct inoculation, and separate germination in rich medium, 
are displayed. The microscopy pictures represent samples taken from the subsequent experiment in 
minimal medium. Samples from each culture were taken at T=17h and T=21h. From previous experience it 
was possible to verify growth after around 20 hours, as this would be the time when the experiments enter 
into exponential growth phase, and can be sampled regularly. At T=17h in Figure 4 it can be observed that 
the spores that were not separately germinated, i.e. directly placed in the minimal growth medium, have 
not germinated. No spores can be found that display a germtube, or vegetative hyphae, suggesting that the 
spores are still dormant. The spores that were separately germinated in the rich 2YT medium seem to have 
mostly germinated, and many vegetative hyphae are found, some have even started branching. 
At T=21h for the spores that were not separately germinated, still no vegetative hyphae are found, and no 
spores sprouting a germ tube were found in the screened samples. For the spores separately germinated in 
rich medium, clumps and highly branched vegetative hyphae can be found, showing normal growth.  
The test was performed on a total of three strains, just to rule out strain specificity, WT, XEG and mRFP; the 
protein producing strains mRFP and XEG are plasmid carrying WT-strains, thus chromosomally the same 
strain.  
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Figure 5 Microscopy pictures of the cultivation after either germination or direct inoculation, the pictures displayed are from the 
mRFP strain 
The experiment was further monitored as intermittent measurement of OD over the following two days 
(for a total of 6 samples from each culture), and the highest final OD was found to be 2.02 and 10.4 
respectively for the direct inoculated spores and the separately germinated spores of the mRFP strain. 
Despite attaining some growth, then the directly inoculated strains had a very long lag-phase, which is 
unfavourable, only few samples are available which made determination of growth rate difficult, though 
direct inoculation gave approx. 0,12h-1 and pre germination gave 0,17h-1. The mRFP strain was the only one 
that produced any growth in the direct inoculation. Neither the WT nor the XEG strain produced any 
growth without a separate germination step 
Germination time 
Having established that a separate germination step was required to ensure growth, a time course study 
was made in order to determine what duration was required to obtain the highest possible percentage of 
germinated spores, but the least amount of exponentially growing cells. This experiment set the precedent 
for how spores were handled in all subsequent experiments. 
Two strains were compared: the wild type (WT) and a xyloglucanase producing strain (XEG), since these 
seemed to be the most susceptible to the germination conditions, in the previous experiment.  
As can be seen in Figure 6, ten hours of germination, as the in-house SOP suggested for S. coelicolor, in a 
rich medium results in large multicellular aggregates, which means that a too developed stage has been 
reached. There is too much biomass growing already, and large visible pellets are observed. Hence, there is 
little hope that this biomass will form a dispersed mycelium during the ≈3-4 generations that will be the 
exponential growth phase (10-20 hours).  
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Figure 6 A time course development of germination of spores of S. lividans in 2YT medium. The pictures are of representative 
spores found in the medium. 
Going back through the time points, it can be seen that the germination is asynchronous across the culture, 
for both strains. As can be seen for the WT at 6 and 7 hours, some spores have just started developing into 
vegetative hyphae (T=7h), whereas some multicellular aggregates are already seen (T=7). At T=6h 
vegetative and branching hyphae can be found, though none of the samples screened contained large 
multicellular aggregates. It is likely that the large clump depicted at T=7 is a result of imperfect filtration of 
the original spore stock (see Sporestock heading in the Materials and methods section), since too many 
cells are present to have been formed within just 1-2 doubling times (an average growth rate between 0.1-
0.2h-1 would result in doubling times of 3.5-6.9h, which makes it impossible that the large clump can be 
resulting from a single germinated spore, or clump of spores). No such biomass clumps were found during 
the first time points, but each time point represents a separate sample from the shake flask, which 
introduces the possibility of not detecting the exponentially growing cells at the earliest possible time. 
6 hours is the latest time point where no large clumps are observed, albeit some growing and branching 
hyphae can be found. It is a trade-of between how long the spores require in the rich medium, before most 
have germinated, but not so long that they will be in exponential growth. The final decision was that 6 
hours seemed to be the right balance to not be able to find still un-germinated spores, nor a large number 
of exponentially growing cells. 
Growth experiments in batch 
Having established the basics for generating reproducible growth, the production capability of various 
strains had to be ascertained. The wild type (WT) was used as control, both to test endogenous cellulase 
and xyloglucanase activity, as well as to test if the cells were encumbered by producing heterologous 
proteins. The producing strains investigated are mRFP, XEG and CelA. All three strains expressed the 
product from the multicopy pIJ486 plasmid, harbouring a thiostrepton resistance marker. The mRFP strain 
produced a monomeric Red fluorescent protein, the XEG strain produced a xyloendoglucanase (Sianidis, et 
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al., 2006), and the CelA strain (CelA-19) produced a thermostable cellulase, and was provided by Olafur 
Friðjónsson, Matis, Iceland (Anné, et al., 2012). The initial experiments were performed in batch, and 
priorities were to determine the kinetic parameters: growth rate (µmax), biomass yield (Ysx) and rate of 
product formation (potentially yield of product as well). 
Initial characterisation 
The growth rate can both tell whether the strain was hampered by producing the protein, thus hinting at 
(severe) stress, and was also a necessary parameter for designing further experiments. Future 
investigations were to be made in chemostats, so a plausible range of dilution rates could be determined 
from µmax in batch. 
The batch experiments were performed in 1L lab-scale reactors, and the medium was a defined minimal 
medium, adapted from the medium described by Evans (Borodina, et al., 2005) (see Materials and Methods 
section). The reactors were inoculated with germinated spores, obtained by the method described in the 
previous section. Measurements were taken for analysis of extracellular metabolites (in this case substrate 
and product, i.e. glucose and the protein of interest, though later analysis of other metabolites would be 
possible), dry cell weight and OD was determined, and off gas was continually monitored for CO2 and O2. 
 
 
Figure 7 Growth rates determined on biomass concentration for comparing the WT and protein producing strains, µmax 
determined on CO2 
As can be seen in Figure 7, there was no significant difference in the maximum specific growth rate of the 
producing strains XEG and CelA and the non-producing wildtype strain. The mRFP strain grew significantly 
faster than any of the other strains, and produced a more dispersed morphology than any of the other 
strains, the WT included. For the wild type and the two cellulytic strains, clumps or pellets could be seen 
during growth in the defined minimal medium. When considering production, unexpectedly, the XEG strain 
did not produce any significant level of active enzyme.  
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Data for the XEG strain has been published (Sianidis, et al., 2006), and the strain was characterised as a high 
producer. The published final titer of product was 0.48 U/mL, with a maximal activity at pH 7.5 at ~50°C. In 
the present study AZCL-Xyloglucan from Megazyme was used for determination of xyloendoglucanase 
activity. No activity was observed in the fermentation samples. The assay was verified using a purchased 
standard enzyme (E-CELTR EGII from Trichoderma Reesei, from Megazyme) as positive control, and the 
procedure seemed to work satisfactorily in a wide concentration range of the enzyme; even when diluting 
the standard up to 16-20.000 fold, was it possible to get an activity reading, which in the best of cases 
corresponded to the endpoint readings, approximating 6.25*10-3U. To verify that the strain performance 
was not an artefact, or caused by plasmid loss in the working stock, a new vial of the strain was received 
from the Belgian lab (Lab of Jozef Anné, KU Leuven) that has constructed the strain and a new working 
stock was prepared. Yet, no discernible production was observed. The reason for this is still unknown, and 
it was decided to not include this strain in any of the further investigations beyond batch characterisation.  
The CelA strain was assayed to give activity of the cellulase utilising carboxymethyl cellulose, as per the 
standard defined by (Ghose, 1987). Since it is thermostable, and had a tentative optimum temperature 
around 90°C, and the thermostable standard enzyme (E-CELTM, from Thermogata maritima, from 
Megazyme) was characterised at 80°C, the assay was performed at 80°C). The units are based on the 
amount of released sugar in a set amount of time. Since the result of the assay is an enzyme activity, the 
measured activity cannot directly be related to a specific amount of protein, since activities are heavily 
dependent on temperature, but also influenced by among others metal ions in the medium. This 
unfortunately makes the comparison with the mRFP strain difficult, since mRFP can be compared to a 
standard protein, and a concentration can be obtained. It seems the mRFP strain may have picked up a 
beneficial mutation since it produces a more amenable morphology, and higher growth rate. Since both of 
the cellulytic strains have the same growth rate, but only one of them produces any discernible amount of 
active enzyme, then it can be suggested that there is agreement with the finding that the growth is not 
affected by protein overload in the cells. 
The yield of protein can only be determined for the mRFP strain, since it is the only one of the producing 
strains, for which the actual protein concentration in grams is available. The yield coefficient of product per 
substrate is 2,65 mg / g glucose, which essentially is without impact on the carbon balance. 
Using an amino acid as nitrogen source 
I was mostly interested in running the experiments in a defined minimal medium, since the future 
objectives were to run chemostats, and possibly perform a flux analysis of the producing vs. non-producing 
strains.  A minimal medium makes the flux analysis clearer to interpret, since no alternative carbon enters 
the cell, and the characterisation is greatly facilitated by using a defined medium composition. A further 
benefit in using a defined minimal medium is the general ability to interpret results is facilitated through 
simplifying the conditions, and thus allows gaining a deeper mechanistic understanding of the physiology 
and metabolic capabilities. We had reports from a collaboration partner that it gave higher growth and 
product titer when using glutamate as a nitrogen source instead of ammonium. The first assumption I made 
upon this report was that adding glutamate instead of ammonium would also supply extra carbon (5 
carbons per nitrogen); therefore the strain would essentially have the double amount of available carbon 
compared to our minimal medium. Though, it would be prudent to test this hypothesis, and therefore 
experiments were setup comparing the two media recipes side by side.To control the conditions to the 
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highest degree, and not depending on comparing the effects of a phosphate buffer (the MAN medium) with 
a MOPS buffer (DTU medium, in flasks or plates), the experiments were run in 1L labscale reactors at 30°C, 
with pH 6.8, controlled by addition of 2M NaOH or H2SO4, with 1VVM airflow and stirring was set to 600 
RPM. 
 
Figure 8 Estimating the effect on growth rate and product formation rate of supplementing the medium using glutamate, the 
growth rates are determined on CO2 – the blue bars are growth rate, the red bars are specific production rate measured in mg/(g 
DW*h) 
The strains are compared based on their growth rate determined from the CO2 data, which is presented in 
Figure 8. When comparing the mRFP strain on the two media, the average growth rate is a little higher 
when using the supplemented medium compared to the standard minimal medium, though the standard 
deviation makes it difficult to determine whether there actually is a difference. Product formation is greatly 
increased in the supplemented medium. Since it is the specific product formation rate, which is normalised 
against biomass concentration the extra carbon can likely not be attributed to the increased rate. For the 
WT strain, a more marked difference in growth rate is observed, favouring the supplementation of the 
medium, there is obviously no product formation in the WT strain. Further, the most striking difference was 
the shortening of the lag-phase, when using the supplemented medium. With equal inoculum, which would 
normally mean that the culture entered exponential phase after 20 hours in the minimal medium, then 
using the glutamate supplemented medium the exponential phase was reached after about 10-15 hours. 
The reason why the mRFP strain seems unaffected in terms of growth rate is not clear, but since it generally 
produces higher growth rates and better morphology, it has likely gained a beneficial mutation during the 
transformation, or selection of the original transformant. The trait has been present in all stocks of the 
strain used in this project.  
Influence of thiostrepton concentration 
An experiment was made in deepwell microtiter plates, using the method described by (Sohoni, et al., 
2012), where all the strains were grown with various levels of thiostrepton, to determine whether it was 
possible that the non-producing strain of XEG had lost the plasmid. A further verification was made in an 
SDS gel, to see if it was possible to detect a protein that could be inactive XEG, and to see if it was possible 
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to estimate the amount of CelA in grams, relative to mRFP. The levels of thiostrepton were 0 (blank) – 
25µg/mL. All strains were tested at all levels. It is mostly a qualitative test, since there is only a single end-
point sample from each well of the deepwell plate. 
The SDS verification was performed on the end-point samples, and no specific normalisation has been used, 
it is merely a screen, if it is possible to detect the cellulytic enzymes. As can be seen from Figure 9, there 
seems to be no product resembling XEG (~97 kDa). Despite knowing CelA is active, it is not clear which band 
in the lanes that could correspond to CelA (~25/28 kDa, depending on whether the vsi signal peptide is 
attached), which practically eliminates estimating the protein concentration of the CelA protein. The 
concentration would have been estimated by relative comparison to mRFP, of which the concentration is 
known from the mRFP assay. Finally the mRFP band is very visible (27 kDa); mRFP has been observed in 
titers up to 0.2 g/L, very close to the highest titer reported for any heterologous protein produced in S. 
lividans, though it seems that the sizes of the bands in the samples don’t fit too well to the ladder. Further, 
it seems that a higher concentration of thiostrepton results in neither higher nor lower productivity, and 
there were no obvious visible effects detectable, i.e. the strains seem not to be stressed by the higher 
concentration. Finally, in none of the lanes does there seem to be visible signs of protease activity, as there 
are no smears, supporting the expectation that the lacks of activity of the XEG protein is not a result of 
degradation. 
 
Figure 9 An SDS page gel comparing the effects of using glutamate as nitrogen source instead of ammonium, and varying levels 
of thiostrepton (marked in red letters in µg/mL) 
Only minor differences between the two conditions were observed. It may even be suggested that there 
seem to be fewer extracellular proteins in the glutamate supplemented broth (MAN), as compared to the 
defined minimal medium (DTU), though no normalisation on protein concentration or biomass has taken 
place. There is a band around 100 kDa in the XEG lanes in the MAN conditions, though still no activity was 
measured in the assay. There is a similar, but slightly smaller, band in the WT in the glutamate 
supplemented medium, owing to the suggestion that no XEG is produced. The plasmid can be expected to 
still be present, since the selection with thiostrepton seems functional, even at high concentrations of 
thiostrepton. 
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There seem to be no inducing effect of increasing the level of thiostrepton on any of the bands, and the 
missing activity of the XEG protein cannot be explained, though all samples have been frozen before being 
assayed, possibly the XEG protein was damaged in the freeze-thawing, in a more profound way than CelA, 
which retained activity, and mRFP that seemed not to be affected, since mRFP activity can be assayed, and 
remains relatively constant despite being subjected to several freeze-thaw cycles. Activity has not been 
tested before and after freezing, so some activity may have been lost. 
Conclusions on the batch experiments 
The protein producing strains were compared in batch, and the conclusion is that the XEG producing strain 
does not secrete active product, in neither the minimal nor the glutamate supplemented medium, and will 
therefore be left out of further studies. 
The CelA strain did produce a measurable amount of product, and suggests that S. lividans can be used as 
an expression host for thermostable proteins. The benefit of using glutamate was not characterised for the 
CelA strain, though a qualitative test in an SDS gel was performed, and no clear protein band was seen, 
making it difficult to assign a protein concentration for the product. 
The WT strain benefitted from having the medium supplemented by glutamate, in that the growth rate was 
improved by approx. 20%. 
The mRFP strain performs very well in both bioreactor and smaller scales, where it displays an improved 
morphology compared to the other strains. The specific reason is unknown. Using glutamate to supplement 
the medium does seem to have a marked effect on production rate, and it can therefore be suggested that 
further investigation should be made of the effect of other carbon / nitrogen sources in the next section, 
and chapter 4 respectively. 
Extending the range of carbon sources, functional genomics. 
Although Streptomyces lividans has been studied as a host for producing heterologous proteins for more 
than 20 years (Brawner, 1994) (Anné & Mellaert, 1993) little has been reported on physiology regarding 
products directly derived from primary metabolism. Therefore, the full potential of S. lividans as cell factory 
has not been explored. The literature is generally focused on developing the secondary metabolites and the 
physiology of their production. Although some themes are commonly applicable between primary and 
secondary matebolites; secondary metabolites are in nature generally produced as part of an ecological 
adaptive strategy (Bibb, 2005), and therefore as a response to some kind of stress or limitation e.g. 
phosphate (Bruheim, et al., 2002). 
While many various carbon and nitrogen sources have been tested, the aim has usually been to develop 
secondary metabolites. Though, in order to estimate the potential range of carbon sources that can be 
utilized as single C-sources a screen was performed using the commercial Biolog phenotype assays, plates 1 
and 2 (PM01 and PM02), carbon sources (Bochner, et al., 2001). This way 190 carbon sources can easily be 
screened for growth and product formation. The scale of the experiment is 100µL, thus expanding the 
number of tested carbon sources, though limiting the amount of quantitative data from each source. It is 
the classical trade-of between insights vs. scope, see Figure 10. 
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Figure 10 Showing the trade-of between the amount of data or insight that can be gained as opposed to the amount of 
conditions/strains that can be tested. 
The screen can be used to give an initial idea of how well a carbon source can be converted to biomass and 
product. Any findings from the Biolog scale will have to be verified in larger scale fermentations, since the 
Biolog screening system among other issues relies on natural polymers to reduce evaporation, and a 
quantitative analysis will substantiate any finding. The system can support a functional genomics approach, 
and does reduce the amount of conditions that needs to be tested in a larger scale. No complex sources are 
included in the plates since they have been designed to give a phenotype fingerprint (Bochner, et al., 2001), 
and thus inform very well on the capabilities of uses of single substrates. 
The experiment is handled in a liquid automation system, where frequent reading (sampling) can take 
place, and thus a large amount of growth and product formation data, including time-course 
developments, can easily be gathered. 
Carbon source screening 
Due to the many sample points, of the many parallel experiments, the data from the plate reader was 
handled in Matlab, and a simple time-course development of growth, and fluorescence respectively was 
produced. The raw output of the OD and RFP development over time is displayed in Figure 11 and Figure 
12, to illustrate the type and amount of data that had to be handled, but also to give an impression of 
which carbon sources are promising. Due to the size, the data for the PM02 plate are presented in appendix 
A. 
The axes of the plots are designed to be the same in all of the subplots, and the maximum limit on the Y-
axis was defined by the plot which reached the highest value, exactly therefore the plots can be directly 
compared. Some of the things that can readily be observed from the growth curves in Figure 11, is that 
besides some of the expected good carbon sources, like amino acids, and organic acids, the 3 Tween 
compounds (Tween 20, 40, and 80) are readily being consumed. It seems that the longer the Tween side 
chains, the higher is the output from metabolising the Tween compound. This is not surprising since 
compounds with the molecular formulas of Tween40 (C58H114O26) or Tween 80 (C64H124O26), contain high 
amounts of carbon, and compared to e.g. glucose, then even dilute concentrations of any of the Tween 
compounds will support both biomass and product formation to a higher degree than a similar 
concentration of glucose (C6H12O6). Interestingly, Tween is also used in preparation of spore stocks, which 
might be unfortunate, since such a rich carbon source could be expected to initiate germination. It is not 
something that I have been aware of before, and therefore I have not observed this, though it may very 
well explain the reason for keeping the spores on ice, as described by (Kieser, et al., 2000). 
Getting a comprehensive overview from the time course plots is complicated, because they are intricate 
compared to the amount of data that is provided, therefore, in order to reduce the presentation of the 
data, and produce a better overview, each curve is summed up as the area under the curve (AUC), whereby 
each carbon source becomes represented as a single pair of values (representing amount of growth and 
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fluorescence), as can be seen in Figure 13. This AUC can be considered to be a measure of the Ysx and Ysp 
respectively, since it represents the total amount of biomass/product obtained from the initial substrate, as 
well as it indirectly contains the growth rate, since a high growth rate would yield a high AUC, and a low 
growth rate a low AUC. A feature that is hard to discern from the AUC is whether a value is caused by e.g. a 
constant mediocre growth or a high growth after a longer lag-phase, which may result in the same value. 
An alternative would be to take the end-points, though this method also does not inform on the growth 
rate, and some of the cultures seem to have a drop in the OD in the end, which would reflect negatively in 
their standing. Further, the signal from the RFP reading is prone to noise, because of the low amounts of 
protein in the small volume, but this noise is better counteracted due to the summation. Finally I chose to 
use the AUC, due to the reduced impact of the noise, as well as it seemed to best represent growth 
capacity (final attainable OD) as well as rate (to some degree, despite being susceptible to lag-phase off-
set). 
As can be noted, the negative control in the top left corner (circled in red) has almost no growth (Figure 11) 
as expected, but a rather high production of RFP (Figure 12). This is both unexpected and quite 
unfortunate, since such a high amount of fluorescence in the negative control, would mean that production 
has taken place from a well that should contain no carbon. One of the problems this causes is that the 
obvious methods of normalising the experiment would be to subtract the negative control from all other 
well, after having normalised each well for their individual background measurements. First, the 
adjustment for the individual background readings is done by subtracting the initial measurement (time 
point zero) from each subsequent measurement in the related well. Hereafter the determination of the 
AUC takes place followed by subtracting the negative control in order to express the produced amount of 
biomass or product caused by the source in each respective well. This limits the reliability on the 
fluorescent data, and it would be advisable to verify not only all of the promising findings, but also include 
some of the mediocre and poor findings, to validate the experiment. The growth data seems to be 
unaffected by this curious result. I have had contact to other people who have expressed problems with 
obtaining growth in the negative control of the Biolog plates. 
Further, it is not possible to use one of the wells that show no growth, instead of the negative control, 
because while only a very slight growth is seen in the negative control, it can be assumed that any well with 
no growth may be caused by a carbon source which has an inhibitory effect on the cells. And a little growth 
can be expected, since the cells have been germinated in a rich medium, and would therefore have a slight 
amount of carryover of carbon from the rich medium, thus substantiating the claim that the sources 
producing no growth are actually inhibitory.  
The absolutely most positive aspect is to see how little the variance is between the two separate plates. In 
the vast majority of the wells, there is very good correlation between the replicates (The magenta and 
green lines represent the individual experiments, the blue line is the average between the two). There is a 
large number of high growth compounds, thus suggesting many useful carbon sources. The next step, 
where these plates support functional genomics, is to investigate which carbon sources produce any 
appreciable growth, and correlate these to, among others, (Hodgson, 2000), and map out active pathways. 
This can then be further combined with blast searching the draft genome, and thus a functional annotation 
can be made. The genomic and annotation work is outside of the scope of this thesis, though the results 
will be shortly discussed. 
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Unfortunately the RFP readings gave an unexpected high signal for the negative control, which means that 
there will be quite a number of C-sources that after calculating the AUC, and normalising the data, get a 
negative amount of product in Figure 13. I will accept this, while keeping in mind that a negative 
fluorescence is unlikely, but a result of removing the background and centring the data. It is necessary to 
normalise the data, i.e. divide every single AUC by the norm of the vector, because otherwise the values of 
the growth and fluorescence are of different orders of magnitude, and the distance measure used in the 
hierarchical clustering cannot take this into account. Further, the centring is required to ensure the 
mean=0, because the method used to determine the sources that perform remarkably well on either 
growth or production is finding those points that have higher values than 2* the standard deviation (2*σ); 
but this relates to the mean of the population, and therefore the values need to be higher than µ+2*σ, or 
simply centre the data, and select those points that have higher value than 2*σ. Regardless, the relative 
positions of all points will remain the same, despite the changing of magnitude and centring of the data. 
Subtracting the negative control, because it is done to each point in the entire population, is just a matter 
of shifting the baseline, which yields some negative results for production by some carbon sources. When 
considering the growth only a few C-sources produce a lower growth than the negative control, which may 
suggest an inhibitory effect of those C-sources. 
Hierarchical clustering 
After having summed up the areas, a hierarchical clustering is performed in order to investigate a possible 
grouping of compounds, in an unsupervised manner. The hierarchical clustering is performed by using the 
‘Euclidean’ distance measure, and in the agglomerative clustering using the ‘average’ metric. These are 
options for the built in function in Matlab, with the input being a matrix with the AUC of growth in one 
column, and AUC for production in the other column, together with a list of labels. First performing the 
clustering allowing 96 leafs, and from the dendrogram deciding that there was a natural division into 9 
groups.  
The scatterplots in Figure 13 displays the normalised, centred, and grouped AUC’s of growth and product 
formation. Group 1 (red) is the group termed ‘no-growth’. It is the group containing the negative control 
(marked with an ‘x’). It seems in PM01 that there is a bit of an artefact in the hierarchical clustering 
methods, since the group seems to be triangular in shape, and that causes some compounds, which have 
higher growth than the subsequent better growing group, to be included in the “no-growth” group. A 
different grouping could be obtained by changing the distance measure, possibly even choosing a K-means 
method, though as the method is used to get a preliminary overview of the compounds, and not for 
thorough statistical analyses, further effort will not be made. 
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Figure 13 The scatterplots representing PM01 (left) and PM02 (right). The colours are their grouping as determined by 
hierarchical clustering. Each point represents 1 carbon source (including the two negative controls, further marked with an X), 
and is the average value of the two separate replicates. 
It is interesting to note that in both plates from Figure 13 a pattern seems to suggest that when it comes to 
carbon sources, as opposed to nitrogen sources (in chapter 4), there is either a preference for growth OR 
product; no compounds are situated in the top right corner, and few are close to the axis from origo to the 
top right corner. This finding is somewhat surprising; since the product is expressed from a constitutive 
promoter thus a tight correlation between growth and production was expected. It could almost be 
insinuated that there is a slight tendency towards an inverted relationship between growth and product 
formation, as soon as some threshold is crossed. 
The carbon sources across the two plates that show the highest growth (those that have higher growth 
values than the 2*σ) are as follows: Gelatin, Laminarin, 2-Deoxy-D-Ribose, L-Histidine, Putrescine, D-
Mannose, D-GlucosaminicAcid, PyruvicAcid 
Gelatin is a degradation product of collagen, Laminarin is a glucan, 2-Deoxy-D-Ribose is a C5 
monosaccharide, L-Histidine is an amino acid, Putrscine is a degradation product of amino acids 
(polyamine), D-mannose is C6 mono saccharide, D-glucosaminic acid is related to chitin degradation, 
Pyruvic acid is a TCA intermediate.  
Laminarin has not been annotated (β-1,3-β-1,6-glucanase for coelicolor), though (Tamashiro, et al., 2012) 
seem to report that S. lividans has a xylanase with laminarin binding affinity. Chitin has been reported as 
substrates of S. lividans (Krištůfek, et al., 1999). Gelatin is hydrolysed protein, and since it can be used, it 
seems S. lividans does have extracellular proteolytic activity, which has been described for some strains, 
though regulation may control reduce the amount when other C-sources are present. Lysine and polyamine 
degredation happens via 2-ketoglutarate (Leitão, et al., 1999). 
Conclusions C- sources 
While the best C-sources are amino acids, and degradation products of polymers, mirroring the nature of S. 
lividans habitat it is interesting to note that none of the selected compounds are glucose, or glutamate, 
sources that were remarkably good in the nitrogen screen, as will be shown in chapter 4. It can be noted 
from Figure 13, glutamate has been grouped with the negative control, and glucose has been grouped with 
the slightly better growing, but not producing group (3). This is despite displaying promising growth, and for 
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glutamate, production in Figure 11 and Figure 12. The method is promising, but using the Biolog plates, the 
negative control is quite sensitive, which I have found that others have also remarked upon (Unpublished 
personal communications). 
Summing up 
One of the most significant things relevant to cultivating filamentous organisms, and specifically S. lividans, 
is that thorough attention must be paid to how inoculation takes place, to generate repeatable 
experiments. Many methods have been developed, and each group will have their preferred way of 
handling these organisms. But even if the method for inoculation is in place, the stock from which it takes 
place must be handled with care as well. One of the things that introduced the highest level of variability 
was the stock. It is difficult to say precisely what it was about the stock, but when inoculating to the same 
spore concentration across stocks, variability is observed in among other the growth rate. This obviously 
complicates matters, but it also suggests that sporulation is not completely understood, and regulation in 
terms of “morphological history” does have an effect in a way that is difficult to anticipate. 
For the batch experiments it was found that there seem to be no adverse effect on growth rate from 
producing any of the 4 heterologous proteins, despite that XEG seems to not be produced in its active form. 
It was not possible to find the protein concentration of CelA, though it was produced and active. mRFP is an 
excellent model protein, as production can be followed on-line or at-line, this model protein was found to 
be suited for the extended carbon screening. 
For the extended carbon screening the polymers seem to be performing best in relation to growth. There 
was a very high, and unexpected, production of mRFP in the negative control, with very little growth, which 
indicates that the experiments should be performed again, to ensure better use, and more clear 
conclusions. In a functional genomics perspective the method is valuable, though the experiment would 
benefit greatly from being re-run, so that productivity can be introduced as a selective criterion.  
Materials and methods 
Sporestock 
The spore stock was made, as described in (Kieser, et al., 2000), growing the spores for approximately 8-10 
days on mannitol-soy flour agar plates. The spores are ready to be harvested when the colonies (preferably 
dense lawn) have changed colour from white to a darker grey, and a noticeable geosmin scent is present. 
The colonies do not spread very far from where they start growing, as opposed to filamentous fungi where 
a triple stab will cover an entire plate with mycelium, so in order to get lawn growth, a high inoculation as 
well as dispersing with glass beads or Drigalski spatula is necessary. 
Harvesting of spores was performed according to the description of (Kieser, et al., 2000) using 0.1% Tween 
80 in 15mL water, per 15cm plate). The solution is rubbe thoroughly with a Drigalski spatula, and pipetted 
into a 50mL Falcon tube. The solution is agitated violently to disperse the spore chains. The solution is 
thereafter filtered through a 5mL tip with glass wool used as filter, to remove cells. Herafter is the solution 
centrifuged at 5000g for 10min at 4°C, and the supernatant discarded. The spores are resuspended with a 
known amount of water, depending on how many plates have been used, and an equal amount of 40% 
glycerol is added. The spores were stored in 210µL aliquots in 20%vol glycerol at -80°C. Of each strain a 
master stock has been made, which has been the progenitor of any successive working stocks. 
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Germination 
Germination was performed in 2YT medium, the composition of which can be found in (Kieser, et al., 2000), 
in g/L Yeast extract 16, Tryptone 10, NaCl 5. The germination was found to occur best 6 hours at 30°C, 150 
rpm in baffled shake flasks, with 30-40 4mm glass beads. After which the contents of the flask, without the 
glass beads, was transferred to a 50mL falcon tube and centrifuged for 10 minutes at 4000 g at room 
temperature, after which the supernatant was discarded, the cells re-suspended in water, and used for 
inoculation. 
Inoculation conc. 
For fermentation experiments a final concentration of spores in the liquid medium was 1*108 spores/L, 
giving an estimated start OD600≈0.01-0.03. The minimal medium does not have a relevant OD absorbtion. 
Medium composition 
For growth in liquid culture a defined/minimal medium was used containing in g/L:  NaH2PO4·H2O 
2.76,NH4Cl 5.35, KCl 0.75, Na2SO4 0.28, Citric acid·H2O 0.42, MgCl2.6H2O 0.25, CaCl2·2H2O 0.18, Trace metal 
sol 5 mL/L, Antifoam (sigma 204) 0.2 mL/L. After autoclavation vitamin solution (1 mL/L) and separately 
autoclaved glucose·H2O (20 g/L, giving 100 mM glucose) was added. – pH was maintained in reactor by 
addition of acid/base, and in the microtiter plates by addition of MOPS buffer (see subsection 
microtiterplates) 
Trace metal solution has the following compositions in g/L: FeCl3.6H2O 5.406, CuCl2.2H2O 1.705, ZnCl2 
6.815, MnCl2.4H2O 1.98, Na2MoO4.2H2O 0.00484, CoCl2.6H2O 4.76, and H3BO3 0.618. 
Vitamin solution g/L: Biotin 0.05, Ca-pantpthenate 1, nicotinic acid 1, myo-inositol 25, thiamine-HCl 1, 
pyridoxine-HCl 1, para-aminobenzoic acid 0.2. 
Thiostrepton was added to the medium to a final concentration of 5mg/L. 
The medium composition of the glutamate fortified medium (MAN) was, as received by our collaboration 
partner, in g/L: Glutamic acid 10, MgSO47H2O 0.6, Trace element 1mL. After autoclaving, separately add 
150 mL NaH2PO4/K2HPO4 buffer (0.1M, pH 6.8) and glucose 50mL 20% (=10g/L final konc) 
Trace elements fortified medium in g/L: ZnSO4.7H2O 1; FeSO4.7H2O 1; MnCl2.4H2O 1; CaCl2 anhydrous 1.  
Though vitamins were not specifically mentioned in the recipe, for comparison sake 1mL/L was added. 
Bioreactors 
Fermentation experiments were performed in Sartorius 1L bioreactors controlled by BioPAT towers. 
Temperature was 30°C, stirring 600 rpm with two 6-bladed rushton impellers, pH was kept at 6.8+/-0,1 by 
addition of either 2M NaOH or 2M H2SO4. Aeration was adjusted to 1VVM. Samples were taken for biomass 
dry weight, extra-cellular metabolites and mRFP analysis.  
Microtiter plates 
The microtiter experiments were based on the method described by (Sohoni, et al., 2012), with a 
temperature of 30°C, 150 rpm (with 50mm throw), in mircotiter plates by Enzyscreen (Enzyscreen.com, 
Netherlands). The plates are 24 square deep well plates, with a pyramid bottom, 5mL total volume per well 
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and 3 mL working volume. To each well six 3mm glass beads were added to increase gas transfer and 
improve morphology. To control pH 100mM of MOPS was added and pH was adjusted to 6.8. 
Sampling 
Dry weight sampling was performed by filtrating 5 mL (3 mL or pooling of two wells for microtiter plates) 
culture through a 0.45µm PES membrane (Sartorius Stedim, Germany) using a vacuum pump. The 
supernatant was collected and stored at -18°C for later analysis of glucose and mRFP concentrations. The 
dry weight filters were dried in a microwave oven before and after filtration for 20 min. at 150W – allowed 
to cool in a dessicator, and weight was noted before and after respectively. 
Concentration of glucose was analysed using a glucose dehydrogenase kit (ABX pentra Glucose HK CP, 
Hobira Montpellier, France). Off-gas was recorded using a Prima PRO Process Mass Spectrometer (Thermo 
Fisher Scientific). 
 mRFP concentration was obtained by measuring fluorescent activity in a Biotek plate reader, using 50µL 
culture, and an mCherry protein from Biovision as standard. For fluorescent measurement black-sided 96 
well plates from Greiner were used. The filters used in the Biotek reader were excitation 530/25nm and 
emission 595/35nm  
Enzymatic assays 
The CMC assay is performed as a measure of endo-b-1,4-glucanase activity, according to IUPAC guidelines, 
as published by (Ghose, 1987). The principle of the assay is the hydrolysis of CMC by endoglucanases, and 
subsequent detection of the liberated glucose by reducing sugar assay. 
Reagents 
Sodium citrate buffer 50mM 
Prepared from 1M Na-cit buffer  
 210 g citric acid monohydrate in 750 mL 
dH2O 
 NaOH solids, to adjust pH to 4,3 
 Adjust volume to 1 L with dH2O  
 Subsequent, use 50 mL 1M Na-cit buffer, fill 
to 1L dH2O and adjust to pH 4,8 
Note: Autoclave the 1M solution in smaller aliquots, 
as Na-Cit buffer is an excellent growth medium for 
fungi. 
2xDNS 
 1416 mL dH2O 
 21,2 g 3,5-dinitrosalicylic acid (CAS 609-99-
4) - Add and dissolve little at a time 
 19,8 g NaOH solids 
 306 g potassium sodium tartrate 
tetrahydrate (Rochelle salts CAS 6381-59-5) 
 8,3 g Disodiumsulfit (Na-metabisulfit CAS 
7681-57-4) 
 7,6 mL Phenol (Sigma P4682-100) add in 
fume hood. 
Filter solution and store at room temperature in 
dark bottles, as DNS reagent is light-sensitive. 
CMC 
Carboxymethylcellulose (P-CMC4M. Megazyme) 
2% (w/vol) in 50mM Na-Cit buffer pH 4,8 
Glucose standard 
A 10 g/L Stock is prepared, from which suitable 
standard solutions are prepared. The standards are 
to be produced in the range 0,5-4 g/L 
 
Remember to have one blank glucose, and one 
blank enzyme well 
The assay is performed in V-shaped 96 well PCR plates 
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 30 µL CMC is added to all wells except those for the standards. (Use a multichannel pipette – have 
patience, the substrate is highly viscous) 
 30 µL of enzyme (as the assay is dependent on obtaining the critical glucose release, it is suggested 
to make several dilutions of each sample) 
 Standards: 30 µL of glucose solutions are added to 30 µL 50mM Na-Cit buffer pH 4,8 
 The PCR plate was incubated for 30 min at assay temperature (50/90oC), using a silicone overlay, to 
prevent evaporation 
 Place PCR plate on ice, and add 60 µL 2xDNS reagent to all wells. 
 Incubate 5 min at 95oC, to allow DNS reagent to react. Place on ice. 
 Take 30 µL of reaction mix and transfer to 150 µL dH2O in a flat bottom microtiter plate. (Mix well, 
both when removing sample, and when diluting) 
 Read the plate at 550 nm using a microtiter plate reader. 
The enzyme E-CELTM, from Thermogata maritimus from Megazyme was used as thermostable standard for 
comparison to CelA-19. 
 
The AZCL-xyloglucan assay is based on the AZCL-Xyloglucan substrate from Megazyme. AZCL is azurine 
crosslinked substrate, which releases a blue color upon digestion. The substrate is insoluble in water, but 
will form gel pellets. Xeg activity was measured by following the hydrolysis of AZCL-xyloglucan. 900 µl 
substrate (0.2% AZCL-xyloglucan in 0.2M sodium phosphate buffer pH 6.0, 0.01%Triton-X-100) was 
preheated (50°C; 10 min) and then 100 µl of pure enzyme in 0.01% Triton-X-100 or 100µL of sample was 
added. After incubation (50°C; 30 min), the reaction was stopped by transferring the samples on ice. After 
centrifugation (1 min; 20,000×g) the supernatant was transferred to a micro titer plate and was measured 
at 595 nm in a Biotek MX plate reader. The protocol was adapted from (Sianidis 2005), temperature was 
raised, as no measureable activity was found at 30°C, and the enzyme has according to the source optimum 
at 50-55°C. Longer incubation has also been used. 
First Xeg1 xyloglucanase from B. licheniformis (Novozymes) was used as standard under the same reaction 
conditions; later E-CELTR EGII from Trichoderma Reesei, from Megazyme was used.  
Biolog experiments 
Screening in the Biolog plates was performed with the medium composition suggested by Biolog, which is a 
minimal medium, at pH7, assuming the sources in the plate does not affect the pH. All important elements, 
except for carbon are in the medium. The carbon sources in the plates PM01 and PM02 are as defined by 
Biolog, see Appendix B. 
The plates were incubated in a Cytomat 2 C450 (by Thermo Scientific) incubator, connected to a Hamilton 
(Microlab (ML) Star, with iSwap Landscape) liquid handling platform. Growth and RFP production was 
determined in a BioTek (Biotek SYNERGY MX "SMATBL" Monochromator based multi detection reader) 
plate reader with monochromator on the fluorescence part. Growth was monitored by following OD at 
600nm and RFP was determined by a fluorescence reading at excitation 543nm emission 595nm with a 
20nm slit-width. 
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The plates were incubated at 30°C and moved by the Hamilton robot to the plate reader every 2 hours for a 
total of 100 hours, and a final reading at 110 hours to ensure the cells had reached stationary phase. 
The data was handled in Matlab, as the level of automation eases processing. 46 measurements were 
recorded for each of the 96 wells, of absorption at 600 nm and fluorescence of RFP respectively.  
The data was arranged in matrices by well. Measurements of OD and fluorescence were placed in separate 
matrices. Initially each column was adjusted for any offset by subtracting the first data point. Following 
that, the area under the curve was estimated for each column, for OD and RFP respectively. This was to 
estimate the Ysp and Ysx, since the area under the curve signifies the accumulative amount of 
biomass/product obtained by the initial amount of carbon. 
To investigate any grouping present, an unsupervised method was used. The hierarchical clustering was 
performed as an agglomerative clustering by using the Euclidean distance measure, and then the ‘average’ 
method for linking the clusters, allowing 96 leaves, thus ending with only 1 C-source per leaf. 
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Abstract 
The medium composition has great effect on the production of heterologous protein in bioreactors. It is a 
parameter that can be adjusted regardless of GMO concerns or knowledge of genomic sequence. 
Actinomycetes are widely known for production of antibiotics, though as hosts for heterologous protein 
expression they show great potential which should be further developed. Streptomyces lividans is especially 
interesting due to low endogenous protease activity and the capability to secrete proteins to the medium. 
As saprophyte it also has the ability to use a diverse range of substrates including cellulose. Furthermore, a 
growing array of genetic tools has been developed, while annotation is expected to follow.  
Having used a strain of Streptomyces lividans that produced mRFP as a model protein a potential high 
throughput method was tested for optimizing medium composition. Focus was placed on selecting a 
nitrogen source to improve heterologous protein production. A large number of nitrogen sources were 
tested. The method had the great advantage that the initial steps had a high degree of automation, which 
allowed retaining a relatively high number of candidates. Further a substantial deal of physiological 
knowledge was gained about the S. lividans model strain with no published sequence. 
From 95 potential nitrogen sources, the seven best were selected for testing in milliliter scale, of these the 
3 best were chosen to be tested in 1L scale. The best N-sources seemed to retain their mutual performance 
across the scales, indicating the validity of this approach. 
 
Introduction 
Microbial cells have long been used as production hosts for both metabolites and proteins. Using microbes 
as production hosts is useful because of their high growth rate and, depending on the choice of host, 
straightforward biology (Zhang et al., 2010). Many compounds can be produced from an endogenous host, 
but typical limitations for production are stringent regulation or competing by-products. The former can 
result in low productivity, the latter in low yield and complicated purification of the wanted product. The 
possibilities of optimization are related to either genetic engineering, should knowledge of the genomic 
sequence be available, or else classical strain improvement and medium optimization schemes. 
54 
 
For protein production, as for other biological products, using endogenous hosts tends to result in low 
product yields. With heterologous hosts, the challenge lies in avoiding problems with folding, secretion, and 
product degradation in the extracellular medium. These are all problems to be addressed in each specific 
case, and have received much attention in literature (see e.g. (Mahmoud, 2007; Mattanovich, et al., 2012; 
Punt, et al., 2002). There are many available hosts for protein production, spanning all kingdoms of life. For 
bacteria, the most well-known are Escherichia coli and Bacillus subtilis. Among yeasts we find 
Saccharomyces cerevisiae and Picchia pastoris and among filamentous fungi, Aspergillus spp.  and 
Trichoderma spp. are well known industrial protein producers (Van Ooyen, et al., 2006; Morello, et al., 
2008; Westers, et el., 2004; Van den Homberg, et al. 1997; Macauley-Patrick, et al., 2005; Keränen & 
Penttilä, 1995). A parameter of high importance is product stability. It is widely recognized that proteases 
are of detriment to heterologous protein production. Typically filamentous fungi and bacilli with high 
specific productivities suffer from also having high protease production (Morello, et al. 2008; Vitikainen, et 
al. 2005; Van den Homberg, et al., 1997). Many solutions have been attempted, among others deletion of 
genes encoding extracellular proteases, with varying degrees of success. Even strains with several genes 
deleted tend to still have remaining protease activity (Punt, et al., 2008). 
Streptomyces lividans is a filamentous gram positive bacterium belonging to the order Actinomycetales. The 
actinomycetes are recognized to produce 60% of the known antibiotics (Kieser, et al., 2000). In this order 
several enzymes have been produced in large scale and thus can be considered industrially well known 
(Binnie, et al., 1997; van Wezel, et al., 2006; Brawner, 1994). Though, more knowledge is still needed 
before they can be considered general hosts. Their most prominent features are their excellent capability 
of secreting proteins to the medium and, especially for Streptomyces lividans, the low endogenous 
protease activity (Jain, et al., 2009; Vrancken & Anné, 2009; Strickler, et al., 1992). 
Whether using an endogenous or an engineered host; the strain will react to the environment experienced 
during the process, which will impact the outcome. Process parameters that may influence the productivity 
and yield include pH, aeration, agitation/stirring, temperature, and substrate availability. Optimizing these 
parameters can be very time consuming, since it is a multidimensional problem, with many of the 
parameters being to some degree interdependent. The classical approaches in process optimization regard 
media composition and feeding strategies. When addressing media composition, several aspects need to 
be considered. Complex carbon/nitrogen sources are cheaper, but result in higher batch-to-batch variation, 
as well as set higher demands on the product purification. If the product is therapeutic then regulatory 
affairs may become simpler using defined, salt-based media, and downstream processing will be eased. 
Further, depending on the product, the choice of a carbon/nitrogen source that best supply precursors for 
the product can be beneficial. For the production of heterologous proteins, the nitrogen source is 
particularly interesting (D’Huys, et al., 2011; Voelker & Altaba, 2011; Macauley-Patrick, et al., 2005; 
Hodgson, 2000). 
 We wished to investigate the effect of various nitrogen sources on growth and protein production in S. 
lividans and to find a systematic way of testing a large range of nitrogen sources efficiently. Hence, a 
fluorescent protein (mRFP) was chosen as a model protein as it can be easily detected, also on-line. 
Furthermore, we have taken advantage of the commercial BioLog system, a system that has been designed 
to phenotypically identify microbes based on their behaviour when subjected to various sources of carbon, 
nitrogen, phosphorous, sulphur, pH and osmolarity. One of the plates of the phenotype assays contains 95 
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different nitrogen sources (Bochner, et al., 2001), which allowed an initial screen, with a minimum input of 
manual labour. Hereby, both growth and product formation were detected over the course of the 
experiment (in 100µL scale) and then used to estimate the performance of the various compounds. Based 
on these estimations a subset of nitrogen sources were selected and experiments repeated in 3mL liquid 
microtiterplate cultures. The larger scale enables a more precise estimation of product formation, 
determination of possible by products, and determination of the yield of product on substrate. A much 
higher degree of physiological data can be gathered, while keeping the amount of manual labour per 
cultivation to a minimum. Moreover, improved mass transfer can also be achieved compared to the 100µL 
scale, resulting in better performance and reproducibility. Lastly, a smaller selection of N-sources was 
selected for verification in bio-reactor scale, i.e. 500-1000mL, where highly controlled conditions and on-
line off-gas analysis enables statistical verification of kinetic parameters and yields. The increased volume 
available also allows for an expanded set of analyses and hence, provides further physiological insight into 
the effect of different nitrogen sources on metabolism. 
Materials and Methods 
Strains and media 
The strain was Streptomyces lividans TK24, expressing mRFP from pIJ486 (Kieser, et al., 2000) plasmid 
bearing a thiostrepton resistance marker, as well as the sequence for mRFP behind the strong vsi promoter 
and signal peptide (Sianidis, et al. 2006; Pozidis, et al., 2001; Lammertyn, et al., 1997). The strain was kindly 
provided by the lab of Prof. Jozef Anné, Catholic University Leuven. The medium used for germination was 
2YT containing in g/L: Yeast extract 16, Tryptone 10 and NaCl 5 (Kieser, et al., 2000). Solid sporulation 
medium used was MS agar containing in g/L: Mannitol 20, Soy flour 20, agar 20 . Spore stocks were 
prepared according to (Kieser, et al., 2000), to give a final concentration of glycerol in the stock of 20%vol 
and spores were stored at -80 C until use. 
For growth in liquid culture a defined/minimal medium was used containing in g/L:  NaH2PO4·H2O 2.76, N-
source supplying 100mM nitrogen (weight  according to table 1), KCl 0.75, Na2SO4 0.28, Citric acid·H2O 0.42, 
MgCl2.6H2O 0.25, CaCl2·2H2O 0.18, Trace metal sol 5 mL/L, Antifoam (sigma 204) 0.2 mL/L. After 
autoclavation vitamin solution (1 mL/L) and separately autoclaved glucose·H2O (20 g/L, giving 100 mM 
glucose) was added. 
Trace metal solution has the following compositions in g/L: FeCl3.6H2O 5.406, CuCl2.2H2O 1.705, ZnCl2 
6.815, MnCl2.4H2O 1.98, Na2MoO4.2H2O 0.00484, CoCl2.6H2O 4.76, and H3BO3 0.618. 
Vitamin solution g/L: Biotin 0.05, Ca-pantpthenate 1, nicotinic acid 1, myo-inositol 25, thiamine-HCl 1, 
pyridoxine-HCl 1, para-aminobenzoic acid 0.2. 
Thiostreptone was added to the medium to a final concentration of 5mg/L. 
Biolog experiments 
The Biolog experiments were performed using the medium composition recommended by Biolog for 
Streptomyces spp. The working volume in the Biolog plates is 100µL in a semisolid medium containing a 
gelling agent to minimize evaporation. This experiment was based on the PM03 microbial phenotype plate, 
containing 95 different N-sources. 
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The plates were incubated in a Cytomat 2 C450 (by Thermos scientific) incubator, connected to a Hamilton 
(Microlab (ML) Star, with iSwap Landscape) liquid handling platform. Growth and RFP production was 
determined in a BioTek (Biotek SYNERGY MX "SMATBL" Monochromator based multi detection reader) 
plate reader with monochromator on the fluorescence part. Growth was monitored by following OD at 
600nm and RFP was determined by a fluorescence reading at excitation 543nm emission 595nm with a 
20nm slit-width. 
The plates were incubated at 30°C and moved by the Hamilton robot to the plate reader every 2 hours for a 
total of 100 hours, and a final reading at 110 hours to ensure the cells had reached stationary phase. 
Microtiter experiments 
The microtiter experiments were based on the method described by (Sohoni, et al., 2011), with a 
temperature of 30°C, 150 rpm (with 50mm throw), in mircotiter plates by Enzyscreen (Enzyscreen.com, 
Netherlands). The plates are 24 square deep well plates, with a pyramid bottom, 5mL total volume per well 
and 3 mL working volume. To each well six 3mm glass beads were added to increase gas transfer and 
improve morphology. To control pH 100mM of MOPS was added and pH was adjusted to 6.8. 
The culture was germinated in rich 2YT medium for 6 hours, in baffled shake flasks containing 20-30 4mm 
glass beads. The germination medium was inoculated with approx. 1*10^8 spores. At the end of 
germination phase, the liquid culture was centrifuged at 4000g for 10 min, the supernatant was discarded, 
the pellet was washed, centrifuged again, supernatant discarded, and the pellet resuspended in 5mL sterile 
water. 
A master medium was prepared containing everything but the nitrogen source. 90 mL of the master 
medium was transferred to 7 sterile flasks, to which 10 mL sterile nitrogen source was added to a 
concentration according to table 1. During the cultivation samples were taken at regular intervals. With 
each sample an entire well was harvested, and for the low biomass concentrations, two wells were pooled 
to obtain sufficient amount of biomass for dry weight analysis. 
 
Fermentation experiments 
Fermentation experiments were performed in Sartorius 1L bioreactors controlled by BioPAT towers. 
Temperature was 30°C, stirring 600 rpm with two 6-bladed rushton impellers, pH was kept at 6.8+/-0,1 by 
addition of either 2M NaOH or 2M H2SO4. Aeration was adjusted to 1VVM. Samples were taken for biomass 
dry weight, extra-cellular metabolites and mRFP analysis.  
Dry weight sampling was performed by filtrating 5 mL culture through a 0.45µm PES membrane (Sartorius 
Stedim, Germany) using a vacuum pump. The supernatant was collected and stored at -18°C for later 
analysis of glucose and mRFP concentrations. The dry weight filters were dried in a microwave oven before 
and after filtration for 20 min. at 150W – allowed to cool in a dessicator, and weight was noted before and 
after respectively. 
Concentration of glucose was analysed using a glucose dehydrogenase kit (ABX pentra Glucose HK CP, 
Hobira Montpellier, France). Off-gas was recorded using a Prima PRO Process Mass Spectrometer (Thermo 
Fisher Scientific). 
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 mRFP concentration was obtained by measuring fluorescent activity in a Biotek plate reader, using 50µL 
culture, and an mCherry protein from Biovision as standard. For fluorescent measurement black-sided 96 
well plates from Greiner were used. The filters used in the Biotek reader were excitation 530/25nm and 
emission 595/35nm  
Yield coefficients were calculated as the linear correlation between two components, in the exponential 
growth phase. The yield of product with regard to biomass, Yxp, is defined as the specific rate of product 
formation divided by the specific rate of biomass formation, which is the same as µmax during the 
exponential growth phase. This means that the specific rate of product formation (rp) can be calculated as 
Yxp (g/gDW)*µmax (h^-1) = rp in g/(gDW*h). 
Data handling 
 
The data was handled in Matlab, as the level of automation eases processing. 46 measurements were 
recorded for each of the 96 wells, of absorption at 600 nm and fluorescence of RFP respectively.  
The data was arranged in matrices by well. Measurements of OD and fluorescence were placed in separate 
matrices. Initially each column was adjusted for any offset by subtracting the first data point. Following 
that, the area under the curve was estimated for each column, for OD and RFP respectively. This was to 
estimate the Ysp and Ysx, since the area under the curve signifies the accumulative amount of 
biomass/product obtained by the initial amount of carbon. 
To investigate any grouping present, an unsupervised method was used. The hierarchical clustering was 
performed as an agglomerative clustering by using the Euclidean distance measure, and then the ‘average’ 
method for linking the clusters, allowing 96 leaves, thus ending with only 1 N-source per leaf. 
Results 
Initial Screening of 95 nitrogen sources 
Working in small volumes in an automated environment allows handling of many parallel experiments. 
Therefore, to facilitate screening of a large variety of nitrogen sources, a Streptomyces lividans strain 
expressing mRFP was cultivated on plates from the Biolog system and analysed using a standard plate 
reader. Biolog plates have been designed to give a phenotypical fingerprint, and thus span a wide range of 
nitrogen sources (95 different), selected to give optimal information on the biology of the organism 
(Bochner, et al., 2001). Using a standard plate reader coupled to a robotic system instead of the Omnilog 
system, delivered by Biolog, has the distinct advantage of being able to read not only optical density (OD), 
but also fluorescence (RFP), besides the automated handling of the plates. 
Development of OD and RFP over time was followed and used for selecting a subset of promising nitrogen 
sources. The criteria for selecting candidates were a high final product titer in addition to high growth. It 
may be argued that growth and production rates would be preferred selection criteria, though due to the 
RFP data being noisy at this scale, it was decided to first calculate rates in the subsequent, larger-scale steps 
where more sample volume is available. To reduce the complexity of the data, as well as to minimize the 
influence of the noise in the fluorescent data, in this first step all growth and production time course plots 
were converted to the area under the curve (AUC), resulting in 2 data points per nitrogen source. In order 
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to investigate a possible relation between nitrogen sources, the data was grouped using a hierarchical 
clustering routine, and then manually curated. The hierarchical clustering algorithm identified 8 clusters, 
based on the performance in relation to growth and product formation. The nitrogen sources included in 
each cluster are listed in table S1 (in supplementary materials). 
For further evaluation, the data was plotted as growth vs. production and the data points coloured 
according to the group association obtained by the hierarchical clustering (figure 1 –scatterplot-). As 
assumed a vast number of nitrogen sources performed unfavourably, as can be seen from the large number 
of data points grouping around the negative control, group 8 (light purple). For some nitrogen sources less 
growth than for the negative control was observed, indicating that these nitrogen sources are inhibitory. 
Nitrogen sources belonging to the groups 4 (dark green), 5 (light blue) and 6 (dark blue) favoured growth, 
at the expense of product formation. These groups displayed a fluorescence similar to that seen for 
nitrogen sources grouping with the negative control and therefore will not be regarded as possible 
candidates for further investigation. Likewise, some nitrogen sources seemed, despite disfavouring growth, 
to support high levels of fluorescence; one nitrogen source in this group (group 7, dark purple) showed less 
growth than the negative control and the other had a small amount of growth, though not more than that 
of group 8 (light purple), containing the negative control. The cause of the high fluorescence is unclear; 
however, it seems unlikely that high amounts of mRFP were produced by the low amount of biomass 
observed. Data for all wells were normalised according to the first measurement in the respective well, 
therefore the fluorescence should not be contributed to by the nitrogen source.  
It can be assumed that beneficial nitrogen sources would be found in the scatter plot (figure 1) along or 
above a diagonal line going through origo, but separating from group 8, containing the negative control. 
Using this criterion, we selected glutamate, aspartate, Ala-Gly peptide, allantoin, D-glutamic acid, histidine, 
L-pyroglutamic acid and nitrate as being the most promising nitrogen sources for further investigation. The 
chosen nitrogen sources belong to the groups 1 (red) + 2 (yellow) + 3 (light green) from the hierarchical 
clustering. As an alternative method to decide which nitrogen sources were interesting candidates, it was 
tested which nitrogen sources lie outside of the 95% region of the normal distribution. This was done 
testing whether each point was more than 2 times the standard deviation (2*σ) away from the mean. The 
test was independently performed on growth and fluorescence, respectively. The analysis summarised in 
figure 2 showed that 33 nitrogen sources were selected using growth as parameter; 10 nitrogen sources 
distinguished themselves on production. The 7 nitrogen sources chosen were those that distinguished 
themselves on both parameters, and the result of the test confirmed that nitrogen sources from groups 
1+2+3 were those that behaved significantly different from the average regarding growth and fluorescence 
and hence were interesting candidates for further investigation.  
Verification of physiological performance on selected nitrogen sources in 3-mL scale 
In order to gain increased physiological insight, as well as to verify the findings of the Biolog experiments, 3 
mL-scale submerged cultivations with 6 of the most promising nitrogen sources were performed, these 
were as mentioned above glutamate, aspartate, allantoin, histidine, L-pyroglutamic acid and nitrate. In 
addition, ammonium was included as it is the most commonly used nitrogen source and hence served as a 
reference. D-glutamate was deselected due to price, and the Ala-Gly peptide was considered too specific to 
be included. 
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This 3 mL scale enables biomass dry weight measurement, and thereby a more accurate calculation of the 
yield of g product per g DW of biomass (Yxp). Yxp is a value that enables comparison between different 
growth conditions because the rates have already been taken into account due to the definition of the 
yield, as described in materials and methods section. Further, with a larger sample volume available, the 
noise in the fluorescence data was greatly reduced, albeit the sampling frequency was lowered. All 
parameters were normalized to biomass concentration, ensuring optimal comparability between 
experiments. For medium composition, we have chosen a standard defined medium for actinomycetes, as 
described by (Borodina, et al. 2005). Further, to increase comparison between the conditions, we decided 
to keep the absolute level of glucose constant, as well as to normalize the nitrogen source to 100mN-mol/L. 
The total amount of carbon will hence vary between experiments, but this was considered to be more 
comparable, than varying the amount of nitrogen or glucose to maintain a fixed C:N ratio. 
Out of the 7 nitrogen sources tested, pyroglutamic acid and histidine did not support growth to a level 
where a growth rate could be calculated. Growth rates observed for the remaining 5 nitrogen sources 
ranged from 0.07 to 0.13 h-1, with the highest one estimated for glutamate closely followed by aspartate 
(figure -3 growth/product plot-). Ammonium and nitrate were almost indistinguishable, and the lowest 
growth rate was obtained for allantoin, around 60% of that observed for ammonium. 
In terms of productivity, the highest values were obtained for cultivations with glutamate or aspartate as 
nitrogen source, having specific productivities 4 times the level seen for cultivations with ammonium 
(figure 3). Nitrate and ammonium performed almost equally well and lastly for cultivations with allantoin 
the specific productivity was less than 50% of the productivity observed when ammonium was used as 
nitrogen source. 
As can also be seen in figure 3 the two predominant sources were still glutamate and aspartate in terms of 
both productivity and growth. The differences in growth rate between the amino acids and the inorganic N-
sources were less than 20% in favor of the amino acids, though there was a large difference in specific 
product formation rate in favor of the amino acids.  
The results when using ammonium as nitrogen source were similar to what we have experienced earlier. 
The same was true for the faster glutamate. Why ammonium was deselected in the automatic screen is 
unclear, since ammonium and nitrate seem to result in the same growth rate, and production (data not 
shown). 
In this milliliter scale liquid culture the undoubtedly best results were obtained using aspartate or 
glutamate as nitrogen sources. The inorganic sources were in the second best group, and allantoin is the 
only nitrogen source that can be considered ‘exotic’ that produced any appreciable growth, and at least in 
the screening produced enough product to be selected.  
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Detailed characterisation of growth and production on selected nitrogen sources  
To further investigate the findings, and gain a more comprehensive physiological insight, the 4 nitrogen 
sources aspartate, allantoin, nitrate, and ammonium (reference) were chosen for further characterization 
in bench-scale cultivations, glutamate had been left out since there was no relevant difference between 
glutamate and aspartate. In the bioreactors, the experimental conditions can be controlled to a much 
greater degree than what is possible in microtiter plates. The most crucial advantage is the on-line control 
of pH by addition of acid or base, as opposed to relying on a buffering system in the smaller scales. This is 
especially important in the comparison of the nitrogen sources, since it eliminates any concern of a pH 
related effect. Precise control of aeration, temperature and agitation is of further merit to the bioreactors, 
as well as the recording of off-gas data and dissolved oxygen. 
Typical cultivation profiles are presented in figure 4 showing the development of biomass, product 
formation, glucose consumption and accumulated CO2 over time for the selected nitrogen sources. From 
both the CO2 evolution rate and the biomass accumulation data it can be seen that with all nitrogen 
sources 2 growth phases occur. For ammonium and aspartate, the two experiments with the highest 
growth rates, there was a marked reduction in growth rate in the second growth phase caused by oxygen 
limitation, as verified by data from the DO-probe (data not shown). There was still carbon left, and a further 
increase in both biomass and product was seen. For ammonium and nitrate it is important to note that 
there is only one C-source whereas allantoin and aspartate both supply extra carbon besides nitrogen. This 
could be seen, as allantoin had 2/3’s of its glucose left, when a limitation, likely nitrogen, set in. For 
allantoin the growth was not as affected when the CO2 curve changed, but growth stopped, when glucose 
ran out, simultaneous with the onset of oxygen limitation (data not shown). 
Product formation is, because of the constitutive promoter used for mRFP expression, likely to be directly 
dependent on growth rate. As could be seen from the product profiles, product was produced 
simultaneously during growth. In the experiments using ammonium as N-source, glucose was not depleted 
until after the onset of oxygen limitation, and product was still formed though at a slower rate; just as for 
biomass formation. Even after depletion of glucose there was some growth, suggesting further degradation 
of primary metabolites. The same picture was seen for aspartate, though glucose seemed to be used after 
aspartate, since the reduction in concentration was offset in time, when compared to ammonium and 
nitrate 
As can be seen from the filled symbols in figure 3, the compounds sorted by growth from highest to lowest 
were aspartate, ammonium, allantoin and nitrate. The growth rates spanned the range: 0,11 – 0,19 h-1. 
Previous experiments in-house, but with a different medium composition, places glutamate in the same 
scale – around 0,2 h-1 (data not shown). For the bioreactor experiments nitrate as nitrogen source was 
located near allantoin, at 70% relative to ammonium. 
In terms of productivity the same picture was seen – aspartate as nitrogen source resulted in the highest 
production, followed by ammonium, allantoin and lastly nitrate. Aspartate has a 4 times higher specific 
product formation rate, relative to ammonium, and allantoin in terms of productivity performs similar to 
ammonium. Nitrate gave the lowest product formation rate. 
Using allantoin as nitrogen source resulted in higher growth and product formation rates  in the bioreactor 
experiments compared to the microtiter plate experiments; whereas nitrate as nitrogen source has 
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deteriorated on both accounts in the larger scale. In the bioreactors both productivity and growth were 
lower when using nitrate rather than allantoin as nitrogen source, the reason is unclear, but pH could be a 
factor. Aspartate kept its relative position to ammonium, and remained the fastest growing and highest 
producing of the tested nitrogen sources.  
This would suggest that aspartate was used as both nitrogen and carbon source in the beginning of the 
fermentation, and later glucose became the carbon source. Alternatively they could be co-metabolized, 
with glucose supplying glycolysis, and aspartate supplying TCA. For allantoin the reduction in production 
rate coincided with depletion of glucose, and oxygen limitation. Over all, nitrate had a longer lag-phase, 
and slower growth rate, therefore product titers were still so low, that the estimation of a yield was 
complicated.  
It was seen that ammonium, allantoin and aspartate retained their mutual positions/performances, across 
the three scales. Why nitrate changed so drastically between the milliliter and liter scale is yet unknown. 
Discussion 
We have successfully demonstrated a method for rational selection of nitrogen source.  As an initial screen 
the Biolog system is extremely useful, since it covers a wide array of nitrogen sources. A large dataset 
providing a great deal of physiological information, despite the minimal input of labour, is generated. 
Though, at such a small scale there is some uncertainty tied to the results, and for a production study the 
actual biomass concentration should be known. Therefore, as a basis for selecting a suitable nitrogen 
source for heterologous protein production, further experiments, using a subset of nitrogen sources, have 
to be performed in a larger scale. We chose to use a two-step procedure applying a 3mL and a 1L scale. The 
3 mL scale gives the required sample volume for making dry weight assessment, and thus it is possible to 
determine the specific growth rate, and the Yxp, from which the specific production rate can be deduced. 
In the larger scales we define the medium composition, and can therefore choose the exact premises for 
the comparison. For the 1L scale, not only is there more sample volume available, but the amount of data 
that can be collected also increases significantly. Depending on the probes available, on-line monitoring of 
pH, dissolved oxygen, redox potential and optical density is possible, likewise is the recording of the off-gas 
that allows measuring CO2, O2, and other volatiles, such as ethanol and methanol. 
All of the nitrogen sources in the screen were defined. In terms of industrial relevance, it would have been 
prudent to add some complex nitrogen sources, such as corn steep liquor. However, an important aim of 
the present study was to gain a physiological understanding of the impact of the nitrogen source on protein 
production. The fact that it is very challenging, if not impossible, to obtain a detailed, quantitative 
understanding of metabolism when using complex substrates, led us to leave these types of substrates out 
in favor of interpretability of the data. 
Nitrogen source groups 
Examining the scatterplot (Figure 1), the 7 selected compounds are located in the top right part of the plot. 
As stated in the results section there are a total of 33 sources selected on growth alone, though many of 
these compounds did not show an appreciable amount of production. This is very interesting, since the 
product is expressed from a constitutive promoter from a plasmid, and as such a close growth-production 
relationship would be expected. Why this is not the case is so far unknown. The findings of the selection 
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process are summarized as a Venn diagram in figure 2. The groups, as they are found in figure 2 will be 
discussed in the following sections, as will the observations presented in the Venn diagram 
High performing nitrogen sources 
The amino acids that produced the highest amount of growth and product, across all three scales were 
glutamate, and aspartate. These two amino acids performed remarkably well compared, not only to other 
amino acids but also, to the entire group of nitrogen sources. Why are these two so efficient? The reason 
may be that they enter directly into the TCA cycle when being metabolized. Aspartate is converted to 
oxaloacetate and glutamate via a transamination step; glutamate is together with NAD(P)+ converted to 
alpha-ketoglutarate + NAD(P)H + NH3 + H
+ (Hodgson, 2000; Voelker & Altaba, 2001; D’Huys, et al., 2012). A 
follow up question is then why Alanine was not represented among the high performing nitrogen sources. 
Alanine likewise enters directly into TCA, but at the pyruvate node. Alanine is formed by condensation of 
pyruvate with ammonium which uses reducing power, the catabolism is via the same reactions though in 
reverse; the responsible enzyme is alanine dehydrogenase (ADH) (Hodgson, 2000). Alanine enters TCA at 
the pyruvate node, and was expected to perform better – though the cost of reduction power by the ADH 
enzyme could be speculated to be the cause of the lower performance. It may therefore be either transport 
related, or it could be hypothesized that carbon from the pyruvate node could feed upwards in 
glycolysis/gluconeogenesis, and thus create a reduction imbalance, or it may be the cost of reduction 
power in the uptake that causes alanine to underperform. 
Nitrogen sources giving growth but no product 
Alanine, that was discussed above, is grouped with those nitrogen sources that supported growth, but did 
not yield a sufficient amount of product to be selected. Another amino acid in this group is Glutamine, 
which as sole nitrogen source performed less well than glutamate; likewise did asparagine perform less 
well than aspartate. Glutamine is directly interconvertible with glutamate requiring water, and releasing 
NH3. Considering the fact that the compounds were added as nitrogen sources, it could be speculated that 
glutamine and asparagine should be the more promising candidates, supplying 2 nitrogen molecules, as 
opposed to 1 from glutamate and aspartate. More so when comparing the amount of carbon each of the 
compounds contain relative to nitrogen. The reason why glutamine and asparagine were performing less 
well is yet to be determined; it could be related to uptake, or it could be the cost of reducing power, in the 
hydrolysis of the first ammonium. pH is unlike as the cause, since the pKa’s of all of the amino acids indicate 
no one of them should carry an unintended charge. A further observation that could be made was that 
glutamate performed better than aspartate, and glutamine performed better than asparagine – glutamate 
and glutamine are both C-5 compounds, whereas asparagine and aspartate are C-4. The difference in 
amount of growth and product that was achieved from these very similar compounds may be related to 
this extra carbon atom, giving the C-5 compounds a slight advantage over the C-4 compounds. 
Further amino acids that were found in this group were: Cysteine, Glycine, Homoserine, Lysine and Serine, 
together with all of the peptides except for Ala-Gly. It is interesting that this group is so vast, since product 
formation should be expected to be closely correlated to growth, due to the product being expressed from 
a plasmid harboring a constitutive promoter. For cysteine, little has been reported on uptake and 
metabolization, but in Bacillus spp. it is metabolized via methionine (Burguière, et al., 2004).  
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D-Glutamate was also found in this group. D-glutamate is directly interconvertible with glutamate, using a 
racemase EC 5.1.1.3, for a non-energy requiring reaction, thus it shouldn’t be expected that there would be 
a marked difference between L- and D-glutamate, though according to results from BRENDA deprotonation 
may be the rate limiting step, and thus slowing the further conversion of L-glutamate. There could also be a 
limitation in transport into the cells. 
For quite a few of the amino acids, only little has been published, and it is not easy determining when a 
homologue can be expected. For Glycine nothing has been reported (Hodgson, 2000), though a 
decarboxylating dehydrogenase (from the glycine cleavage system) has been found on the genome of S. 
coelicolor (Bentley, et al., 2002), indicating that glycine can be used. Lysine is metabolised via cadavarine, 
(Hodgson, 2000), though it has been reported that S. lividans makes poor use of lysine as sole N-source 
(Madden, et al., 1996). Serine utilization is doubtful, the relatives S. aureofaciens, S. rimosus (Parada, 1981) 
and S. clavuligerus do not utilize serine as sole N-source (Hodgson, 2000). 
A number of the sources that are located in the group with low-to-no production but a notable amount of 
growth are in the literature those that result in poor or no growth as single nitrogen sources in S. lividans or 
relative strains. This contradictive finding may be related to the nature of the Biolog plates, as opposed to 
the liquid cultures used in literature. 
No growth – no production 
Most of the amino acids are located in the “no-growth-no-production group”. When relating our results to 
what is known for streptomycetes, there is generally agreement. There are though some discrepancies; and 
some of our findings have not been published before. All of these sources produced too little growth and 
product to be worth investigating further in the scope of the paper. All of the sources marked with a star (*) 
are according to (Hodgson, 2000) not considered useful as sole nitrogen sources, and therefore show 
agreement to our results 
The amino acids in this group are Methionine, Arginine, Phenylalanine *, Leucine*, Threonine*, 
Tryptophan*,Tyrosine*, Valine*, Isoleucine* and Proline (capable as metabolite in S. coelicolor) (Hodgson, 
2000), as well as Ornithine and Citrulline.  Voelker had a supporting observation, that branched chain 
amino acids, leucine, isoleucine and valine did not support growth when used as sole nitrogen sources 
(Voelker & Altaba, 2011). 
The sources present in this group that are not in agreement with (Hodgson, 2000), are: Threonine, which it 
should be possible that Streptomyces could de-aminate, and thus use. Proline can be metabolized by S. 
coelicolor, and would be expected to be used by S. lividans, though in this case we did not see growth, in 
either replicate. Tryptophan can be degraded, but, by most streptomycetes, not completely which results in 
accumulation of anthranilate and formyl-anthranilate. So while growth is possible, only a small amount can 
be expected when using either of the shikimate amino acids as sole nitrogen source. Little or nothing has 
been published on the degradation of methionine, and (Hodgson, 2000) mentions only one strain that can 
use methionine. For arginine, S. coelicolor can use this as single nitrogen source, and a GOGAT mutant 
created by random mutagenesis could not. S. lividans could grow on asparagine and alanine; therefore we 
can exclude the possibility that GOGAT is damaged, but there is still no apparent reason why arginine 
should not be used as sole nitrogen source. 
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Overall for the observations made in the Biolog plates, it is necessary to verify these findings in a more 
controlled medium. Especially the pH is difficult to control, and there is no verification what the pH actually 
is in the wells, so many of the discrepancies may be caused by pH related effects. 
Scale up of experiments 
In the scale-up to the 3 mL scale, some nitrogen sources did not result in the expected amount of growth. 2 
of the initially selected nitrogen sources, pyroglutamic acid and histidine, did not support growth in the 
larger scale, according to literature, some Streptomycetes should be capable of growing on histidine – 
however only a very slight growth was observed, which halted at very low biomass titers. The reason for 
the halted growth has not been found, despite Hodgsons reports that S. coelicolor is capable of growth on 
histidine (Hodgson, 2000; Kendrick & Wheelis, 1982). 
Pyroglutamic acid, or 5-oxoproline is being degraded in glutathione metabolism, to glutamate, and can 
from here enter glutamate metabolism, or together with L-cysteine re-enter glutathione metabolism. The 
gene for 5-oxoprolinase (ATP-hydrolysing) [EC:3.5.2.9] is annotated in Streptmyces avermilitis, but 
apparently not in S. coelicolor, which in turn may mean that S. lividans also will not have it. There is a 
putative protein (ORF: SCO0627) in S. coelicolor that has some similarity to other known 5-oxoprolinases, 
and does contain signatures of an ATP binding cassette. Considering the lacking growth in a defined 
medium, may mean that the selection in the initial screen could have been an artifact. Further study, 
outside the scope of this paper, will be needed if it is to be verified whether either S. coelicolor or lividans 
possess the 5-oxoprolinase, and is indeed capable of metabolizing L-pyroglutamic acid. Allantoin as well as 
uric acid is degraded as part of the purine metabolism. In fact, uric acid is degraded to allantoin, and the 
final products in the pathway are ammonium and CO2, via urea most likely, when looking at the KEGG 
annotations for S. coelicolor. However uric acid was not among the nitrogen sources that were selected, 
whether this is a transport matter or pH related effect is unknown. 
Another compound that made the first round of selection, but was disregarded, was the Ala-Gly peptide. It 
is interesting to note that it solely of the peptides seems to perform well enough to be selected. It even 
outperforms its monomeric amino acids. Possibly this could be a benefit from a synergistic effect, as all 
peptides in this plate contain either Ala or Gly. All peptides scored med-high on growth, but not production. 
An option for speculation is that glycine by itself may enter gluconeogenesis, with glycine moving upwards 
in the glycolysis. Glycine, in conjunction with alanine, may on the other hand be forced into the TCA cycle, 
and therefore perform better. Whether it is the synergy of 2 favoured amino acids, a coincidence of a 
peptidase recognition sequence or an unbalanced amount of carbon that causes this peptide to score so 
well does remain unknown. 
From previous experiments in large scale ammonium chloride and glutamate have been compared, and 
both perform well, and very similar to what was seen in these experiments. Ammonium has in some cases 
been reported to be a poor N-source resulting in a low growth rate, unlike our experience (Madden, et al., 
1996). Using Nitrate though, results in high level of excretion of organic acids, pyruvate and 2-oxoglutarate 
(Madden, et al., 1996; Lee, et al., 1997), which can mostly be re-assimilated, but does it does affect growth. 
In general ammonium is considered the best N-source for streptomycetes, followed by amino acids, and 
lastly nitrate. 
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Medium composition 
The Biolog system is a commercial system, and the medium composition is proprietary, though similar to 
what is reported by (Bochner, et al., 2001). Further it seems as though the gelling agent may be 
metabolised, it is not defined what is being used, but in a patent they claim to use alginate, carrageenan 
and gellan gum (Bochner & Ralha, 1997), all sources that can be metabolised. To increase the comparability 
of our experiments, we have chosen to keep the amount of glucose and the total N-molarity of the nitrogen 
source fixed. The result is varying the total amount of carbon, but keeping the media as equal as possible, 
also across the scales, 3 mL – 1 L. 
A balanced medium composition can be obtained where no unwanted limitation occurs; it is though 
difficult when comparing many chemically different N-sources. Some of the N-sources contain large 
amounts of carbon, in relation to the amount of nitrogen. The amino acids, glutamate and aspartate have a 
5:1 and 4:1 C:N ratio respectively. That means that comparing these with ammonium and nitrate, which 
contain one nitrogen and no carbon per molecule, does give the amino acids an advantage, since they have 
more available carbon. Having chosen a smaller subset of nitrogen sources, the next likely study would be 
to compare those, under conditions where the C:N ratio is kept constant. This may be done by either 
adding a further N-source, so as to balance the amount of carbon supplied by the N-source, or by accepting 
that the final amount of glucose will change between the experiments. 
Final remarks 
The general application of choosing a number of nitrogen sources to screen for increased production, with 
RFP as a model protein yielded not only a number of candidates showing good productivity, but by virtue of 
using the Biolog system yielded an astounding amount of physiological information. Coupling these findings 
to larger volumes, and more defined parameters confirmed the mutual growth/productivity pattern, as in 
the small volumes. The screening principle demonstrated fitness, and has the potential to be taken further 
to a more automated selection. A possible further step could be to find good combinations of 
carbon/nitrogen sources, or even complete media compositions based on such a screening. 
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Figure 1  Scatterplot-Plot of Area under curve (AUC) values of growth and fluorescence, averaged between two plates, colored 
according to the groupings obtained by hierarchical clustering 
 Figure 2  A venn diagram displaying how many N-sources  were selected by growth, fluorescence  or both 
Figure 3 Growth rate versus specific production rate for the 3-mL scale and reactor experiments. Histidine and pyroglutamic acid 
did not support growth at and are left out. The filled symbols are from the reactor experiments, the hollow are from the 
microtiter. Diamond is Allantoin, square is ammonium, triangle is aspartate, circle is nitrate, the bar is glutamate, and only 
represented in the microtiter scale. All growth rates, and production rates are relative to ammonium, therefore the hollow 
square is on top of the filled square in (1,1) 
Figure 4a,b,c,d  - Representations of fermentation time profiles for (a) ammonium, (b) aspartate, (c) allantoin and (d) nitrate. 
Biomass measured in (g/L) is marked by green triangles, glucose measured in (g/L) is marked purple crosses, mRFP measured in 
(g/L) is marked with blue stars (for nitrate, the concentration of mRFP has been multiplied by 10), CO2 measured in volume % is 
marked by the blue line. 
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Table 1 Amount of nitrogen source, to supply 100mM N 
N-source g/L 
Ammonia 5.35 
Sodium nitrate 8.49 
L-AsparticAcid 13.31 
L-GlutamicAcid 18.71 
L-Histidine 6.99 
D-GlutamicAcid 14.71 
L-PyroglutamicAcid 12.91 
Allantoin 3.95 
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Figure 1 - Scatterplot 
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Figure 2 – Venn diagram 
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Figure 3 
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Figure 4a
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Figure 4b 
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Figure 4c
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Figure 4d
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Chapter 5. Chemostats 
Fermentation 
As a term fermentation historically refers to the anaerobic conversion of substrates by microorganisms. 
With time the meaning, when considering the process, has changed to encompass any kind of controlled 
cultivation of microorganisms; aerobic and anaerobic alike. Many products are produced through 
fermentation, and more recently, many industrial products, including solvents that can be polymerised to 
plastics have become part of the repertoire. The most basic type of fermentation is the batch process, 
which in the very simplest of cases literally is putting substrates in a pot, waiting a bit (to gather wild 
microorganisms), then sealing the pot; a method that has been used in beer brewing since the middle ages. 
Industrially less reliance is placed on luck, and a thorough sterilisation scheme is used, as well as 
monoseptic inoculation. Batch fermentations are characterised by having a high concentration of 
substrates, and through most of the process a low concentration of biomass, making the process 
susceptible to effects like catabolite repression (both carbon and nitrogen), as well as resulting in a low final 
titer of the product. Batch processes have been used in chapters 3 and 4 to test the initial performance of 
S. lividans as heterologous host, and impact of nitrogen source on heterologous protein production. Due to 
catabolite repression the fed batch was invented, as it was discovered that by slow addition of sugar to a 
fermentation of Penicillium chrysogenum, penicillin could be produced without being limited by carbon 
catabolite repression. After the initial batch, the growth rate in a Fed-batch is controlled by the feeding 
rate, depending on the scheme chosen. The schemes available are exponential, linear, and constant. The 
exponential profile is chosen to extend the exponential growth phase, though this method is severely 
limited by mass transfer issues, both of medium addition, but also oxygen supply etc. The linear profile, 
which is technically much simpler than the exponential, limits the growth rate to a linear profile, but allows 
continuous development of biomass under non catabolite repressing conditions. Lastly, the constant profile 
is akin to the continuous culture, except for the dynamic volume. Industrially all types of processes are 
used, including a repeated-fed-batch, which is run as a fed-batch, mostly emptied, and fed again in a semi-
continuous manner. Lastly, the continuous process is a setup that requires the continuous addition and 
removal of medium. Many specific subtypes of continuous cultures have been developed each with their 
specific purposes; some seek to push dilution rates as high or higher than µmax (Hoskisson & Hobbs, 2005), 
among these are the retentiostat, where biomass is separated from the waste stream and fed back into the 
reactor (Bull, 2010), allowing D>µmax. In other cases very low dilution rates are of interest, in the literature 
doubling times of more than 700 h have been reported for continuous cultures of Saccharomyces cerevisiae 
(Boender, et al., 2009). Other examples are the auxostat types of continuous culture, where an external 
parameter is used to control the feed addition rate, e.g. pH or optical density (OD) (Bull, 2010). There are 
also the serially linked processes to impose different limitations in each step, e.g. serially lower and lower 
growth rate. In the following I will limit myself to the chemostat, which is characterised by a fixed volume, 
and constant concentrations in time, at steady state. 
Chemostat 
The continuous culture, in our case more specifically the chemostat is advantageous when examining the 
conditions that lead to optimal productivity, and they have been used as such since the sixties. One of the 
preconditions, and major benefits, of the chemostat is that the growth rate of the organism is limited by a 
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single substrate, all other substrates are in excess, and this allows the precise control of the growth rate of 
the organism (Hoskisson & Hobbs, 2005). Chemostats can be used for studies of genetic stability, strain 
evolution, physiology, and regulatory mechanisms. Further with the advent of systems biology tools and 
‘omics’ technologies, the chemostat can be used to reliably, repeatedly, and reproducibly generate biomass 
for advanced ‘omics’ analyses under different conditions (Bull, 2010). One thing that is important to keep in 
mind is that while the chemostat was originally designed to study cultures at steady state as defined by 
Monod, it also offered the unprecedented opportunity to study accelerated evolution, as the very high 
selective pressure in the chemostat causes forced adaptation (Ferenci, 2006). Limiting a single nutrient 
does cause a starvation response, and it can be argued whether a chemostat is ever in an actual steady 
state, since the residual nutrient concentration will continue to decrease over time (Ferenci, 2006). The 
usefulness of the chemostat in generating controlled repeatable experiments is so pronounced that 
accepting a ‘quasi’ steady state with the proper precautions, considering the before mentioned potential 
side effects when studying e.g. the metabolome, transcriptome or proteome, still warrants its use  
(Hoskisson & Hobbs, 2006).  
The general chemostat setup physically differs from a batch reactor in that feed is constantly added, and 
spent medium, containing cells for most processes, is constantly removed. The way in which a chemostat 
differs from a continuous culture, or can be considered as a specific sub-type of continuous cultures, is that 
the chemostat has no time dependent developments, at steady state. In reality mutations are prone to 
occur, and could give a subpopulation an advantage that will allow it to take over the culture  (Ferenci, 
2006) (Hoskisson & Hobbs, 2005) (Hoskisson & Hobbs, 2006) (Bull, 2010); the selective advantages in a 
chemostat would likely relate to substrate specificity.  
 
 
Figure 14 A depiction of a general chemostat setup. What is special about the chemostat, compared to other types of continuous 
culture, is that the volume (V) is constant, and at steady state all concentrations are constant. For V to be constant, 
Flowin=Flowout. The concentration of the limiting substrate in the Flowout=0.  
 
For the setup of the experiment it is required to choose one limiting substrate, typical choices are carbon, 
nitrogen or phosphorous, as exemplified by glucose, ammonium or phosphate respectively; though any 
medium component, as long as it is growth rate limiting, can be used. The experiment is started as a normal 
  Feed 
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batch, to build up biomass concentration. When a sufficient biomass concentration has been reached, and 
the limiting nutrient is almost expended, the pumps can be started for exchanging the medium. In batch 
the cells will grow at their, for the given conditions, maximal growth rate (µmax). In a chemostat, the 
constant exchange of medium is intended to cause the convergence of a steady state. In essence the 
growth rate of the organism is being controlled by controlling the flow rate of fresh medium addition. This 
medium has the single nutrient limitation, and therefore excess of all other nutrient components. When a 
steady state is achieved, all parameters are constant in time. The relation between growth and substrate 
can be given by the Monod equation: 
       
  
     
 
Cs is the substrate concentration, µ the growth rate, µmax the maximal growth rate, determined in the 
batch, and Ks is the substrate specificity, or half velocity constant, found as the substrate concentration 
when µ=½*µmax. The change in biomass over time in any continuous process can be defined as: 
  
  
                
D is the dilution rate xin is biomass going in with the feed, for a chemostat this value is 0, xout is the biomass sampled 
from the out flow (equal to the concentration in the vessel). Since the change in biomass with time at steady state is 0, 
the result is: 
               ⇔      
  
 
 
 
F is flow rate in, and V is the liquid volume in the vessel. Since the definition of the chemostat requires the 
volume to be fixed, then it is clear that the growth rate µ, is equal to D, the dilution rate, and that it is 
controlled as a function of the flow rate. 
 
Previous studies with filamentous bacteria 
Studies in chemostats can besides physiological characterisation and determining the optimal growth 
productivity relation (Fazeli, et al., 1995) also be used to estimate physiological factors, such as genetic 
stability and investigate regulation of various limitations. The environment in a chemostat is as mentioned 
before highly selective, and depending on the type of limitation, mutations are prone to arise, or plasmids 
can be lost. One study of genetic stability of S. lividans in a chemostat was performed by Roth in 1985 
(Roth, et al., 1985), where the cultivation lasted for more than 100 generations. This study showed that 
apparently carbon and phosphate limitation impose the strongest selective pressure on S. lividans, as 
independent of growth rate, these conditions caused plasmid loss faster than observed for nitrogen 
limitation. The growth rate (D in the range 0.1-0.2h-1) seemed to only have a limited impact on plasmid loss, 
but temperature had a more pronounced impact; temperatures of 28°C and 36°C, with the higher 
temperature causing the loss.  
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Most available physiological studies of production in Streptomycetes are related to antibiotics. Although 
some features can be learnt from these, they generally require a nutrient limitation imposed on the 
organism, which induces secondary metabolism, in order promote antibiotic production. Phosphate has 
been reported as the nutrient of choice to limit if the desire is to produce antibiotics (Bushell, et al., 2006). 
This seems reasonable since phosphate is required to be incorporated in the cell wall, and that the 
environment in the soil is reported to be phosphate and nitrogen limited (Hodgson, 2000).  In Table 2 the 
studies are referenced where S. lividans has been cultivated in a continuous culture. The list may not be 
perfectly exhaustive, though it represents the studies that could be found, as well as their purpose. 
Table 2 A list of papers where chemostats or continuous cultures are used with Streptomyces lividans. 
Name Limitation Pupose 
(Roth, et al., 1985) C/N/P Genetic stability 
(Noack, et al., 1988) N Basic physiology – Mutant 
selection / Heterologous protein 
(Undisz & Noack, 1993) C Genetic stability 
(Lee & Lee, 1994) C Genetic stability / heterologous 
protein production 
(Parro, et al., 1998) Mg / PO4 Phosphate limitation on 
heterologous protein (CCR?) 
(Isiegas, et al., 1999) P Glucose repression? 
Heterologous protein 
(Wang, et al., 1998) Complex Heterologous protein 
(Sarrà, et al., 1998) P Antibiotic 
(Rossa, et al., 2002) P Flux – antibiotics 
 
Having determined that the literature on S. lividans as a heterologous host is broad, but contains few 
physiological studies, the next step is to shed some light on this area of S. lividans physiology. What is 
sought in this physiological study, is investigating the connection between growth rate and productivity, as 
well as study how S. lividans performs as a producer of heterologous proteins.  
Physiological studies 
In batch it is possible to investigate the highest possible growth rate (µmax), and by extension the highest 
Yxp (yield of product on biomass). Many products are not directly growth related, or in the case of 
secondary metabolism, have an inverse relationship between productivity and growth. In the chemostat it 
can be investigated how the connection is between growth and productivity (Fazeli, et al., 1995), as well as 
comparing strains under exactly the same conditions, even growth rate, since µ=D, which is the 
fundamental basis of the chemostat. There is a limit to the range of growth rates that can readily be used in 
a chemostat, the Dcrit is the upper limit of flow rate that can be used, since anything beyond this causes 
washout, or requires change of the experimental setup to a retentiostat.  
Carbon is a common limitation to impose for heterologous protein production; the benefits include limiting 
the risk of activating secondary metabolism and limiting the effect of catabolite repression. Carbon is 
straightforward to limit, since it is among the most abundant elements in the biomass. If the medium is of 
the defined minimal type, then there should only be one carbon source. Whereas it is possible to limit 
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some of the less common nutrients and minerals, it makes higher requirements for buying of chemicals; 
e.g. magnesium limited chemostats (Parro, et al., 1998) and (Utkilen, 1982). Some of these nutrients can be 
growth limiting, albeit they are required at low concentrations. The experiment by (Utkilen, 1982) found 
that in batch, µmax was reached with addition of 5µM magnesium, thus at this concentration the limitation 
was overcome.  
Strains and media 
The strain used was Streptomyces lividans TK24. All proteins, mRFP and CelA are expressed from the 
plasmid pIJ486 (Kieser, et al., 2000), which is a multicopy plasmid bearing a Thiostrepton resistance marker, 
as well as the sequence for the protein behind the strong vsi promoter and signal peptide of the 
Streptomyces venezuelae subtilisin inhibitor (Sianidis, et al., 2006). The CelA-19 strain (will be referred to as 
Cel-A) was kindly supplied by Olafur Friðjónsson (Anné, et al., 2012). The mRFP strain was kindly provided 
by the lab of Prof. Jozef Anné, Catholic University Leuven. The medium used for germination was 2YT 
containing in g/L Yeast extract 16, Tryptone 10 and NaCl 5 (Kieser 2000). Solid sporulation medium is MS 
agar containing in g/L Mannitol 20, Soy flour 20, agar 20. Spore stocks were prepared according to (Kieser, 
et al., 2000), in a final concentration of glycerol of 20%vol. 
For growth in liquid culture a defined/minimal medium was used containing in g/L NaH2PO4·H2O 2.76, 
NH4Cl 5.35, KCl 0.75, Na2SO4 0.28, Citric acid·H2O 0.42, MgCl2·6H2O 0.25, CaCl2·2H2O 0.18, Trace metal sol 5 
mL/L, Antifoam (sigma 204) 0.2 mL/L Adjust volume 0.9 L. After autoclavation add Vitamin 1 mL/L and 
separately autoclaved Glucose·H2O 20 – giving 100 mM glucose. The medium composition is adapted from 
Evans (Borodina, et al., 2005) 
Trace metal solution has the following compositions in g/L: FeCl3·6H2O 5.406, CuCl2·2H2O 1.705, ZnCl2 
6.815, MnCl2·4H2O 1.98, Na2MoO4·2H2O 0.00484, CoCl2·6H2O 4.76, and H3BO3 0.618. 
Vitamin solution g/L: Biotin 0.05, Ca-pantpthenate 1, nicotinic acid 1, myo-inositol 25, thiamine-HCl 1, 
pyridoxine-HCl 1, para-aminobenzoic acid 0.2. 
Thiostreptone was added to the medium to a final concentration of (5mg/L) 
Fermentation experiments 
 
Two fermentation setups have been used: 
1) Sartorius 1L bioreactors controlled by BioPAT towers. Temperature was 30°C, stirring 600 rpm with 
two 6-bladed rushton impellers; pH was kept at 6.8+/-0.1 by addition of either 2M NaOH or 2M 
H2SO4. Aeration was adjusted to 1VVM. Off-gas was recorded using a Prima PRO Process Mass 
Spectrometer (Thermo Fisher Scientific), capable of measuring ethanol, methanol, O2, CO2, 
Nitrogen, Argon etc, and autocalibrating regularly. 
a. Chemostats where run using gravimetric feed control connected to an analog controlled 
Watson-Marlow pump. Level control was weight based, using the digitally controlled “anti-
foam” pump on the BioPAT tower 
2) Applikon 1L reactors, with two 6-bladed Rushton impellers. Stirring was set to 600 rpm, pH was 
adjusted to 6.8+/-0.1 by addition of either 2M NaOH or 2M HCl. The pH controller was capable only 
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of controlling two channels, thus one per fermentor. Aeration was set to 1 VVM, using a mass-flow 
controller. Temperature was adjusted to 28°C using an open water bath with manual temperature 
control. DO was measured using a Mettler-Toledo unit. Off gas was measure using a Brüel & Kjær 
acoustic gas analyser, capable of measuring CO2 and O2. The setup is presented in Figure 15. 
a. Chemostats where run using constant feed on a manually calibrated Watson-Marlow 
pump. Level control was weight based, using a digitally controlled Watson-Marlow pump. 
The feed bottle was standing on a scale, where weight was manually noted at regular 
intervals, to verify the feed rate. 
 
Figure 15 A picture of the Applikon setup of chemostats. The picture is added for historical purposes. 
 
Samples were taken for biomass dry weight, extra-cellular metabolites and enzymatic activity analyses.  
Dry weight sampling was performed by filtrating 5 mL culture through a 0.45µm PES membrane (Sartorius 
Stedim, Germany) using a vacuum pump. The supernatant was collected and stored at -18°C for later 
analysis of glucose and mRFP concentrations. The dry weight filters were dried in a microwave oven before 
and after filtration for 20 min. at 150W – allowed to cool in a dessicator, and weight was noted before and 
after respectively. 
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Glucose is measured using a glucose dehydrogenase kit (ABX pentra Glucose HK CP, Hobira Montpellier, 
France). 
mRFP concentration is obtained by measuring fluorescent activity in a Biotek plate reader, using 50µL 
culture, and an mCherry protein from Biovision as standard. For fluorescent measurement black-sided 96 
well plates from Greiner are used. The filters used in the Biotek reader are excitation 530/25nm and 
emission 595/35nm 
Results 
The strains investigated are the WT and the mRFP producing strain. First step is to determine whether it is 
possible to establish a steady state, because Streptomyces as mentioned grows filamentous, which can 
cause large heterogeneity and oscillations of the culture. Morphologically it can be quite challenging, since 
part of the population of cells can grow as pellets (as the wild type does), which can cause mass transfer 
limitations. Even if establishing something that resembles a stable condition, the absolute stability from a 
steady state can be eluding, e.g. due to plasmid loss, or variance in mass transfer (see (Sarrà, et al., 1998)). 
To enable chemostat cultivations a single limiting nutrient has to be chosen to fit the desired experiment. 
Few have reported chemostats at all in S. lividans, most are not C-limited, but rather phosphate or nitrogen 
limited, and interested in studying other aspects of physiology, among others antibiotic production.  
 
 
Figure 16 Establishing a steady state 
As can be seen from Figure 16 a steady production of CO2 can be initiated from almost the time when the 
feed is added. The continuous culture depicted in Figure 16 is run in the setup showed in the picture in 
Figure 15. The setup was somewhat more rudimentary than what was later installed, though for all intents 
and purposes it worked admirably. As can be seen from Figure 16 the WT strain adjusted to a steady state, 
after 3-5 residence times. It started by growing in large dense pellets, but as the growth was limited by the 
feed, the morphology opened up, and the strain started growing freely dispersed. The mRFP strain on the 
other hand, was growing freely dispersed throughout the cultivation. It changed colour, and became blue, 
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
-5 0 5 10
g 
D
W
 
%
 C
O
2
 
Time RT 
WT
RFP
WT DW
mRFP DW
Pump speed  
WT 30,52 mL/h D=0,05 
RFP 20,66 mL/h D=0,035 
85 
 
due to actinorhodin production. After the change it did not maintain biomass concentration or obtain a 
new steady state, within the timeframe of the experiments. As can also be seen from Figure 16, the dilution 
rates are 0.05h-1 and 0.035h-1 for the WT and mRFP strain respectively. The aim was to obtain a D in the 
scale of 0.04-0.05h-1, as this was half the µmax of the very initial experiments; choosing half of µmax allows for 
room for error in estimation of µmax, and in operating the equipment. The duration of each experiment in 
Figure 16 is equally long, but because of the lower dilution rate of the mRFP strain, the amount of residence 
times were less. It also seems that for the mRFP strain it was the very low dilution rate that resulted in 
starving of the cells and caused the onset of the secondary metabolism; there is no other indication from 
the data that any other perturbation took place. This sets the lower limit for running a chemostat 
somewhere between D=0.035h-1 and D=0.05h-1, assuming the primary purpose is to avoid secondary 
metabolism, and secondly to investigate heterologous protein production. Having a protein that is 
expressed from a plasmid using a constitutive promoter does not exclude production of protein 
concurrently with the secondary metabolism, though a major shift of the metabolism would suggest that 
less carbon would be expected to be directed towards protein production, as well as when antibiotics are 
produced there are more stringent requirements for waste disposal. 
With an unsuccessful run of the mRFP strain, a higher dilution rate was attempted. This next experiment 
was performed in the newer reactor setup with the Sartorius reactors. This means that the level and the 
feed control both are gravimetric, in contrast to the older setup where the feed was constant, based on 
precalibrating the pump together with the tubing and later verifying the rate by noting the weight change 
of the feed bottle manually. This makes the newer system less labour intensive   
The benefits of using a classical pre-calibrated system is that it is quite stable, though it will tend to drift 
slightly over time, as the tubing gets worn in the peristaltic pump. The main con is that it is very labour 
intensive setting up. The gravimetric feed pump is not susceptible to air bubbles and the PID will set the 
pump speed based on the feed weight, which prevents drifts in dilution rate over time. Unfortunately my 
experience is that it takes longer to reach a stable pump speed, since the PID has a tendency to start at max 
pumping speed, and the gradually reduce the speed, which causes pulsing addition in the early part of the 
experiment. The gravimetric system, while precise, is more susceptible to fluctuations, and risky if using a 
shared lab. Very importantly, when using a gravimetric system all wires and tubing should be fixed as 
efficiently as possible, since even small changes in how the tubing drags, or lies on the table, can affect the 
final volume of the weight based system, as well as the dilution rate. 
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Figure 17 Testing if it is possible to establish a steady state in a chemostat at D=0.08h
-1
 
 
In Figure 17 an experiment is presented, with only the mRFP strain, this time with a dilution rate d=0.08h-1. 
The experiment has been performed in the newer Sartorius bioreactors, coupled to the BioPAT towers. It 
can be seen that the adaptation phase is somewhat longer, but a steady state is found, and maintained. 
Surprisingly almost 6 residence times were needed to obtain a steady state, once this was attained though, 
the system was very stable. It seems the long adaptation was caused by beginning of the feeding phase too 
soon, which resulted in the culture not having enough biomass to quickly adapt, and thereby extending the 
time in rapid growth. For comparison, when running yeast in chemostat, it is conventional practice to start 
the feed after CO2 drops, just after the exponential phase when glucose is expended; if however this 
method was followed for the Streptomyces strains we used, it was observed that secondary metabolism 
was initiated, and a stable steady state was not obtained. Therefore we found that it was necessary to 
observe the residual glucose concentration by regularly sampling using a glucose stick, usually used to test 
for glucose in urine of diabetes patients. The stick has a maximum limit of 1000 mg/dL = 10 g/L – where it is 
dark green, and then with different graduations towards “normal” which is less than 500 mg/L. Once less 
than 1 g/L is left the pumps can safely be started. 
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WT batch @10x 
 
mRFP batch @40x 
 
WT t=193h @40x 
 
mRFP t=193h @40x 
 
Figure 18 Microscopy pictures of chemostat experiments, WT on the left, and the mRFP producing strain  on the rigth. The two 
upper pictures are from the batch phase, and the two lower pictures are from the steady state. 
In Figure 18 microscopy pictures from the chemostat experiment are presented, and it was observed that 
the WT strain, which grew pelleted in batch, started to loosen up in its morphology and eventually became 
freely dispersed. The pellets of the WT strain can become quite large, and as can be seen the microscopy 
pictures below, the pellets are very dense. The RFP strain on the other hand grows freely dispersed all the 
way. 
Investigating the productivity in chemostats 
Having determined that it was possible to establish a steady state, the relationship between growth and 
productivity was to be explored. For doing this, three dilution rates were chosen: D= 0.04, 0.08 and 0.12h-1. 
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Figure 19 rp vs D – specific rate of productivity plotted against D - the square is the batch results plottet to extend the range to 
include µ_max 
 
Figure 20 Ysx vs D – yield of biomass on substrate plotted against D, the square is the batch results plottet to extend the range to 
include µ_max 
As can be seen in Figure 19 there is a relationship between growth and productivity that resembles 
linearity. This is expected, as the product is transcribed from a constitutive promoter on a plasmid, and as 
long as cellular machinery is not saturated, the correlation should be linear. It is not obvious why D=0,04 h-1 
and D=0.08h-1 separate so little in terms of productivity. When including the productivity data from the 
batch (red square), the results suggest that there is room for further optimization of production, since there 
seem to be no excessive burden of production on the strain, and it seems D=0.08h-1 should have had a 
higher rp. Using the data presented in Figure 20, the yield of biomass on substrate in relation to D, it can 
indeed be suggested, that it is the D=0.08h-1 that underperforms, in relation to productivity. The Ysx of 
D=0.08h-1 is at batch level, indicating a partial loss of plasmid. 
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Discussion 
In order to relate our results to those of the previously performed studies, the elements of these will be 
discussed shortly below. From Table 2 it was seen that most of the previous studies performed on S. 
lividans, relating to continuous culture, are intent on studying genetic stability or regulation. While these 
are useful studies, the amount of studies that are dedicated to investigate the heterologous protein 
production and characterisation of the producing strain are few. Two are concerned with glucose 
repression on the specific product, and one uses a complex nutritional source. 
One of the studies with carbon limitation was performed by (Roth, et al., 1985), and here the chemostat 
experiments were started by running a prolonged cultivation at D=0.1h-1, from which a mutant strain was 
selected that had developed a free mycelial structure, and retained this even after making a stock, and 
starting new experiments; this strain could be cultivated at D=0.2h-1. It is interesting, though very difficult 
to determine, what mutation the strain had picked up, and as such it makes it difficult to directly compare 
the findings of Roth, though this group does present the best experiment. Further, Roth uses the S. lividans 
66 strain, which is the parental strain of the TK24, with an integrated fertility plasmid (Lewis, et al., 2010). 
(Rossa, et al., 2002) used a P-limited medium to investigate flux distribution in an S. lividans strain 
producing the antibiotics actinorhodin and undecylprodigiosin (UDP).  One finding that was made was that 
there is an inverse relationship between antibiotic productivity, and growth rate. 
The two papers of Mellados group (Isiegas, et al., 1999)and (Parro, et al., 1998) claim to use chemostats to 
investigate heterologous expression. Though it is undefined why magnesium limitation is chosen as the 
reference condition. The chemostats are run, with either glucose or mannitol as carbon source, first on 
magnesium limitation, and after 5 residence times shifted to phosphate limitation. Unfortunately no full 
fermentation profiles are displayed for verification of the steady states. It seems as though, but it is not 
really defined as a goal, that magnesium limitation is used with intent to retain a high residual 
glucose/mannitol concentration in the vessel, so that phosphate limitation can be compared to another 
condition with high residual carbon. When shifting to the phosphate limited medium not only phosphate 
limitation is tested, but also carbon catabolite repression because in both cases a high residual carbon 
concentration is maintained, while controlling the growth rate with another nutrient source. It seems 
unfortunate choosing Mg2+ as the limiting nutrient as this could have a host of secondary/indirect effects, 
not unlike those that was attempted to be avoided by not adding the selective antibiotic; despite that the 
argumentation of avoiding secondary effects was exactly the reason for not adding the selective marker. 
Further, not running with a selective marker is a risky proposition, as Roth showed that exactly phosphate 
limitation seems to induce plasmid loss. Lastly Mg2+ is used in a large number of enzymes, among others in 
transport and glycolytic enzymes.  And the paper by Isiegas is based on the same promoter, and same 
assumptions, though a different protein product.  
(Wang, et al., 1998) is studying expression of a heterologous protein in S. lividans, though the experiment is 
performed in a continuous culture using a rich medium. This may be very interesting in terms of producing 
the enzyme, though in academia, running a continuous culture using a complex medium, as trypticase soy 
broth is, makes for an outcome, with very hard to interpret results. It could also potentially result in 
different limitations depending on batch variation of the complex medium. (D'Huys, et al., 2011) has 
described the amino acid uptake, in a parallel experiment, where the complex part was supplied by 
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casamino acids, Though D’Huys studied only batch experiments, and later made steady state inferences 
from late exponential phase flux, but still from batch data. 
While the setup chosen by (Sarrà, et al., 1998) seems to be well thought through, the extremely low 
dilution rates that were chosen also become the limitation of the system. With a dilution rate of D=0.014h-1 
and D=0.007h-1 result in residence times of 71 and 143 hours respectively. For the duration depicted where 
the experiment was set to D=0.014h-1 it can be observed that antibiotic production ceased. After four 
residence times, where biomass seemed steady, the dilution rate was shifted to D=0.007h-1 to attempt to 
restart abtibiotic production. The duration depicted that was chosen for running D=0.007h-1 is 150h, thus 
only one residence time, and therefore not enough to establish and verify a steady state. Normal 
convention requires at least three residence times for establishing a steady state, and the steady state 
samples from three consecutive residence times, to verify the steady state. Further, (Sarrà, et al., 1998) 
mentions a Glutamic acid limitation, while feeding both another carbon and nitrogen source. While 
glutamic acid is a favored amino acid, it can supply mainly carbon and nitrogen, and if other sources are 
available, it can’t be an ultimately growth limiting substrate.  
Having considered the work of these other groups, how has development been in terms of Streptomyces 
lividans as a heterologous protein producing strain. We have established, that it is possible to perform 
chemostat experiments with S. lividans, and that a range of dilution rates are available. There seem to be a 
level, slightly faster than D=0.12h-1, where at least, a two-step chemostat will have to be performed in 
order to obtain reliable steady states at the higher dilution rates, as in the experiments of Roth. This is 
despite using the mRFP strain with a µmax≈0.22h
-1 which should easily allow dilution rates of 0.16h-1, if not 
higher, though this was not successful. From a genetic stability perspective, there are some problems with 
plasmid stability. A number of chemostats have been performed, where either the addition of thiostrepton 
has been forgotten, or the stock of thiostrepton has been faulty, and here it is very clear that the plasmid 
can be mostly lost within a short timeframe. I say mostly because the mRFP production does not cease 
entirely, and after all it is a multicopy plasmid with 40-100 copies per cell (Ward, et al., 1986); a 
coordinated loss of that many plasmid copies seems unlikely. 
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Chapter 6. Beyond the black box 
The black box 
The experiments described in the previous chapters that were run in either batch or chemostats are in 
general black-box experiments; they are simple representations of fermentation processes. The substrates 
that are going into the cell are known, external parameters are controlled, and products coming out of the 
cells can be measured. That is to say, we know what goes in and what comes out, but we do not know 
exactly how the substrates are distributed into metabolites in the cell. Black box modelling is the basic 
approach when considering modelling, since no a priori knowledge is required and it is based on all the 
measureable parameters around the cell, and even the cell concentration; but we still work with the 
assumption that we don’t need to know precisely what is going on inside the cell, in order to get the 
product out. Depending on which school of modelling one belongs to, some would claim black-box 
modelling requires the biomass to be considered as a single component. Using black box modelling, and 
suitable experimental conditions, much can be learned about the biology of the cell, including revealing 
parts of the network structure. The restraints made on black box models are measurable extracellular 
parameters. Flux analysis is one way of trying to estimate what is happening intracellularly, though it 
requires either that the network structure is simple or additional information to constrain the network in 
order to give a reasonable estimation of the carbon distribution. One of the most often used methods to 
simplify the network structure is by lumping reactions, in e.g. linear pathways, or all reactions going to 
biomass. These simplifications work because using a defined medium, all components are known, so 
consumption of medium components will result in either accumulation of biomass or a metabolite; this can 
be simplified to what goes in must come out. Due to the amount of reactions present in the cellular 
network compared to the parameters that can be readily measured, the system is vastly underdetermined 
(Kauffman, et al., 2003). Biotechnology in general has developed around this paradigm, we can attempt to 
describe what goes on by considering the cells as black boxes; we can isolate and purify intracellular 
enzymes for characterisation in vitro, and thereby develop a picture of the possible reaction network, 
though knowledge about what precisely happens in the cell is still limited by our ability of prediction 
(Palsson, 2002). We have learned to experiment and draw conclusions based on what can be measured. It 
is only relatively recently in the use of microorganisms that the genomic sequences have become known in 
their entirety, and to a great extent has been used to support and extend the reaction networks; further, 
the analytical techniques have undergone vast improvements and are becoming sufficiently advanced in 
both analysing small amounts of analytes, as well as separate the many compounds in the cell (analysing 
many compounds at a time).  
Beyond the Black box 
For initial experiments black-box modelling are fine. Many kinetic models function using extracellular 
parameters, such as glucose uptake rate, yield of product on substrate, yield of biomass on substrate, 
growth rate etc. Models like this can be used, after initially estimating the parameters, to predict the 
outcome of fermentations. The models can become quite robust, and the even the somewhat variable 
nature of the Streptomycetes is not beyond the ability of the models (Nandy, et al., 2013). The models can 
even be expanded to include multiple substrates, each with their own specificity, and from experimental 
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data the specificities can be determined (Gernaey, et al., 2010). The parameters of the black box model 
describes the cellular performance very well, but eventually, if the strain is intended for use as a 
heterologous protein production platform, a deeper knowledge of the intracellular environment is needed. 
The kinetic models, while very useful, have the inherent weakness that they describe a known strain, under 
known conditions, and thus cannot be used to predict the effect of a different genotype (loss or gain). If 
improvements are to be made on the cellular physiology, then as the first step the reaction network needs 
to be clarified, preferably in its entirety. Intracellular networks can help to elucidate possible optimization 
regimes that may contain unexpected, unobvious, or even counter intuitive solutions (King, 1997). As an 
example of this, knockout of the TTA recognising tRNA (bldA) in S. coelicolor, has been shown to have 
effects even on genes in the primary metabolism, despite the expectation that this particular codon was 
confined to secondary metabolism (Hesketh, et al., 2007). 
Overall there are two methods for reconstructing genome scale networks, either a bottom up-, or a top 
down approach (Palsson, 2002) (De Keersmaecker, et al., 2006). The top down approach is trying to define 
the network, without a priori knowledge, from the data alone; a large amount of data, such as transcription 
data from a large number of states, is necessary for this to succeed. The bottom up approach is based on 
defining the network from known reactions, and if inconsistencies appear, then improvement of the 
network is needed.  
Even with an available genome scale reaction network, what precisely is going on inside the cell and the 
regulation of the processes are still largely unknown. In systems biology we try to regain a holistic view of 
the cell, by implementing all available data to describe what is happening (Bull, 2010). This is obviously not 
uncomplicated, and many papers can be found implementing various ‘omics’ data into genome scale model 
networks, and also trying to integrate several different types of ‘omics’ data together, some of which will 
be discussed in the following sections (Zhang, et al., 2010) (De Keersmaecker, et al., 2006).   
Figure 21 presents a schematic overview of the two main approaches. The black-box modelling is a kinetic 
descriptive approach that requires little mechanistic understanding of the system to be applied. It is based 
on simple physiological descriptions, and gives a very good measure of cellular performance; it is one of the 
ways to describe cellular performance from the experiments so far in the thesis. Alternatively, from the 
experiments biomass can be harvested under controlled conditions, and further analysed. The sampled 
biomass, can dependent on sampling technique be used to feed any of the advanced ‘omics’ analyses. The 
purpose is to obtain a better description of the internal workings of the cell, including elements such as 
pathways, the activity of these, and regulation. Finally a predictive model can be generated, which can 
function as a framework to exhaustively describe cellular performance, as well as predict possible 
optimisation methods, or the effect of perturbations to the network. The systems biology approach 
encompasses the integrative use of these methods to gain a holistic description of the cell, and will be the 
focus of the current chapter.  
Related to Streptomyces lividans many of the examples given on how the various methods have been used 
are concerning secondary metabolism, or relative strains. It is therefore important to keep in mind that 
while experiments trying to map or utilise secondary metabolites can only be related to heterologous 
protein expression in a limited fashion, then it is also to show how the methods have been developed, and 
what they are capable of showing. The relevancy of the methods is very much present, despite the 
examples given will not always seem so. 
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Figure 21 A schematic overview over the preparation of a cell factory, the microbial physiology is divided into the methods 
usually used to generate biomass. In itself, the physiological approach can feed information into black box modelling, and 
biomass into the advanced analyses, that can be used to generate more advanced models, that may respond to regulation. 
Either way, the goal of each of the approaches is to improve cellular performance. 
Analytical approaches of looking inside the cells 
A number of advanced analytical techniques are available, and have been developed over the last 20 years. 
These methods represent very diverse disciplines that in the more recent years are being combined under 
the title of systems biology, which is an attempt to study organisms in a more wholesome view.  This 
holistic approach is not a new thing, rather a return to a methodology that was once common across the 
fields of science (Bull, 2010). The divergence seems to have been caused by the fact that developing each of 
the methods required highly specialised skills to be successful. An overview of the methods together with 
some of the key results, in relation to Streptomycetes will be provided in the following sections. In relation 
to systems biology some of the methods have been used very successfully in cooperation, to provide an 
added level of information, as well as hinting at the underlying regulatory mechanisms (Likic, et al., 2010). 
Genetics 
Having access to the genomic sequence is not the be-all-end-all approach; a lot of information can be 
gathered on the physiology of an organism by investing time in the lab growing the strains under various 
conditions, which can give hints at the capabilities of a strain (Hopwood, 1999) (Paradkar, et al., 2003) 
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(Bochner, et al., 2001). Genetic studies, as opposed to genomics, predate even the discovery of DNA as 
hereditary material, and still incredible accurate genetic maps have been designed, without knowing the 
genomic sequence (Hopwood, 1999) (Kieser, et al., 1992). Hopwood divides the Streptomyces genetic 
research into three eras: in-vivo, in-vitro and in-silico, where the first is the collection and study of naturally 
occurring, and induced, mutants. The second is the understanding of genetic elements, characterization of 
the genes, and developing the molecular biology. The last is the rational use of available DNA sequence 
information, to understand and improve the organism; this does not necessarily entail whole genome 
sequences. The two major avenues of research of Streptomycetes that have been followed so far have been 
divided between the basic physiology including primary metabolism, and secondary metabolism, antibiotics 
and developmental physiology (Hopwood, 1999). These two avenues are still the dividing line in 
Streptomyces research, and the vast amount of attention is spent on the secondary metabolism fuelled by 
the economic interest in the metabolites with beneficial properties produced by the Actinomycetes 
(Paradkar, et al., 2003). The main purpose of introducing the advanced analytical techniques to describe 
cellular performance in a systems biology perspective is to allow a model of the system to move from a 
purely descriptive role to a predictive. The wish is to obtain a platform on which it is possible to analyse and 
interpret high data density ‘omics’ data,  as well as obtain sufficient predictive power to suggest metabolic 
engineering optimisations with the purpose of improving S. lividans as a cell factory.  The separate ‘omics’ 
analyses, depicted in Figure 21 will be introduced separately in the following sections, with examples of 
how they can and have been used. 
Genomics  
Actinomycetes in general have been investigated, mostly for their interesting properties, such as a wide 
range of bioactive compounds and highly specialised proteins; in a few cases the interest has been caused 
by the pathogenicity of the strain, e.g. Streptomyces scabies, causative agent of potato scab disease. 
Further, Streptomyces strains are often being found inhabiting old industrial areas, such as mines, and 
these strains have gained resistance towards those environmental protagonists, which makes them further 
interesting to study (Schmidt, et al., 2009) (Lin, et al., 2011).  
With the availability of the genomic sequence, comparative genomic approaches are possible. The 
published full genome sequences and the sequenced but not published and/or not completely annotated 
sequences are presented in Table 3.  According to the Genome online databse (GOLD)2, there are 15 
completed and published genomes, and a further 22 are considered permanent drafts.  In Figure 22 the 
quality level of the genomes are presented, 6 (7) levels are used, from no level, over first draft (L1) to 
finished. It is surprising to see 18 are listed as level 6, and only 15 of those are recorded as complete and 
published. The vast majority are considered incomplete, and have no level. 7 genomes are categorised as 
“targeted”. All except 2 Streptomyces genome sequences are publicly available; the two that are not are 
listed as incomplete, and are S. venezuelae and S. noursei ATCC 11455, both industrial strains, S. noursei is 
used for producing nystatin and S. venezuelae is known as the progenitor of chloramphenicol. It is unclear 
what exactly a permanent draft is, but in the statistics it groups together with completed sequences, and at 
least 1 permanent draft has been published (Erxleben, et al., 2011), and is listed as level 5 (where level 6 is 
complete). Some of the genomes from the Broad institute in Table 3 are considered incomplete, whereas 
                                                          
2
GOLD – Genomes online database: http://www.genomesonline.org/cgi-bin/GOLD/index.cgi sponsored by US. Dept. 
of Energy, Joint Genome Institute (DOE-JGI), accessed (06-06-2013) 
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on Broad’s homepage they are listed as drafts; though 1 was complete, and some are registered as 
permanent drafts. Two of the sequences related to Streptomyces are not publicly available. The Broad 
institute has a large number of draft sequences listed, including that of the S. lividans TK24, a derivative 
industrial strain from the WT S. lividans 66; the industrial TK24 strain is without any integrated plasmids 
(Lewis, et al., 2010).  
 
Table 3 Published and/or finished full genome sequences of Streptomyces spp. Annotation of strains can still be progress. n/p is 
not published (yet) in a journal. All but two should be publicly available. 
Published sequences 
Strain Publication 
S coelicolor (Bentley, et al., 2002) 
S. cattleya (Barbe, et al., 2011) 
S. griseus 
(Ohnishi, et al., 2008) 
(Grubbs, et al., 2011) 
S avermilitis 
(Omura, et al., 2001) 
(Ikeda, et al., 2003) 
S. scabies 
(Yaxley, 2009) 
(Bignell, et al., 2010) 
S. bingchenggensis (Wang, et al., 2010) 
S. flavogriseus   
S. venezuelae Shinobu 719 (Pullan, et al., 2011) 
S violaceusniger n/p 
S. sp. SirexAA-E n/p 
S. hygroscopicus jinggangensis n/p 
Streptomyces albus J1074 Broad, n/p 
Streptomyces sp. PAMC26508 n/p 
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Figure 22 Whole genome sequencing projects overview, for Streptomycetes, from Genome Online Database (GOLD) 
There is a high similarity among the Streptomycetes, and Actinomycetes in general, which can be used to 
study related species, without the full sequence information (Jayapal, et al., 2007) (Lewis, et al., 2010) 
(Paradkar, et al., 2003). The relation is so close, that S. coelicolor has been used to immunize a murine 
infections model against infections from Mycobacterium spp (Arzuaga, et al., 2011). A comparative genomic 
study has also been performed between a number of Mycobacterium spp. Cornybacterium spp, two 
Streptomyces spp. and a few others, in total 31 organisms (McGuire, et al., 2012). (McGuire, et al., 2012) 
makes no specific references to Streptomyces, as the study concerns pathogenicity, though the ESX 
transport system is present in Streptomyces as well (Chater, et al., 2010), and it does seem that some of the 
lipid metabolism regulation that is also being investigated shares some regulatory modes between 
Streptomyces and Mycobacterium Despite Mycobacterium tuberculosis has a circular genome sized 4.4MB, 
a substantial amount of synteny is observed within the core region, i.e. excluding the outer 1-2Mb of the S 
coelicolor genome, which is around 8.6 Mb (Chater & Chandra, 2006) Cross hybridisation of S. coelicolor 
arrays has been successfully utilised in the comparative genomic studies performed between the 
industrially relevant strains S. lividans TK24 and S. coelicolor M145, and the WT S. lividans 66, using either 
the spotted array (Jayapal, et al., 2007) or the 104K microarray (Lewis, et al., 2010). It is from these studies 
evident that the sequence similarity between S. lividans and S. coelicolor is profound. In relation to this it is 
not absolutely clear why S. lividans produces so sparse amounts of antibiotics, unless specifically prompted, 
though, differences were found in the bldB gene, which is required for sporulation in S. lividans and is 
related to antibiotic production in S. coelicolor. The methods used by both (Lewis, et al., 2010) and (Jayapal, 
et al., 2007) have marked this gene as absent/divergent; and from (Lewis, et al., 2010)’s further 
investigation, the 5’ end of the gene may differ sufficiently that three consecutive probes failed, and 
marked the gene as absent, although most of the gene is intact. Further, it was discovered that the genes 
used in the glyoxylate bypass are missing in S. lividans, as are totally 9 genes representing core metabolism, 
including Entner-Doudoroff genes, and breakdown of lactose to glucose and galactose (Lewis, et al., 2010). 
From the Biolog data presented in chapter 3, it was found that S. lividans seem to grow well on lactose as C-
source, suggesting either availability of an alternate pathway, or a false classification has taken place. 
Sequence homology can be advantageous even before performing comparative genomics. Primers from 
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one strain can be produced, sometimes as degenerate, to prove the presence of genes in other strains, e.g. 
the discovery of a Nonomuraea species using ED pathway to metabolise carbon (Gunnarsson, et al., 2004). 
In S. lividans the ED pathway has not previously been verified, and when a homology search was made 
(BLAST_n) in the Broad database of the genes of the ED pathway, candidates were found, though they 
seem to not co-locate on the genome suggesting false positives (Rattleff, et al., 2013b); more information 
from this study will be presented in the section about Flux analysis, below.  
(Zhou, et al., 2012) has made a large scale comparative genomic study between published strains of 
Streptomycetes, where more time is spent on categorising the genes, and describing evolution of 
Streptomyces strains. This kind of evolutionary study can be used to help elucidate how the secondary 
metabolite clusters, and exotic properties have arisen, and possibly help understand the genus. In the study 
of (Ventura, et al., 2007) the search was broadened, and included different clades, all belonging to the 
Actinobaterium class, with a heavy representation by the Actinomycetales order. The result of the study 
was the gained broad understanding of the evolution in this order. Many genomes are highly homologous, 
differing in inversions, and gene duplications. Phylogenetically the Actinobacteria form tight local groups, 
when based on 16S rRNA sequences. (Ventura, et al., 2007)further discusses the merits of using different 
methods of ordering the branches of the phylogenetic trees. 
Availability of the genomic sequence does give the ability to analyse the capabilities of the cells in a more 
concerted manner, and maybe discover abilities previously unanticipated e.g. (Bentley, et al., 2002) 
discovered from the S. coelicolor A3(2) genome an unexpected large number of regulatory genes, and 
several secondary metabolite clusters, as well as three siderophore like proteins hinting at a strong 
selective pressure for harvesting metal ions. It has later been discovered that it seems to be a general trend 
that several siderophores are produced by each strain (Chater, et al., 2010). The sequence of S. avermitilis 
was used to deduce the capabilities of the strain (Omura, et al., 2001), and it was found that there was 25 
putative secondary metabolite clusters. Even with the genomic sequence available, thorough analysis is 
needed to verify whether the putative genes are in fact what they are believed to be, and whether, and 
under which conditions, they are expressed. Experimental conditions impose limitations on the amount of 
conditions a strain can be subjected to in the lab, which means that it can be difficult to find all types of 
regulatory sequences. (Studholme, et al., 2004) tested a method to predict regulatory motifs from the 
known sequence of S. coelicolor. A set of putative regulatory sequences were found, and would be 
suggested to be used in e.g. transcriptomic studies to verify their identities, function and products 
(Studholme, et al., 2004). 
With the sequenced and mostly annotated S. lividans TK24 strain, the basis for creating a genome scale 
model (GSM), as the one proposed by (Lewis, et al., 2010) is present. Following that the ‘omics’ techniques 
can be used to strengthen and verify the model, gaining not only a thorough physiological knowledge, but 
understanding of the regulatory processes at work, which could prove to be very valuable, since the strain 
is capable of producing Actinorhodin either when prompted by the heterologous expression of a 
transcriptional activator (e.g. act II ORF 4), or under conditions of very low growth rates (as in the 
chemostats with D less than 0.035h-1, see chapter 5. This can be utilised to prevent the production of 
antibiotics, and secondary metabolites in general, without hampering the strain, or preventing sporulation. 
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Transcriptome 
The analysis of all transcribed genes, the transcriptome, requires the sequence knowledge of all, or at least 
the major part of, genes. There are two major technologies when it comes to transcriptome analysis, 
hybridization- or sequence-based appproaches. (Jayapal, et al., 2007) describes the use of spotted arrays, 
that have higher flexibility in their design, but eventually less fidelity, as one probe is used per gene. (Lewis, 
et al., 2010) presents the use of high fidelity 104K arrays, which means they carry 104,000 probes, thus 
several probes per gene; a number of Streptomycetes have in the range 7,500 – 10,000 genes (ORF’s) 
(Zhou, et al., 2012), allowing both several probes per gene, thus ensuring redundancy, as well as 
introducing the ability to test the intergenic sequences for possibly regulatory RNA. An emerging 
technology is gaining foothold, RNAseq (Wang 2009), since it can be used without knowing the sequence, 
as it is based on sequencing approach, and therefore can also be used to determine regulatory transcripts 
(Marioni, et al., 2008). Alternatively it is possible to monitor only a subset of genes using a reduced array, or 
qPCR (Marioni, et al., 2008), as in the study by (Facey, et al., 2013), where only specific osmotic shock genes 
were observed in several strains and transcription levels were compared. This way only the sequence of the 
required genes are needed. On the other hand, in strains, or genera, with a high sequence homology the 
array from one sequenced strain can be used (although with care) on an unsequenced relative. This has 
been reported by (Jayapal, et al., 2007), and later (Lewis, et al., 2010), where comparative genomics have 
been based on a S. coelicolor array used for S. lividans. Depending on the arrays used the level of detail and 
resolution varies (Lewis, et al., 2010). An RNA-seq approach was used to investigate the copper sensing in S. 
lividans, though the results seem pleiotropic, or possibly cupper toxicity distort the results, since 400 genes 
show higher expression in the strain containing the regulator knock-out, and none of these genes contain 
the expected regulator recognition sequence (Dwarakanath, et al., 2012). Using one of the older DNA 
microarrays platforms, (Huang, et al., 2005) discovered that regulation of secondary metabolism in S. 
coelicolor seems to be an interconnected regulatory network rather than the hierarchical network, which 
had been the precious dogma. The individual regulators which, previously were thought to be pathway 
specific seems to be able to extend a certain degree of control on parallel pathways and/or secondary 
metabolite cluster; it was even observed that there is an ability to modulate some of the more global 
regulators (Huang, et al., 2005). In a different case, a parallel transcriptomic and proteomic experiment was 
set up to test the effect of phosphate regulation in S. coelicolor (Martín, et al., 2012). There seemed to be a 
good correlation between the tested ‘omics’ methods, and a remodelling of the central carbon metabolism 
was found, possibly in response to a redox imbalance caused by the phosphate depletion (Martín, et al., 
2012). 
As mentioned previously, the amount of experiments focussed on the primary metabolism of 
streptomycetes, especially with focus on developmental biology, is quite limited. A study of the pre-
sporulation mycelium of S. coelicolor growing on solid medium was performed by separating the cells at 
different developmental stages using protoplastation, and performing transcriptomic analyses on the 
separate developmental stages (Yagüe, et al., 2013). It was found that the cellular program started, even 
while the substrate mycelium still exists is consistent throughout all stages of MII (from mycelium, over 
aerial mycelium to spores). It seems the program entails programmable cell death of the mononucleated 
mycelium and simultaneous generation of multinucleated mycelium, separation of nuclei and lastly 
sporulation. Interestingly it seems as though one of the genes found to be differentially regulated was whiJ, 
which seem to act like a sporulation inhibitor (Yagüe, et al., 2013). These studies seem to agree with the 
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developmental biology as described by (Flärdh & Buttner, 2009). The group has also studied the 
developmental biology though a proteomic approach (Manteca, et al., 2010). 
Transcriptome analysis is valuable in that it gives an indication of what genes are used in a given set of 
conditions, of even more useful in comparing sets of conditions, where the change in transcription can 
indicate the use of a gene. This methodology is useful in determining the functional genomics; the 
association of genes to their function. As was the case of (Borodina, et al., 2005), creating a genome scale 
model of S. coelicolor entails it is also incredibly useful in discovering gene products with regulatory 
properties. The level of transcription, while informative, is not necessarily the same as a higher flux, or 
more enzyme product, due to other levels on regulation.  It is a fantastically useful tool, in combination 
with other of the ‘omics’ analyses.   
GSM 
The purpose of creating a genome scale model is to perform investigative analyses, such as to run 
simulations of the cell under different conditions, evaluate the possible effect of genetic manipulation, 
search for metabolic engineering targets, or help interpret experimental data (Durot, et al., 2009). It is 
possible to simulate cellular growth based on these models, and determine the effect on growth rate a 
perturbation might have. All these purposes can be summarised under the title in silico biology. If the 
model is comprehensive, and the predictive power is sufficient, then multiple conditions can be tested, 
before verification is required in the lab. From the outset, a genome scale model can be developed as 
either a top-down, or bottom-up approach (Palsson, 2002). The top down approach is aiming at creating a 
network from observable interactions. The bottom-up is creating a network from comprehensive 
knowledge of known interactions, typically assembled from literature. Ideally the top-down method should 
be resolved on bottom-up foundation, to reduce computational complexity (Oberhardt, et al., 2009), and 
obtain the most comprehensive model (De Keersmaecker, et al., 2006). In either case, the Top down 
approach alone is so data and computationally demanding, that it is almost unviable to not support it by 
bottom-up information, though as a supplement it can likely reveal interactions that have yet to be verified 
otherwise. Many types of software have been developed to support the bottom up network reconstruction 
i.e. to help to interrogate databases, and organise the resultant data into reaction networks. However, 
eventually all reactions have to be manually curated (Feist, et al., 2009) because the annotations are often 
lacking in detail, such as “hypothetical protein”, or are downright false, based on simple BLAST homology 
search, and therefore can point to a different protein, or class of protein (Borodina & Nielsen, 2005). Using 
the proven literature as the scaffold, and the supplementing with knowledge gained from the sequence 
should be the method of choice.   
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Figure 23 All reactions in KEGG, that are annotated for Streptomyces coelicolor 
One of the large databases of annotated reaction available in various organisms (including some 
Streptomycetes) is KEGG, in Figure 23 the reaction network is presented, with all annotated reactions fully 
coloured, and the weakly coloured are possible reactions. It should in this figure be noted that some 
“islands” can be observed, metabolites or short reaction pathways without seeming connection to the 
central carbon metabolism, as those marked with a red circle in the top right corner of Figure 23. This is a 
typical result, and will require gap-filling in the model produced, either from homology search from other 
Streptomycetes, or from computational inference, where the dead-end or orphan metabolites are 
attempted connected to the network from a repository of reaction, using the GapFill method (Durot, et al., 
2009). When a genome wide network has been produced, the initial test is to see if all components 
required for biomass can be produced, and secondly compare physiological data to the results from the 
model, and determine if reactions are missing (Reed, et al., 2006). Alternatively, phenotype arrays such as 
those produced by Biolog can produce hints for missing reactions, or metabolic capabilities. The network 
does not require the knowledge of the genomic sequence, though this knowledge will allow expanding the 
network to include even pathways that haven’t been (well) characterised in the specific organism yet. 
Further, with sequence data, and transcriptional data, regulation can be more thoroughly investigated.   
The network created is the basis for investigating cellular performance deeper. It is the framework around 
which intracellular modelling can be performed. The models can be used to investigate the network 
topology and function, estimate flux distributions, integrate high density data such as transcriptome, and 
guide metabolic engineering efforts. The first models for flux analyses were created from the bottom-up; 
some even before the genomic sequences of the strains were available (Nowruzi, et al., 2011). Such models 
have been created as a reduced network due to computational simplicity. These types of models can be 
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found for most organisms, and as such (Borodina, et al., 2005) has created a model for S. coelicolor, which 
was to expand on the simple models used by (Rossa, et al., 2002) and (Bruheim, et al., 2002).  
The model of S. coelicolor presented by (Borodina, et al., 2005), consisted of 700 unique reactions, and a 
total of 971 reaction, including iso-enzymes. The reactions included in the model represent 13% of the 
estimated ORFs in S. coelicolor. Due to the vast homology between Streptomycetes, a model like this can be 
used on other members, with minimal adaptation. An example of this was presented by (Lewis, et al., 2010) 
in a cross hybridization study between S. lividans and S. coelicolor, where a number of genes were found to 
be divergent/absent in S. lividans. The genes were identified by genome wide hybridisation using a 104k 
microarray (Lewis, et al., 2010), but substantiated the findings performed on a spotted array (Jayapal, et al., 
2007). Of all the genes found absent/divergent 9 were related to the central carbon metabolism. The 
authors removed the reactions from the genome scale model produced by (Borodina, et al., 2005), and 
tested whether loss of these genes would result in a likely viable cell, which they would, indicating that 
these absent/divergent classifications are plausible. The models that have been developed previously have 
mainly focused on steady state conditions, due to the strength of the linear description of the model 
(Durot, et al., 2009). The limitation this imposes is that when secondary metabolism is studied, the switch 
from the exponential growing stage to the production of secondary metabolites in the stationary phase has 
had to be modelled as two separate events. (Alam, et al., 2010) has succeeded in creating a model that can 
model the transition to the production stage. The authors say that including sufficient data allows 
modelling the switch, and they included more than 25 transcriptomic samples over the time course of the 
experiment. The final model was compared to other published models, and was found to compare well to 
the model produced by (Borodina, et al., 2005), although expanded on the part of the secondary 
metabolism, so the total model includes 1015 reactions representing 789 genes. The model by (Alam, et al., 
2010) uses both flux balancing analysis (FBA) (Price, et al., 2004), to create a plausible solution space, and 
included a dynamically changing input function to enable using the time series data represented by the 
large number of transcriptomic samples. 
(De Keersmaecker, et al., 2006) and (Zhang, et al., 2010) present in their reviews the current state of 
integration of various types of ‘omics’ datasets, and describes some of the difficulties, as well as promise, 
this presents. ‘Omics’ data is in its nature noisy (see e.g. (Alam, et al., 2010)), but when using ‘omics’ data 
from several different methods, they can supplement each other, and reduce the impact of the noise in 
each dataset. Further, several levels of ‘omics’ data integration also carries the promise of discovery of 
regulatory systems that have previously eluded discovery. Integrating several complex datasets or using 
these as a basis for generating genome scale networks may result in falsely estimating the impact of a 
change in the network; therefore, when studying the network, the topology as well as the function of the 
network has to be considered (Mahadevan & Palsson, 2005). Network analysis has resulted in determining 
highly connected nodes (metabolites) as crucial, but many linear pathways are known, and knocking any 
gene out in these will result in the functional loss of the final product, not only the highly connected 
precursor.  
While some of the modelling procedures have been developed specifically to focus on secondary 
metabolism, especially the metabolic switch as studied by (Alam, et al., 2010), the methods can be used as 
part of a primary metabolism toolbox. Knowing, what and how secondary metabolism is triggered, can 
offer targets for engineering for reducing the impact, while not losing the ability to sporulate. Sporulation is 
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a useful feature to possess when storing the strains, and creating cell banks. Many of the regulators have 
historically been identified by the loss of the ability to grow aerial hyphae (the Δbld class of mutants), or the 
loss of sporulation (the Δwhi class of mutants). Relying on the models, targets could be sought with less 
impact in the cellular metabolism since e.g. ΔbldA (encoding the tRNA that recognises the rare UUA codon, 
and has been connected to the secondary metabolism) had effects on the primary metabolism (Hesketh, et 
al., 2007). 
Proteome 
Like the other ‘omics’, the aim of proteomics is to give a picture of all present proteins in a given sample. 
The motivation is that the proteins are the workhorses of the cell, and reflect what the cell does to try and 
cope with an external stimulus. To go from stimulus to protein, in a measurable quantity, does take some 
time, but it is none the less a more stable sample. The turnover time of proteins is a lot longer than for 
metabolites, and as such makes the analysis more robust. Further, when analysing proteins a further level 
of regulation can be observed. Proteins have their activity modified by physical change of the protein, e.g. 
phosphorylation or methylation. Therefore protein regulation can be directly observed. The conventional 
methods of separating proteins either by mass/charge or isoelectric point yields an insufficient separation, 
as several proteins will co-elute. 2D-electrophoresis has been the standard operating procedure since the 
70’s, because a good separation is achieved, even between variants of the same protein with different 
regulatory modifications, separation can be achieved. Still, 2D gel electrophoresis is being blamed for only 
resolving in the 100’s of proteins, which is a small subset of the total cellular capability. The more recent 
use of liquid chromatography coupled to tandem MS, have allowed detection of 1000’s of proteins. Even 
the low abundance proteins have become accessible (Zhang, et al., 2010). Unfortunately only 20-40 % of 
the total proteome can be detected, and so far only qualitatively (Zhang, et al., 2010). 
S. lividans possesses 4 extracellular signal peptidases (sip family), where organisms can be found 
harbouring anything from 1 SP, which is essential, to 7 as seen in Bacillu subtilis (Escutia, et al., 2006). Signal 
peptidases are responsible for processing the proteins that are exported by the classical SEC transport 
system. 3 of the signal peptidases are located in the same operon, and one in located separately on the 
genome. It seems that sipY is the major peptidase, however loss of the peptidase can be complemented by 
overexpression of either of the other 3 (Escutia, et al., 2006). In this work the initial estimation of the 
extracellular proteome was pictured on strains growing in casamino acid supplemented minimal medium. A 
number of proteins were identified in the extracellular medium, including some previously annotated as 
hypothetical proteins, opening for the possibility of ascribing functionality to them. The work is by the 
authors own statement not an exhaustive study. An alternative is to overexpress a (putative) regulatory 
gene, and using the proteomic snapshot to try and identify differentially, or newly, expressed proteins, on 
par with, or as supplement to, a transcriptomic analysis (Kim, et al., 2005) (Choi, et al., 2010). (Li, et al., 
2006) and (Hesketh, et al., 2007) have studied the effect of deleting the bldA gene in S. coelicolor using a 
combination of transcriptomics and proteomics analyses. A large number of genes were identified as 
affected by the deletion of the tRNA recognising the TTA (UUA) codon, even gene products from the 
primary metabolism. A surprisingly small number of the affected (less transcribed) genes had the TTA 
codon as part of their gene, or transcription initiation sequence. One of them were SCO6717, annotated as 
“putative acyl-[acyl-carrier protein] desaturase” and a target for TTA regulation (the TTA 
codon was upstream of the start codon) (Hesketh, et al., 2007). Further, (Hesketh, et al., 2007) mentions 
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that most of the TTA regulated proteins may be related to surface growth, or has ecologically adaptive 
functions; therefore these proteins will likely not be identified in liquid culture. 
Many of the advanced analysis methods have so far been used by groups specialising in the analytical 
technique, which results in samples being taken in a biological unstructured fashion. The experimental 
setup does obviously influence the results, and sampling different strains after a specified amount of time, 
e.g. 8 days, irrespective of growth phase will result in unwanted effects. This is commonly observed in 
literature, that sampling is undertaken either regardless of growth phase, or not normalised across strains 
to a feature e.g. biomass, which tells whether an e.g. increased production is caused by better productivity 
or higher biomass. 
A number of tags and isotopes have been developed to give the quantitative view of proteomics. One of 
these is the iTRAQ, which has been used for both relative and absolute quantification in proteomics. This 
method has been used to describe the developmental biology of S coleicolor, as well as suggest proteins 
that change subcellular localisation across developmental stages (Manteca, et al., 2010). Another study 
(van Veluw, et al., 2012) found that in rich media, two distinct populations of pellets sizes co-exist in 
streptomycetes, with the smaller of the populations being almost independent of time (265µm), and the 
larger varying from (300-500µm). Further, this study also found that of the proteins more abundant in the 
large pelleted population was stress related enzymes, possibly due to mass transfer e.g. oxygen; but also 
antibiotic synthesis proteins (Calcium dependent antibiotic CDA) were overrepresented in the large 
population. The smaller population had an overrepresentation of DNA handling proteins, suggesting that 
the smaller sized population is growing rapidly. A previous study (van Wezel, et al., 2006) has suggested 
that the smaller sized population has the highest production of proteins, and a preference for septation and 
fragmentation can be obtained by overexpressing SsgA,  
A subtype of proteomics is the interactome, defining and describing interaction complexes, such as those of 
the primary carbon pathways, where the proteins assemble into closely coordinated protein complexes. As 
such, interactomics is a valid description of all interactions, including genetic and other molecular 
interactions. In proteomics, interactomics can be used to identify proteins of unknown function, by 
identifying its interaction partners, and looking at homology. 
Proteomics, besides enabling identification of regulatory mechanisms, is extremely useful in supplying a 
snapshot of the actual capabilities of the strain at a given time, or under a specific set of conditions. 
Proteomic methodologies have been used since the 70’s, and have steadily been developed. Like other of 
the ‘omics’ technologies one of the hurdles is that it is difficult to indisputably identify all elements present 
in a sample, and since proteomics relies on partially degraded samples there is a risk of detecting false 
positives.  The field is constantly being developed, and large online databases exist, which can be used for 
homology searching, or generating in-silico mass-fingerprints for comparison. Proteomics methods have 
been used in trying to identify the effect of regulatory molecules, in various species of Streptomyces. 
Metabolome 
Metabolome analysis is a much discussed field, and being able to measure the identities and pool sizes of 
compounds/metabolites in the cell at any given moment would yield a tremendous amount of information, 
as well as integrate with other ‘omics’ analyses. The scourge of the analytical chemists is that it will likely 
never be a complete image, due to the very diverse chemical properties of the compounds, and the 
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available technology for detection. There is no “black-magic-box-machine-from-CSI”, which allows to 
measure all metabolites in one go (Dunn, 2008). With proper sampling technique, and with sufficient 
amount of sample available, it is becoming possible to analyse still larger groups of metabolites, such as 
phosphorylated compounds, energy metabolites, sugars, amino acids, organic acids etc. One of the most 
challenging aspects of metabolomics is that due to the very short turnover time, in the less than seconds 
range, and the small pool sizes, the quenching is of paramount importance, when considering 
metabolomics (Wittmann, et al., 2004). Before anything can be studied, the sample has to be withdrawn 
from the culture, in a representative manner, and the sampling should be quick enough that the sample 
does not change significantly in the process. Quenching is the process of halting the metabolism, and 
methods rely on either very high or very low temperatures, coupled to a shock like a shift in pH (Villas-Bôas, 
et al., 2005). 
One of the problems with quenching aside, from the fact that the sampling process has to be fast enough 
to give a proper image of metabolism, is the loss of intracellular metabolites, resulting in the mix of 
intracellular and extracellular metabolites by organic solvent disruption of the cell envelope (Villas-Bôas, et 
al., 2005). For quenching the most often used method relies on methanol, which is a strong solvent, and 
various amounts of leaking have been observed between different organisms and different quenching 
solutions (Bolten, et al., 2007). Leaking is undesirable, since it causes the underestimation of pool sizes and 
it is useful to be able to separate the intracellular and extracellular environment when describing 
metabolism (Villas-Bôas, et al., 2005) (Villas-Bôas & Bruheim, 2007). This has prompted a search for other 
methods/solvents, some of the tested methods has been pure cold methanol, methanol:water 60:40, 
methanol:buffer 60:40, cold glycerol:saline 1:1, liquid nitrogen, cold 10M formic acid (Villas-Bôas, et al., 
2005) (Villas-Bôas, et al., 2006) (Villas-Bôas & Bruheim, 2007). Cold, in relation to metabolomics usually 
means temperatures lower than -30°C, except glycerol:saline, where it is -20°C since lower temperatures 
causes the solution to freeze. (Dietmair, et al., 2010) worked with mammalian cells, and found least 
leakage, as well as an efficient halt of metabolism, proved by estimating the ATP to ADP conversion, when 
using 0.9% saline at 0.5°C. Mammalian cells are physiologically different, and (Bolten, et al., 2007) found 
that low ionic strength wash solutions, including 0.9% saline, resulted in leakage in bacteria, while an 
optimum was found using 2.6% saline, and not a significant reduction, for higher concentrations up to 10% 
saline. This does though indicate that sampling should be thoroughly tested and that the very harsh 
methods reported in literature may not be needed (Dietmair, et al., 2010) (Sellick, et al., 2009). 
The next step is the extraction procedure. Already a selection of available metabolites has been made by 
the choice of quenching method (Fiehn, et al., 2006). This further complicates matters, and may result in 
having to compromise on a less efficient method (Maharjan & Ferenci, 2003). Extraction methods include 
disrupting the cell membrane, which can be done by freeze/thaw cycles in 100% methanol, which would 
support that methanol damages the cell membrane, boiling ethanol or acidic/alkaline extraction (Kassama, 
et al., 2010). Depending on what is to be investigated, the extraction method has a great impact; solvent 
based extractions have yielded good results with amino acids, and central carbon metabolism related 
compounds, though for energy metabolites or tri-phosphates acetonitrile seems to be better (Rabinowitz & 
Kimball, 2007). In a study by (Dietmair, et al., 2010), acetonitrile also proved to be one of the best 
extraction methods, for all compunds, amino aicds, sugar, organic acids, NAD(P), nucleoutide- tri-, di-, and 
mono-phosphates for mammalian cells.  
107 
 
Due to the complications mentioned above, metabolomics is generally divided in two main approaches. 
One option is the targeted search for specific (classes of) metabolites, the other option is a wide screen of 
all detectable metabolites present e.g. metabolic finger/foot-printing, for investigating as many metabolites 
as possible either intra- or extracellular (D'Huys, et al., 2011) (Kassama, et al., 2010) (Villas-Bôas, et al., 
2006). High numbers of compounds are being reported one such report is the identification of 198 out of 
453 metabolites (Likic, et al., 2010), though the ability to identify more metabolites will likely increase over 
time, and with development of both technology and methodology. And one thing is detection of the 
metabolites, in one or all of the samples; another entirely different matter is quantifying the metabolite, 
which usually yields fewer metabolites. The metabolic footprint, or the exometabolome, was used by 
(D'Huys, et al., 2011) to characterise the amino acid uptake in a complex growth medium. They found a 
large amount of alanine and pyruvate to be produced, possibly as part of overflow metabolism, and 
suggesting further investigation, as well as a metabolic engineering target. In a qualitative study by (Kol, et 
al., 2010), osmotic shock from salt stress was studied using a metabolic fingerprint approach. As many 
metabolites as possible was searched for, and based on database homology, 229 metabolites received a 
putative identity. Further, grouping by hierarchical clustering found that 143 metabolites sorted into 4 
types of clusters, where 33 metabolites were consistently more abundant under salt stress, 19 less 
abundant, and 91 metabolites showed ambiguous, or dynamic, response.  
A number of promising techniques are being developed along the way, and some aim at linking ‘orphan’ 
metabolites in a functional genomics manner, and this way an unknown pathway was discovered in E. coli 
(Saito, et al., 2010). Orphan metabolites are those that can be detected/identified, but so far no plausible 
accounts have been made of the pathways or gene-products used to create these metabolites. This 
establishes the possibility to improve annotation of the genome, and extend any existing metabolic model. 
 Metabolomics can also be used for enzymatic characterization in an in-vitro setting, by monitoring the 
changes in the metabolite pool in-situ, as well as verification of possible pathways predicted in-silico, by 
unequivocally identifying the products and intermediates of the pathway (Saito, et al., 2010). Using a strong 
separation technique, followed by different MS detection methods, allow for accurate mass determination 
(indicative of the molecular formula), fragmentation patterns (indicative of molecular structure) (Dunn, 
2008), thus enabling detection of known metabolites, or identification of new/unknown metabolites.  
Metabolomics, despite its limitations, can yield a great deal of information in terms of identification and 
verification of pathways, as well as the extremely powerful coupling to genome scale, or metabolic flux 
models, where the data can be used to constrain the models, thereby improving their predictive capacity.  
Flux 
One of the basal steps to elucidate the internal workings of a cell is found using metabolic flux analysis 
(MFA), which is aimed at describing the activity of the reaction network, under a given set of conditions. 
For instance, MFA can be used to compare producing and non-producing conditions, to investigate if there 
are some obvious limitations/bottle-necks in precursor supply that could be targeted for metabolic 
engineering (Nielsen, 1998). While MFA does not require knowledge of the genomic sequence per se, it 
does require a basic knowledge of the metabolism, the stoichiometric relationship of the network (Daae & 
Ison, 1999), to obtain a somewhat useful reaction network. This could be the core of the central carbon 
metabolism, TCA, ED, EMP, PP pathways, and subsequently lump all reactions that eventually lead to 
biomass accumulation. This would constitute a minimal reaction network; alternatively, if the genome is 
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sequenced and annotated, a genome scale reaction network can be made from the information in genome 
and annotation databases. MFA relies heavily on massin=massout+accumulation, which means that all 
extracellular metabolites should be measured, and uptake/production rates calculated, in order to 
constrain the solution space of the model. Many of the flux models that are in use today are based on 
solving the network as a linear problem (Gombert, et al., 2001) (Christensen & Nielsen, 2000) (Christensen 
& Nielsen, 2000) (Daae & Ison, 1999) (Sauer, 2006), due to the computational simplicity of such system, and 
requiring only a steady state condition (Kauffman, et al., 2003). One of the problems in MFA is that the 
network is likely underdetermined; (Daae & Ison, 1999) attempted to overcome this by creating the S. 
lividans network, and balancing it to prevent dependent reactions, and therefore some reactions had to be 
omitted; the network of (Daae & Ison, 1999) was 53 metabolites and 57 reactions. (Borodina, et al., 2005) 
created a genome scale network for S. coelicolor, based on genome annotation, containing 971 reaction, 
including transport processes, and 500 metabolites. Based on the sensitivity analysis by (Daae & Ison, 
1999), a relatively big change (20%) in monomeric demands on biomass formation, did not significantly 
affect the overall flux, and therefore E. coli biomass requirements were assumed to be acceptable for use in 
Streptomyces; whether this is a feature of the limited network presented by (Daae & Ison, 1999), is 
unknown, but the assumption propagated to the model presented by (Borodina, et al., 2005).  
MFA relies on measured metabolites and rates to constrain the model to an acceptable solution space, 
though all intracellular reactions are unconstrained, unless further measurements take place. It is possible 
to manually include information from the literature for each specific reaction about the highest possible 
rates in either direction, despite this; the model may not produce a single optimal solution (Price, et al., 
2004). Another way to restrict the network is via the use of Flux Balance Analysis (FBA), which is a 
mathematical method of determining the allowable fluxes through each reaction, and thereby creating a 
possible flux solution space (Varma & Palsson, 1994). One way of introducing information that can help 
constrain the model, is to make measurements relating to the intracellular milieu, this could be coupling 
the metabolome to the analysis, which would constrain the model very efficiently, assuming the 
measurements are reliable (Lee, et al., 2006). Another option is to feed the organisms with isotope labelled 
substrates (Christensen, et al., 2002) (Christensen & Nielsen, 2000), followed by hydrolysis of the biomass, 
to investigate the label incorporation, which gives very reliable information on how carbon exchange has 
taken place in the reaction network. Using labelled substrates (e.g. 13C1-glucose) allows to identify active 
pathways, e.g. in the central carbon metabolism, the labelling pattern of pyruvate tells exactly how active 
ED, EMP and PP pathways are, since PP results in unlabelled pyruvate, due to decarboxylation of C1, ED 
results in 50% labelling in C1 of pyruvate, and EMP results in 50% labelling in C3 of pyruvate. The reason for 
50%, and not 100%, is that 1 13C1-labelled glucose molelcule will be broken into 2 pyruvate molecules. This 
is exactly how we found which actinomycetes have an active ED-pathway, without knowing the sequence 
of many of them (Rattleff, et al., 2013b), the draft of the paper is found in appendix C. Other labelled 
substrates can be used, e.g. U-13C-glucose, which can be used to supplement 13C1-glucose, or used when 
several substrates are being used (Fischer, et al., 2004). 
Many optimisation possibilities are available when considering flux analyses. It could be the calculation of 
the optimal growth medium, minimisation of by-product formation, identifying metabolic engineering 
targets for optimal product formation (Varma & Palsson, 1994). (Bushell, et al., 2006) has used a variant of 
FBA, flux variability analysis, to define medium composition for a S. coelicolor zwf mutant. Further, 
integration with e.g. metabolomics seems very promising, and would allow reducing the degrees of 
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freedom in the flux system (Lee, et al., 2006). FBA can be used to determine the possible solution space for 
fluxes, and when investigating knock-outs a variant of FBA has been developed called minimisation of 
metabolic adjustment (MOMA), which aims at most precisely describing how the mutant strain acts in 
relation to its wildtype counterpart, since simple optimization has shown to be imprecise (Lee, et al., 2006) 
(Price, et al., 2004). Further, flux models have begun to include Boolean rules to describe regulatory control 
in the flux system (Lee, et al., 2006) (Kauffman, et al., 2003).  
MFA can be used to understand how the cell utilises various medium components, and in extension thereof 
increase the understanding to improve certain traits of the cell. In the genome scale flux model presented 
by (Borodina, et al., 2005) the co-factor requirements are included, which can help predict imbalances 
when producing a specific product. As was the case for S. coelicolor and S. lividans producing actinorhodin 
and undecylprodigiosin, (Borodina, et al., 2008) found that deleting the phosphofructokinase (pfk2) in S. 
coelicolor, and forcing flux through pentose phosphate pathway increased the antibiotic production; 
whereas (Butler, et al., 2002) found that a reduced PP-flux, in S. lividans, gave higher production. (Butler, et 
al., 2002) limited the flux through the PP pathway by deleting one of two zwf genes, or the devB gene 
encoding some of the early steps in the PP-pathway. (Butler, et al., 2002)’s results were supported by 
(Rossa, et al., 2002), who ran flux analysis on chemostat grown cells. It is surprising that two so closely 
related organism react so differently, and (Borodina, et al., 2008), does speculate that overflow metabolism 
may be involved, and further concludes that the central carbon metabolism is so tightly regulated that 
overexpression of enzymes may not be enough to counter the effect of flux controlling steps, that should 
rather be deleted, if deregulation is sought. 
An area that has been of much interest concerning flux and Streptomycetes, is the connection between the 
primary and secondary metabolism. Many of the antibiotics, or other secondary metabolites, are produced 
from precursors drained from the primary metabolism, and therefore has this specific utilisation attracted 
some attention. Some of the studies have already been mentioned (Bushell, et al., 2006) (Borodina, et al., 
2008) (Butler, et al., 2002) and (Rossa, et al., 2002).  When the drain from primary metabolism is amino 
acids, or intermediates in amino acid metabolism, it seems there is a positive correlation between 
supplying the needed precursors in the medium, and product formation (Bushell, et al., 2006). A study by 
(Kiviharju, et al., 2007) indicated that for the specific strain they were studying, it seemed that a shift from 
growth to product formation could be obtained best by perturbation of the pH. Further, it was found that 
phosphate limitation is very effective for initiating secondary metabolism, which by now has become a 
well-known fact (Kirk, et al., 2000). It seems that there is an inverse relationship between growth rate and 
flux through PP, TCA and shikimate pathways (Kiviharju, et al., 2007). For TCA a similar relationship was 
observed in S. noursei by (Jonsbu, et al., 2001). Whether these relationships are significant in terms of 
product formation, or if they are a feature of the strains specifically is not known (Rattleff, et al., 2013b), 
but it is interesting that the same optimisation criterion, namely antibiotic production, can be achieved by 
opposite means in two closely related strains, S. lividans and S. coelicolor relating PP-flux (Borodina, et al., 
2008) (Bushell, et al., 2006). According to (Bruheim, et al., 2002) calcium seems to be rather important for 
obtaining high biomass concentrations, and seems to have an inverse relationship with actinorhodin, 
suggesting that calcium in excess should be good for protein production, assuming no other untoward 
regulation occur. (Ryu, et al., 2006) found that deletion of pgm (phosphoglucomutase) was expected to 
yield higher production of actinorhodin, because a smaller amount of carbon was expected to be sourced 
into glycogen. The findings were the opposite, suggesting both that pgm seems to be equally related in 
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build-up and breakdown of glycogen, as well as the understanding at present about glycogen metabolism 
needs to be elucidated. Overexpression of the ACCase (Acetyl Co-enzyme A carboxylase) gave very high 
improvements in the production antibiotics (actinorhodin and undecylprodigiosin). 
Two studies have been found, specifically addressing flux analysis of protein production in S. lividans 
(D'Huys, et al., 2012) and (Nowruzi, et al., 2011). The paper by (D'Huys, et al., 2012) is an extension, of 
(D'Huys, et al., 2011), where the extracellular metabolome was followed to determine amino acid uptake 
profiles, for a heterologous protein producing strain of S. lividans. The data has then subsequently been 
used to define the bounds of a flux analysis, in pseudo steady state, in late exponential growth. The findings 
of (D'Huys, et al., 2012) are that biomass formation is not a suitable optimisation goal, and a second goal 
has to be added for the predictions to fit the data. The secondary goal was found to give the best 
agreement, when using optimal ATP yield, as secondary objective. Further, little flux was found to go 
through PP-pathway, and NADH generation seems to happen in TCA (D'Huys, et al., 2012). The results of 
(D'Huys, et al., 2012) are obtained purely as flux analysis, without isotope labelled substrates, there is 
therefore room for further elucidation of the findings. It is however an excellent example of integrating 
metabolomics and flux analysis. (Nowruzi, et al., 2011) uses a relatively simple model, of the central carbon 
metabolism, and finds that the growth rate limitation is not carbon but nitrogen uptake, either amino acids, 
in the early growth phase (E1), or ammonium in the ‘late’ growth phase (E2). Interestingly, the growth rates 
found by (Nowruzi, et al., 2011) are all below 0.08h-1, which is a lot less than what I have observed during 
my experiments. As far as can be determined, the largest difference between the medium composition of 
(Nowruzi, et al., 2011) (Nowruzi, et al., 2008) and mine, is that I add a vitamin solution (1 mL/L, see chapter 
3), which may relieve further growth limitation.  
Flux analysis, with its various derivations, has been exceedingly helpful in determining the intracellular 
division of carbon, in the Streptomycetes. Successful studies have both improved growth and product 
formation (whether heterologous protein or antibiotic), medium compositions have been optimised and 
links between the primary and secondary metabolism has been established. With the extension of the 
other ‘omics’ analyses there is great hope that the various flux analyses can become even better predictive 
tools. 
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Chapter 7. Discussion and 
perspectives 
While much research has gone into implementing new hosts for heterologous protein production, and S. 
lividans has taken a promising place among the Actinomycete hosts, work is still required before it can be 
considered a generally applicable host. This thesis is the result of a project that has been connected to an 
EU project named STREPTOMICS, with the specific purpose of introducing S. lividans among the general 
hosts for heterologous protein expression. Many of the prerequisites mentioned in chapter 1 are already in 
place, products produced in S. lividans are available, and despite the few actual products, it does indicate 
that S. lividans is capable of use in an industrial setting. Some of the work that needs to be performed is 
gaining a better understanding of the quantitative physiology of strains of S. lividans producing various 
industrially relevant proteins. 
Summing up 
The basic quantitative physiology has been studied in the chapters 3 and 4 of this thesis. Further an 
approach that is compatible with high throughput methods, has been used to screen a large number of 
carbon and nitrogen sources for their influence on growth and product formation. The effect of the carbon 
sources seemed polar, either a high amount of growth or a high amount of product, whereas with the 
nitrogen sources a number of n-sources resulted in high amount of growth and productivity. These were 
tested in larger scales, where more quantitative data could be obtained at the expense of the amount of 
studied sources. The study of the nitrogen sources resulted in a paper submitted to Applied Microbiology 
and Biotechnology. The ultimately best sources were aspartate and glutamate, even beyond normalising 
for carbon contribution. Ammonium seems to be a mediocre nitrogen source, on par with nitrate, though 
when using nitrate more by-products were found, thus making ammonium more preferable.  
The quantitative physiology was more thoroughly studied in chapter 5, where chemostats were used to 
study the effect of growth rate on product formation. Subjecting S. lividans to extremely low dilution rates, 
resulted in a forced production of actinorhodin, but only at dilution rates of less than D≤0.035h-1. 
Morphologically it has been observed that at medium to low dilution rates the WT would grow freely 
dispersed, whereas in the batch experiments, the WT would always form pellets. The mRFP strain for 
unknown reasons obtained higher growth rates in batch, and displayed a freely dispersed morphology at all 
growth/dilution rates. It was seen that protein production was coupled to growth rate, i.e. the higher the 
growth rate the higher the productivity. Within the range of growth rates studied no upper limitation was 
found. 
As supporting foundation of chapter 6 are two papers that have yet to be submitted. One is the preliminary 
flux analysis of several actinomycetes to asses ED-pathway activity, using labelled substrates. The other is a 
co-authorship with Subir Kumar Nandy, of the development of an unstructured kinetic model to predict 
growth and product formation taking both carbon and nitrogen source into account. This model has both 
been used with two and three substrates (one carbon and one nitrogen source, or one carbon-, one 
nitrogen-, and one mixed source [i.e. an amino acid]), see chapter 6. The purpose was to estimate the 
effect of adjusting the C:N ratio, also when comparing to mixed sources as amino acids. The findings 
119 
 
suggest that a higher productivity can be obtained by addition of more nitrogen, and from the results the 
better productivity was observed for ammonium relative to ammonium glutamate mix. In order to optimize 
comparability a fixed amount of glutamate was chosen (to maintain a fixed total level of carbon), and the 
C:N ratio was adjusted by the addition of NH4Cl. 
The physiology of S. lividans has been described across several laboratory relevant volumes of 
fermentations. A degree of variability has been observed that suggests more research in strain propagation 
is necessary, as well as it would be prudent to test the expression from chromosomally integrated genes.  
Perspectives 
The fields of research that are currently being expanded regarding S. lividans, and related strains, include 
development of genetic tools, the study of morphology and developmental biology, fermentation 
knowledge across scales (including this thesis), and genomics with availability of 18 completely and 26 
partially sequenced and/or annotated genome sequences within the genus Streptomyces. 
Genomics 
Genomics open for some interesting fields of study, some of which are already being examined. With the 
publication of genome sequences for S. coelicolor (Bentley, et al. 2002) and S. avermitilis (Ikeda, et al. 2003) 
came also the realisation that a large number of so-called cryptic secondary metabolites were encoded. 
This enabled genome mining for unknown metabolites, though it was realised that it was necessary to 
move these clusters to a strain with a clean background. The relevant developments here includes, artificial 
chromosomes for moving large segments of DNA (Alduina og Gallo 2012), as well as the various approaches 
used to produce strains with clean backgrounds, i.e. strains which produce little or no endogenous 
secondary metabolites. The ‘cleaning’ of these strains was performed in one of three ways: I) sequentially 
deleting portions of the arms of the chromosomes, which are recognised to carry the largest part of the 
secondary metabolites. II) identification and sequential deletion of secondary metabolite synthases (NRPS 
synthases and polyketide synthases), an approach that has proved useful in S. coelicolor (Gomez-Escribano 
og Bibb 2011). III)  the study and use of regulation. Streptomyces have an extraordinary amount of 
(putative) regulatory proteins, and mapping the regulatory network, would allow deleting/overexpressing a 
set of regulators, and potentially obtaining a strain that produces no secondary metabolites, with fewer 
changes than used by method II. Strains with their background “cleaned” would likewise be promising to 
use as producers of primary metabolites, since little carbon would be lost to secondary metabolism by-
products, and purification/DSP would be eased; further a clean background would also be considered safer, 
in a governmental regulatory view, if producing human/pharmaceutical products for human use. 
Regulation 
Genomics of regulatory processes are an entrance to investigate, and possibly solve, several challenges 
related to Actinomycetes including, as mentioned above, reducing by-products from secondary 
metabolism. Describing and characterising the regulatory network would possibly help control the strains 
under fermentation conditions to benefit both primary and secondary metabolite producers. The ability to 
model the behaviour of the cell in changing conditions would improve the descriptive power of the model, 
as mentioned in chapter 6. (Baltz 2011) reviews some of these methods, and shows several examples 
where heterologous overexpression of a positive regulator, or disrupting a negative regulator, can result in 
high production of secondary metabolites. In the case of primary metabolism products, the opposite 
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method could be used as an alternative to, or in extension of, the sequential deletion method to produce a 
strain sporting a cleaner background, and less competing products. Potentially regulation could be used to 
understand and reduce, or benefit from, stress responses, e.g. unfolded protein response. Otherwise could 
regulation of amino acid catabolism or protein degradation be targeted for improving protein yield. 
Furthermore (van Wezel, et al. 2006) has in a morphological engineering approach tested several strains of 
Streptomycetes overexpressing the morphogene ssgA, which results in a high degree of branching, and 
higher enzyme production. In a later paper (Noens, et al. 2007), describes this gene as a cell cycle control 
protein, and states that overexpression of the protein can result in submerged sporulation. Submerged 
sporulation is unwanted, but the increased branching and protein productivity obtained from 
overexpressing ssgA outlines some of the promise presented by better understanding the regulatory 
network. 
Modelling  and ‘omics’ 
Modelling is a field that shows great promise for obtaining a deeper understanding of the relationship 
between an observed phenotype, and the genetic foundation that causes this. Integrative models are 
emerging where genome scale models are being coupled to time-series measurements of other ‘omis’ data; 
one such model has been used to describe the transcriptomic changes of S. coelicolor over the metabolic 
switch from primary to secondary metabolism (Alam, et al. 2010). A different kind of model has been 
developed to understand the influence of morphology on production (Celler, et al. 2012). These models are 
likewise at present unconnected to the genetic foundation, though obtaining this connection would result 
in strong models, with improved descriptive power. 
 The fact that two point mutations rpoB and rpsL can result in higher production of secondary metabolites 
(Jayapal, et al. 2010) also shows that there is a lot we still do not know, and are not really able to model 
yet. The reasons why these two point mutations increase secondary metabolism is not known, but they 
affect the ribosome, which causes more protein production in the secondary metabolism. The full extent of 
the pleiotropic effects of these point mutations have so far not been fully described, though they would be 
hard to model, since the molecular knowledge of the ribosome, however much it has been studied, is not 
completely understood. Furthermore it would result in extremely computer intensive models, if all 
elements in a genome scale network would have to be modelled at the molecular level. These two point 
mutations represent an example where it is nigh to impossible to foresee the effect and illustrates that 
methods known from classical strain optimisation may still be of excellent use and are complementary to 
the more modern, genetic engineering methods. 
Classical vs. modern methods 
Historically random mutagenesis has been used to improve production of either primary products like 
amino acids and organic acids, as well as products from the secondary metabolism. One example of 
sequential mutagenesis has increased antibiotic production in a strain of S. albus from 0.25 g/L to 10 g/L, 
and further to 15 g/L with a directed application of the rpsL mutation. This clearly suggests that some of the 
classical strain optimisation routines are not yet obsolete, and some of the methods have been refined to 
produce e.g. laboratory scale evolution (directed evolution) (Charusanti 2012). 
Directed evolution is a rational approach which aims at obtaining the beneficial mutations (randomly) to 
cope with an increasing selective pressure, and afterwards the resulting strain can be sequenced, either full 
genome or selected regions of the genome, to try to understand what happened. Potentially knowledge 
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from such experiments will lead to increased molecular understanding, thus benefitting both basic research 
as well as the specific product, should the strain become publicly available. The difficult part in directed 
evolution is choosing the proper selective criteria, which will allow the strain to improve production of the 
wanted product. This can be achieved for strong selective pressures, like resistance to environmentally 
harsh conditions, e.g. extreme temperatures/pH or solvent/salt concentrations. With proteins that can 
potentially release nutrient from otherwise inaccessible sources, e.g. xyloglucanase/cellulases etc., 
selection can be introduced as limitations in nutrients, only provided by the specific source, though cellular 
optimisation may be improvement of transporters, or changes in the protein itself, which may be 
undesired. It is a method that shows great promise, especially for the secondary metabolite products, 
though the method has been used for optimising primary metabolism products. Directed evolution is a 
useful extension of genetic engineering, since it allows recovery of the growth rate after genetically 
modifying the cell. 
Genetic stability 
Genetic stability was studied in the 80’s, and the plasmid stability of the pIJ101 plasmid was assessed. 
However, it is still an issue, especially since one of the obvious optimisation criteria for heterologous 
expression is integrating several copies of the gene of interest, followed by using strong promoters. The 
rationale is that this will ensure a higher level of available transcript, which potentially can result in higher 
product formation, though the relation between transcript and protein is not linear. Several copies of the 
genes increase the genetic instability due to homologous recombination, resulting in a strain that is 
unviable for industrial use (Baltz 2011). One method to circumvent gene loss is utilising integration sites 
flanked by essential genes. This way loop-out can be effectively eliminated, as in the case of (Mikkelsen, et 
al. 2012). This method would of course suggest, like for the genome minimised strain or the cleaned strain, 
creating a library of strains prepared for industrial use, with selected and characterised integration sites 
already prepared. The method also highlights the importance of knowledge transfer from entirely separate 
domains, such as yeast and filamentous fungi. Filamentous fungi have some of the same 
features/challenges as Streptomycetes with respect to morphology, while yeast is very well studied and 
methods are developed and tested in a fast pace; therefore the most promising technologies can be 
transferred to Streptomycetes, such as the integration strategy by (Mikkelsen, et al. 2012) mentioned 
above. 
While a large number of vectors exist for heterologous expression in Streptomycetes, many of them are 
multicopy plasmids. One problem with this approach is that multicopy plasmids introduce an extra level of 
population heterogeneity; there is already a great level of heterogeneity, since cells are in found in several 
growth stages, with each their specific penchant for producing enzymes/secondary metabolites/spores, 
especially when large clumps or pellets are present. Adding variability in the number of plasmid per cell, the 
multicopy plasmids that are pIJ101 derived have on average between 40 and 100 copies, unnecessarily 
complicates the analyses of the data. Ensuring an equal level of transcript across the population would 
greatly reduce complications, and risk of plasmid loss can also be avoided by using integrative plasmids 
when establishing a production strain; which is already a known fact, though for cursory tests plasmid 
expression can suffice. Phage integration sites, and vectors utilising these, are available and could be used 
for chromosomal integration of heterologous genes, to increase strain genetic stability (Baltz 2011). Some 
of the phage sites are located in the stable core region of the chromosome (e.g. φC31 or φBT1) (Baltz 2011) 
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Fermentation conditions 
Further (Alduina og Gallo 2012) outlines the importance of optimising the fermentation conditions, e.g. by 
feeding precursors for the products, or by changing the concentration of the limiting nutrient. Alternatively 
the choice, and ratio, of C- and N-sources greatly affect protein production and cellular regulation, and are 
therefore important to optimise likewise. These are important steps for the production of primary 
metabolites. As a metabolic engineering strategy for improving production, the first step may well be to 
feed precursors, followed by the second step, which would be to genetically alter the cell to improve 
precursor supply. With heterologous products spanning both bulk and high value-added products spheres; 
financially some products simply do not allow addition of defined components to the medium. 
Fermentation optimisation does also include optimising the physical parameters, in a more traditional DoE 
approach, adjusting e.g. pH, temperature, stirring, aeration and nutrient supply. I have introduced one 
method, which is compatible with high throughput automation, which allows screening large numbers of 
carbon/nitrogen/phosphorous/sulphur sources for effect on growth and product formation. This method is 
presented in chapters 3 and 4, where the latter has been submitted as a paper to AMB. Further, to fully be 
able to exploit the ‘omics’ methods, the reproducibility of the experiments have to be high. This can be 
obtained either by thoroughly defined batch experiments in bioreactors; this has been established in the 
chapters 3 and 4, or by the application of continuous cultivations, e.g. chemostats, where highly controlled 
highly reproducible samples can be obtained, for improving the reliability of ‘omics’ analyses. 
Model strains 
Streptomyces lividans, as well as S. coelicolor have become the model organisms for heterologous 
expression in the Streptomyces genus, as for several other Actinomycetes. S. lividans is known for its 
relaxed restriction system, low antibiotic production and remarkably low protease activity, whereas S. 
coelicolor has become the model for antibiotic production, and developmental biology, as well as host for 
several heterologous antibiotic clusters. In the heterologous expression of secondary metabolites, some 
methods have been developed that could be beneficial for primary products as well. Artificial 
chromosomes, as reviewed by (Alduina og Gallo 2012), have promised to ease the movement of large DNA 
fragments, especially with regard to secondary metabolite clusters. In the same paper they describe several 
methods for producing clean background strains, as has successfully been applied for S. coelicolor. 
Physiological studies are among the studies that are still needed in developing S. lividans as a production 
host. Recently this avenue of research has been followed by more groups, and advanced analyses, like flux 
(D'Huys, et al. 2011) and time-course transcriptomics (Alam, et al. 2010) are appearing with greater 
frequency. (Anné, et al. 2012) published a review, as a summation of what was achieved in the 
STREPTOMICS project, which also contained the outlook on further developments needed.  They likewise 
point out that physiological characterisation, as well as characterisation of the transport machinery and 
signal peptides are of key importance in the final developing steps.  
Concluding remarks. 
The work in this thesis has primarily focused on developing the methods to be used for obtaining the best 
data from the advanced ‘omics’ analyses. To achieve this, a thorough physiology platform had to be 
established. Firstly basic quantitative physiology was to be estimated, and reproducible conditions in a 
batch reactor had to be obtained. This was supported by a screening set up, where the optimum nutrient 
sources were identified. Subsequently this knowledge was applied to design continuous cultivations, that 
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could reliably and reproducibly be sampled for advanced ‘omics’ analyses. Further, the use of chemostats 
entirely eliminated the effect of the growth rate when comparing mutants, under comparable conditions. 
Thereby the optimal benefit can be gained in the future from the advanced analyses, since the data will be 
robust, the conditions controlled, the experiments repeatable. Lastly a deeper understanding of the 
organism was, and in future experiment will be, obtained, and possibly underlying regulatory events can be 
uncovered. 
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Chapter 8. Appendix A – 
Additional carbon source figures 
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Chapter 9. Appendix B – Table of 
contents of Biolog plates 
 
Figure 26 The list of substrates in the plates PM01, PM02, PM03 and PM04, referred from a text file received from Biolog 
PM01 A01 Negative Control C-Source 
PM01 A02 L-Arabinose C-Source 
PM01 A03 N-Acetyl-D-Glucosamine C-Source 
PM01 A04 D-Saccharic Acid C-Source 
PM01 A05 Succinic Acid C-Source 
PM01 A06 D-Galactose C-Source 
PM01 A07 L-Aspartic Acid C-Source 
PM01 A08 L-Proline C-Source 
PM01 A09 D-Alanine C-Source 
PM01 A10 D-Trehalose C-Source 
PM01 A11 D-Mannose C-Source 
PM01 A12 Dulcitol C-Source 
PM01 B01 D-Serine C-Source 
PM01 B02 D-Sorbitol C-Source 
PM01 B03 Glycerol C-Source 
PM01 B04 L-Fucose C-Source 
PM01 B05 D-Glucuronic Acid C-Source 
PM01 B06 D-Gluconic Acid C-Source 
PM01 B07 D,L-a-Glycerol Phosphate C-Source 
PM01 B08 D-Xylose C-Source 
PM01 B09 D,L-Lactic acid C-Source 
PM01 B10 Formic Acid C-Source 
PM01 B11 D-Mannitol C-Source 
PM01 B12 L-Glutamic Acid C-Source 
PM01 C01 D-Glucose-6-Phosphate C-Source 
PM01 C02 D-Galactonic Acid-g-Lactone C-Source 
PM01 C03 D,L-Malic Acid C-Source 
PM01 C04 D-Ribose C-Source 
PM01 C05 Tween 20 C-Source 
PM01 C06 L-Rhamnose C-Source 
PM01 C07 D-Fructose C-Source 
PM01 C08 Acetic Acid C-Source 
PM01 C09 a-D-Glucose C-Source 
PM01 C10 Maltose C-Source 
PM01 C11 D-Melibiose C-Source 
PM01 C12 Thymidine C-Source 
PM01 D01 L-Asparagine C-Source 
PM01 D02 D-Aspartic Acid C-Source 
PM01 D03 D-Glucosaminic Acid C-Source 
PM01 D04 1,2-Propanediol C-Source 
PM01 D05 Tween 40 C-Source 
PM01 D06 a-Ketoglutaric Acid C-Source 
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PM01 D07 a-Ketobutyric Acid C-Source 
PM01 D08 a-Methyl-D-Galactoside C-Source 
PM01 D09 a-D-Lactose C-Source 
PM01 D10 Lactulose C-Source 
PM01 D11 Sucrose C-Source 
PM01 D12 Uridine C-Source 
PM01 E01 L-Glutamine C-Source 
PM01 E02 m-Tartaric Acid C-Source 
PM01 E03 D-Glucose-1-Phosphate C-Source 
PM01 E04 D-Fructose-6-Phosphate C-Source 
PM01 E05 Tween 80 C-Source 
PM01 E06 a-Hydroxyglutaric Acid-g-Lactone C-Source 
PM01 E07 a-Hydroxybutyric Acid C-Source 
PM01 E08 b-Methyl-D-Glucoside C-Source 
PM01 E09 Adonitol C-Source 
PM01 E10 Maltotriose C-Source 
PM01 E11 2'-Deoxyadenosine C-Source 
PM01 E12 Adenosine C-Source 
PM01 F01 Gly-Asp C-Source 
PM01 F02 Citric Acid C-Source 
PM01 F03 m-Inositol C-Source 
PM01 F04 D-Threonine C-Source 
PM01 F05 Fumaric Acid C-Source 
PM01 F06 Bromosuccinic Acid C-Source 
PM01 F07 Propionic Acid C-Source 
PM01 F08 Mucic Acid C-Source 
PM01 F09 Glycolic Acid C-Source 
PM01 F10 Glyoxylic Acid C-Source 
PM01 F11 D-Cellobiose C-Source 
PM01 F12 Inosine C-Source 
PM01 G01 Gly-Glu C-Source 
PM01 G02 Tricarballylic Acid C-Source 
PM01 G03 L-Serine C-Source 
PM01 G04 L-Threonine C-Source 
PM01 G05 L-Alanine C-Source 
PM01 G06 Ala-Gly C-Source 
PM01 G07 Acetoacetic Acid C-Source 
PM01 G08 N-Acetyl-D-Mannosamine C-Source 
PM01 G09 Mono-Methylsuccinate C-Source 
PM01 G10 Methylpyruvate C-Source 
PM01 G11 D-Malic Acid C-Source 
PM01 G12 L-Malic Acid C-Source 
PM01 H01 Gly-Pro C-Source 
PM01 H02 p-Hydroxyphenyl Acetic Acid C-Source 
PM01 H03 m-Hydroxyphenyl Acetic Acid C-Source 
PM01 H04 Tyramine C-Source 
PM01 H05 D-Psicose C-Source 
PM01 H06 L-Lyxose C-Source 
PM01 H07 Glucuronamide C-Source 
PM01 H08 Pyruvic Acid C-Source 
PM01 H09 L-Galactonic Acid-g-Lactone C-Source 
PM01 H10 D-Galacturonic Acid C-Source 
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PM01 H11 b-Phenylethylamine C-Source 
PM01 H12 2-Aminoethanol C-Source 
PM02A A01 Negative Control C-Source 
PM02A A02 Chondroitin Sulfate C C-Source 
PM02A A03 a-Cyclodextrin C-Source 
PM02A A04 b-Cyclodextrin C-Source 
PM02A A05 g-Cyclodextrin C-Source 
PM02A A06 Dextrin C-Source 
PM02A A07 Gelatin C-Source 
PM02A A08 Glycogen C-Source 
PM02A A09 Inulin C-Source 
PM02A A10 Laminarin C-Source 
PM02A A11 Mannan C-Source 
PM02A A12 Pectin C-Source 
PM02A B01 N-Acetyl-D-Galactosamine C-Source 
PM02A B02 N-Acetyl-Neuraminic Acid C-Source 
PM02A B03 b-D-Allose C-Source 
PM02A B04 Amygdalin C-Source 
PM02A B05 D-Arabinose C-Source 
PM02A B06 D-Arabitol C-Source 
PM02A B07 L-Arabitol C-Source 
PM02A B08 Arbutin C-Source 
PM02A B09 2-Deoxy-D-Ribose C-Source 
PM02A B10 i-Erythritol C-Source 
PM02A B11 D-Fucose C-Source 
PM02A B12 3-0-?-D-Galactopyranosyl-D-Arabinose C-Source 
PM02A C01 Gentiobiose C-Source 
PM02A C02 L-Glucose C-Source 
PM02A C03 D-Lactitol C-Source 
PM02A C04 D-Melezitose C-Source 
PM02A C05 Maltitol C-Source 
PM02A C06 a-Methyl-D-Glucoside C-Source 
PM02A C07 b-Methyl-D-Galactoside C-Source 
PM02A C08 3-Methylglucose C-Source 
PM02A C09 b-Methyl-D-Glucuronic Acid C-Source 
PM02A C10 a-Methyl-D-Mannoside C-Source 
PM02A C11 b-Methyl-D-Xyloside C-Source 
PM02A C12 Palatinose C-Source 
PM02A D01 D-Raffinose C-Source 
PM02A D02 Salicin C-Source 
PM02A D03 Sedoheptulosan C-Source 
PM02A D04 L-Sorbose C-Source 
PM02A D05 Stachyose C-Source 
PM02A D06 D-Tagatose C-Source 
PM02A D07 Turanose C-Source 
PM02A D08 Xylitol C-Source 
PM02A D09 N-Acetyl-D-glucosaminitol C-Source 
PM02A D10 g-Amino-N-Butyric Acid C-Source 
PM02A D11 d-Amino Valeric Acid C-Source 
PM02A D12 Sodium butyrate C-Source 
PM02A E01 Capric Acid C-Source 
PM02A E02 Caproic Acid C-Source 
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PM02A E03 Citraconic Acid C-Source 
PM02A E04 D,L-Citramalic Acid C-Source 
PM02A E05 D-Glucosamine C-Source 
PM02A E06 2-Hydroxybenzoic acid C-Source 
PM02A E07 4-Hydroxybenzoic Acid C-Source 
PM02A E08 b-Hydroxybutyric Acid C-Source 
PM02A E09 g-Hydroxybutyric Acid C-Source 
PM02A E10 2-Oxovaleric acid C-Source 
PM02A E11 Itaconic Acid C-Source 
PM02A E12 5-Keto-D-Gluconic Acid C-Source 
PM02A F01 D-Lactic Acid Methyl Ester C-Source 
PM02A F02 Malonic Acid C-Source 
PM02A F03 Melibionic Acid C-Source 
PM02A F04 Oxalic Acid C-Source 
PM02A F05 Oxalomalic Acid C-Source 
PM02A F06 Quinic Acid C-Source 
PM02A F07 D-Ribono-1,4-Lactone C-Source 
PM02A F08 Sebacic Acid C-Source 
PM02A F09 Sorbic Acid C-Source 
PM02A F10 Succinamic Acid C-Source 
PM02A F11 D-Tartaric Acid C-Source 
PM02A F12 L-Tartaric Acid C-Source 
PM02A G01 Acetamide C-Source 
PM02A G02 L-Alaninamide C-Source 
PM02A G03 N-Acetyl-L-Glutamic Acid C-Source 
PM02A G04 L-Arginine C-Source 
PM02A G05 Glycine C-Source 
PM02A G06 L-Histidine C-Source 
PM02A G07 L-Homoserine C-Source 
PM02A G08 Hydroxy-L-Proline C-Source 
PM02A G09 L-Isoleucine C-Source 
PM02A G10 L-Leucine C-Source 
PM02A G11 L-Lysine C-Source 
PM02A G12 L-Methionine C-Source 
PM02A H01 L-Ornithine C-Source 
PM02A H02 L-Phenylalanine C-Source 
PM02A H03 L-Pyroglutamic Acid C-Source 
PM02A H04 L-Valine C-Source 
PM02A H05 D,L-Carnitine C-Source 
PM02A H06 Sec-Butylamine C-Source 
PM02A H07 D,L-Octopamine C-Source 
PM02A H08 Putrescine C-Source 
PM02A H09 Dihydroxyacetone C-Source 
PM02A H10 2,3-Butanediol C-Source 
PM02A H11 2,3-Butanone C-Source 
PM02A H12 3-Hydroxy 2-Butanone C-Source 
PM03B A01 Negative Control N-Source 
PM03B A02 Ammonia N-Source 
PM03B A03 Nitrite N-Source 
PM03B A04 Nitrate N-Source 
PM03B A05 Urea N-Source 
PM03B A06 Biuret N-Source 
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PM03B A07 L-Alanine N-Source 
PM03B A08 L-Arginine N-Source 
PM03B A09 L-Asparagine N-Source 
PM03B A10 L-Aspartic Acid N-Source 
PM03B A11 L-Cysteine N-Source 
PM03B A12 L-Glutamic Acid N-Source 
PM03B B01 L-Glutamine N-Source 
PM03B B02 Glycine N-Source 
PM03B B03 L-Histidine N-Source 
PM03B B04 L-Isoleucine N-Source 
PM03B B05 L-Leucine N-Source 
PM03B B06 L-Lysine N-Source 
PM03B B07 L-Methionine N-Source 
PM03B B08 L-Phenylalanine N-Source 
PM03B B09 L-Proline N-Source 
PM03B B10 L-Serine N-Source 
PM03B B11 L-Threonine N-Source 
PM03B B12 L-Tryptophan N-Source 
PM03B C01 L-Tyrosine N-Source 
PM03B C02 L-Valine N-Source 
PM03B C03 D-Alanine N-Source 
PM03B C04 D-Asparagine N-Source 
PM03B C05 D-Aspartic Acid N-Source 
PM03B C06 D-Glutamic Acid N-Source 
PM03B C07 D-Lysine N-Source 
PM03B C08 D-Serine N-Source 
PM03B C09 D-Valine N-Source 
PM03B C10 L-Citrulline N-Source 
PM03B C11 L-Homoserine N-Source 
PM03B C12 L-Ornithine N-Source 
PM03B D01 N-Acetyl-L-Glutamic Acid N-Source 
PM03B D02 N-Phthaloyl-L-Glutamic Acid N-Source 
PM03B D03 L-Pyroglutamic Acid N-Source 
PM03B D04 Hydroxylamine N-Source 
PM03B D05 Methylamine N-Source 
PM03B D06 N-Amylamine N-Source 
PM03B D07 N-Butylamine N-Source 
PM03B D08 Ethylamine N-Source 
PM03B D09 Ethanolamine N-Source 
PM03B D10 Ethylenediamine N-Source 
PM03B D11 Putrescine N-Source 
PM03B D12 Agmatine N-Source 
PM03B E01 Histamine N-Source 
PM03B E02 b-Phenylethylamine N-Source 
PM03B E03 Tyramine N-Source 
PM03B E04 Acetamide N-Source 
PM03B E05 Formamide N-Source 
PM03B E06 Glucuronamide N-Source 
PM03B E07 D,L-Lactamide N-Source 
PM03B E08 D-Glucosamine N-Source 
PM03B E09 D-Galactosamine N-Source 
PM03B E10 D-Mannosamine N-Source 
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PM03B E11 N-Acetyl-D-Glucosamine N-Source 
PM03B E12 N-Acetyl-D-Galactosamine N-Source 
PM03B F01 N-Acetyl-D-Mannosamine N-Source 
PM03B F02 Adenine N-Source 
PM03B F03 Adenosine N-Source 
PM03B F04 Cytidine N-Source 
PM03B F05 Cytosine N-Source 
PM03B F06 Guanine N-Source 
PM03B F07 Guanosine N-Source 
PM03B F08 Thymine N-Source 
PM03B F09 Thymidine N-Source 
PM03B F10 Uracil N-Source 
PM03B F11 Uridine N-Source 
PM03B F12 Inosine N-Source 
PM03B G01 Xanthine N-Source 
PM03B G02 Xanthosine N-Source 
PM03B G03 Uric Acid N-Source 
PM03B G04 Alloxan N-Source 
PM03B G05 Allantoin N-Source 
PM03B G06 Parabanic Acid N-Source 
PM03B G07 D,L-a-Amino-N-Butyric Acid N-Source 
PM03B G08 g-Amino-N-Butyric Acid N-Source 
PM03B G09 e-Amino-N-Caproic Acid N-Source 
PM03B G10 D,L-a-Amino-Caprylic Acid N-Source 
PM03B G11 d-Amino-N-Valeric Acid N-Source 
PM03B G12 a-Amino-N-Valeric Acid N-Source 
PM03B H01 Ala-Asp N-Source 
PM03B H02 Ala-Gln N-Source 
PM03B H03 Ala-Glu N-Source 
PM03B H04 Ala-Gly N-Source 
PM03B H05 Ala-His N-Source 
PM03B H06 Ala-Leu N-Source 
PM03B H07 Ala-Thr N-Source 
PM03B H08 Gly-Asn N-Source 
PM03B H09 Gly-Gln N-Source 
PM03B H10 Gly-Glu N-Source 
PM03B H11 Gly-Met N-Source 
PM03B H12 Met-Ala N-Source 
PM04A A01 Negative Control P-Source 
PM04A A02 Phosphate P-Source 
PM04A A03 Pyrophosphate P-Source 
PM04A A04 Trimetaphosphate P-Source 
PM04A A05 Tripolyphosphate P-Source 
PM04A A06 Triethyl Phosphate P-Source 
PM04A A07 Hypophosphite P-Source 
PM04A A08 Adenosine 2'-Monophosphate P-Source 
PM04A A09 Adenosine 3'-Monophosphate P-Source 
PM04A A10 Adenosine 5'-Monophosphate P-Source 
PM04A A11 Adenosine 2',3'-Cyclic Monophosphate P-Source 
PM04A A12 Adenosine 3',5'-Cyclic Monophosphate P-Source 
PM04A B01 Thiophosphate P-Source 
PM04A B02 Dithiophosphate P-Source 
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PM04A B03 D,L-a-Glycerol Phosphate P-Source 
PM04A B04 b-Glycerol Phosphate P-Source 
PM04A B05 Carbamyl Phosphate P-Source 
PM04A B06 D-2-Phospho-Glyceric Acid P-Source 
PM04A B07 D-3-Phospho-Glyceric Acid P-Source 
PM04A B08 Guanosine 2'-Monophosphate P-Source 
PM04A B09 Guanosine 3'-Monophosphate P-Source 
PM04A B10 Guanosine 5'-Monophosphate P-Source 
PM04A B11 Guanosine 2',3'-Cyclic Monophosphate P-Source 
PM04A B12 Guanosine 3',5'-Cyclic Monophosphate P-Source 
PM04A C01 Phosphoenol Pyruvate P-Source 
PM04A C02 Phospho-Glycolic Acid P-Source 
PM04A C03 D-Glucose-1-Phosphate P-Source 
PM04A C04 D-Glucose-6-Phosphate P-Source 
PM04A C05 2-Deoxy-D-Glucose 6-Phosphate P-Source 
PM04A C06 D-Glucosamine-6-Phosphate P-Source 
PM04A C07 6-Phospho-Gluconic Acid P-Source 
PM04A C08 Cytidine 2'-Monophosphate P-Source 
PM04A C09 Cytidine 3'-Monophosphate P-Source 
PM04A C10 Cytidine 5'-Monophosphate P-Source 
PM04A C11 Cytidine 2',3'-Cyclic Monophosphate P-Source 
PM04A C12 Cytidine 3',5'-Cyclic Monophosphate P-Source 
PM04A D01 D-Mannose-1-Phosphate P-Source 
PM04A D02 D-Mannose-6-Phosphate P-Source 
PM04A D03 Cysteamine-S-Phosphate P-Source 
PM04A D04 Phospho-L-Arginine P-Source 
PM04A D05 O-Phospho-D-Serine P-Source 
PM04A D06 O-Phospho-L-Serine P-Source 
PM04A D07 O-Phospho-L-Threonine P-Source 
PM04A D08 Uridine 2'-Monophosphate P-Source 
PM04A D09 Uridine 3'-Monophosphate P-Source 
PM04A D10 Uridine 5'-Monophosphate P-Source 
PM04A D11 Uridine 2',3'-Cyclic Monophosphate P-Source 
PM04A D12 Uridine 3',5'-Cyclic Monophosphate P-Source 
PM04A E01 O-Phospho-D-Tyrosine P-Source 
PM04A E02 O-Phospho-L-Tyrosine P-Source 
PM04A E03 Phosphocreatine P-Source 
PM04A E04 Phosphoryl Choline P-Source 
PM04A E05 O-Phosphoryl-Ethanolamine P-Source 
PM04A E06 Phosphono Acetic Acid P-Source 
PM04A E07 2-Aminoethyl Phosphonic Acid P-Source 
PM04A E08 Methylene Diphosphonic Acid P-Source 
PM04A E09 Thymidine 3'-Monophosphate P-Source 
PM04A E10 Thymidine 5'-Monophosphate P-Source 
PM04A E11 Inositol Hexaphosphate P-Source 
PM04A E12 Thymidine 3',5'-Cyclic Monophosphate P-Source 
PM04A F01 Negative Control S-Source 
PM04A F02 Sulfate S-Source 
PM04A F03 Thiosulfate S-Source 
PM04A F04 Tetrathionate S-Source 
PM04A F05 Thiophosphate S-Source 
PM04A F06 Dithiophosphate S-Source 
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PM04A F07 L-Cysteine S-Source 
PM04A F08 D-Cysteine S-Source 
PM04A F09 Cys-Gly S-Source 
PM04A F10 L-Cysteic Acid S-Source 
PM04A F11 Cysteamine S-Source 
PM04A F12 L-Cysteine Sulfinic Acid S-Source 
PM04A G01 N-Acetyl-L-Cysteine S-Source 
PM04A G02 S-Methyl-L-Cysteine S-Source 
PM04A G03 Cystathionine S-Source 
PM04A G04 Lanthionine S-Source 
PM04A G05 Glutathione S-Source 
PM04A G06 D,L-Ethionine S-Source 
PM04A G07 L-Methionine S-Source 
PM04A G08 D-Methionine S-Source 
PM04A G09 Gly-Met S-Source 
PM04A G10 N-Acetyl-D,L-Methionine S-Source 
PM04A G11 L-Methionine Sulfoxide S-Source 
PM04A G12 L-Methionine Sulfone S-Source 
PM04A H01 L-Djenkolic Acid S-Source 
PM04A H02 Thiourea S-Source 
PM04A H03 1-Thio-b-D-Glucose S-Source 
PM04A H04 D,L-Lipoamide S-Source 
PM04A H05 Taurocholic Acid S-Source 
PM04A H06 Taurine S-Source 
PM04A H07 Hypotaurine S-Source 
PM04A H08 p-Aminobenzene Sulfonic Acid S-Source 
PM04A H09 Butane Sulfonic Acid S-Source 
PM04A H10 2-Hydroxyethane Sulfonic Acid S-Source 
PM04A H11 Methane Sulfonic Acid S-Source 
PM04A H12 Tetramethylene Sulfone S-Source 
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Chapter 10. Appendix C - The draft 
of the paper (Rattleff, et al., 2013b) 
Included is the current the draft of the paper  
(Rattleff, Nielsen, Rokem, & Lantz, 2013b) 
In its current state 
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Abstract 
The phylum Actinobacteria includes many bacteria of industrial importance for production of 
primary and secondary metabolites. Both the formation of primary and secondary metabolites 
depends on precursors and cofactors that are provided by the central carbon metabolism of 
microorganisms. There are alternative pathways for catabolism of carbon either via the Embden 
Meyerhof Parnas (EMP) and pentose phosphate (PP) pathway or through the Entner Doudoroff 
(ED) pathway. The EMP pathway is energetically more favorable and has therefore been presumed 
to be the dominating route for carbon metabolism in bacteria producing secondary metabolites. 
However, the primary metabolism is poorly studied for most Actinobacteria species, as focus 
traditionally has been on secondary metabolism. With the aim to gain more knowledge about the 
diversity of central carbon metabolism within the phylum Actinobacteria, 16 different species, 
representing four families were investigated. The study included 11 species belonging to the 
family Streptomycetaceae, three belonging to Pseudonocardiaceae, one belonging to 
Micromonosporaceae and one species belonging to the family Corynebacteriaceae. 13C-labeling 
methodology was applied to determine active pathways and to estimate fluxes through the 
central carbon metabolism. Four of the 16 species were found to have an active ED pathway, with 
three of these species belonging to the family Pseudonocardiaceae for which there has not earlier 
been reported presence of an active ED pathway, and one specie belonging to the family 
Streptomycetaceae. Clustering of the strains based on activities in the central carbon metabolism 
does not correlate with their phylogeny. Hence, the results indicate that the pathway in use for 
central carbon metabolism is more connected to the environmental niche the different species 
have evolved in rather than their phylogenetic group. 
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Introduction 
The phylum Actinobacteria contains many species with high industrial relevance as it includes 
many antibiotic producers. Many of the known strains have been discovered in the search for new 
antibiotics and other bioactive compounds and more than half of the known microbial antibiotics 
are produced by Streptomyces spp. (Kieser et al 2000). Actinobacteria are also used for the 
production of enzymes, herbicides and amino acids. Consequently, there has been a great interest in 
studying this group of bacteria. Focus has, however, been on biosynthetic pathways leading to 
secondary metabolite formation and their regulation, and the central carbon metabolism is still 
poorly understood for many Actinobacteria [Hodgson, 2000 #72], Janacek 1997.  
There are three different pathways by which glucose can be converted to pyruvate: the 
Embden-Meyerhof-Parnas (EMP) pathway, the Entner-Doudoroff (ED) pathway and the pentose 
phosphate (PP) pathway. In streptomycetes, glucose has been considered to be metabolized through 
the EMP pathway and the PP pathway, the former normally being the dominating one [Hodgson, 
2000 #72](Cochrane 1961). ED pathway activity is regarded as very rare within the phylum 
Actinobacteria. Until recently the presence of ED pathway activity had only been discovered in one 
single mycobacterium species, Mycobacterium smegmatis (Bai et al 1976), but in the recent years 
our perception of glucose metabolism in Actinobacteria has been revised with reports on ED 
pathway activity in Nonomuraea sp. ATCC 39727 [Gunnarsson, 2004 #69] and in Str. tenebrarius. 
[Borodina, 2005 #67].   
The objective of the present study was to gain more knowledge about the diversity of central 
carbon metabolism within the phylum Actinobacteria. In particular we wanted to address the 
question how wide spread ED pathway activity is in Actinobacteria and whether there is a 
correlation between phylogeny and activities of the central carbon pathways Fuhrer et al 2005, 
Selig et al 1997, Rominus and Morgan 2003. Sixteen strains representing four families, namely 
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Streptomycetaceae, Micromonosporaceae, Pseudonocardiaceae and Corynebacteriaceae, were 
collected from various sources and strain collections.  The strains were grown in minimal medium 
with [1-13C] glucose as carbon source.  The 13C-labeling patterns of the proteinogenic amino acids 
were determined by GC-MS analysis. The resulting isotope patterns reflect the activity of 
intracellular pathways and the network topology of active reactions can be identified. There are 
several recent examples were the use of isotope balancing in combination with metabolite 
balancing has been shown to be useful for identification of novel or unexpected metabolic 
pathways (Fischer 2003) [Gunnarsson, 2004 #69] + wiechert?). In the present study the labeling 
patterns of alanine and valine were of particular interest as they are derived from pyruvate and 
therefore can be used to distinguish whether glucose is metabolized through the ED pathway, the 
EMP pathway or the PP pathway.  
In addition to obtain fundamental information about the inheritance of central carbon pathways 
in Actinobacteria we wanted to gain a better understanding of the central carbon metabolism in 
general. This would provide knowledge that can be used for strain improvement in antibiotic 
production processes as the central carbon metabolism is tightly linked to secondary metabolism 
through supply of building blocks/precursors and co-factors.  
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Materials and Methods 
Strain and propagation. The following strains were used: Streptomyces alboniger ATCC 
12462 (received from The Hebrew University of Jerusalem), Str. avermitilis DSM 46492 (ordered 
from DSMZ), Str. canescus ATCC 15731 (received from The Hebrew University of Jerusalem), 
Str. coelicolor M145 (received from John Innes Centre, Norwich, UK), Str. mediocidicus ATCC 
13278 (received from The Hebrew University of Jerusalem, Israel), Str. refuineus NRRL 3143 
(received from The Hebrew University of Jerusalem, Israel),  Str. roseochromogenes ATCC 13400 
(received from The Hebrew University of Jerusalem, Israel), Str. tenebrarius ATCC 17920 (ordered 
from ATCC), Str. tsusumacensis ATCC 15141 (received from The Hebrew University of 
Jerusalem, Israel), Str. PRL 1642 ATCC 23836 (received from The Hebrew University of 
Jerusalem, Israel), Actinoplanes teichomyceticus ATCC 31121 (ordered from ATCC), 
Amycolatopsis balhimycina DSM 5908 (received from University of Tübingen, Germany), Am.  
orientalis ATCC 19795 (ordered from ATCC), Saccharopolyspora erythraea DSM 40517 (ordered 
from DSMZ), Corynebacterium glutamicum DSM 20300 (ordered from DSMZ), and Streptomyces 
lividans TK24 (received from Katholieke Universiteit Leuven, Belgium). The strains were 
maintained on YESP agar plates (glucose 15 g l
-1
, glycerol 15 g l
-1
, yeast extract 5 g l
-1
, soya 
peptone 15 g l
-1
, NaCl 3 g l
-1
, agar 20 g l
-1
, pH=7.0). For longer storage, stocks (as spore 
suspensions or mycelia) were stored at –80 C in 20% glycerol. For seed culture preparations, a 500 
mL baffled Erlenmeyer flask containing 50 mL YESP medium was inoculated with one loop cells 
from a plate and incubated with shaking (150 rpm) at 28C for 24-48 h until a OD600nm  of  4-6 was 
reached.   
 Cultivation conditions. The cultivations with labeled substrate were carried out in 500 mL 
Erlenmeyer flasks containing 100 mL of a minimal medium. The medium contained 9.9 g l
-1
 
(NH4)2SO4, 1.63 g l
-1
 KH2PO4, 1.5 g l
-1
 MgSO4 · 7H2O, 1 g l
-1
 NaCl, 20 mg l
-1
 FeSO4 · 7H2O, 20 
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mg l
-1
 ZnSO4 · 7H2O, 10 mg l
-1 
MnSO4 · H2O, 10 mg l
-1 
CaCl2· 2H2O, 5 mg l
-1
 Na3-citrate· 2H2O, 50 
mM MES and 20 g l
-1
 glucose, with an initial pH of 7.0. Half of the glucose was [1-
13
C] glucose 
(Omicron Biochemicals, South Bend, IN). The flasks were inoculated to a start OD600nm of 0.3 from 
the seed cultures and incubated at 28C and 150 rpm. Each strain was cultivated twice. 
Cell mass determination. Throughout the cultivations, cell mass concentration was followed 
by measurement of OD600nm. For the end samples dry cell mass was determined gravimetrically. 
Volumes between 5 and 10 ml, depending on the concentration of cell mass, were filtered through 
pre-dried nitrocellulose filters with pore size 0.45 m (Supor-450; Pall Corporation, Ann Arbor, 
MI). The filter cakes were washed with distilled water, twice the sample volume, and dried in a 
microwave oven for 20 min at 150W. The mass gain was measured after the filter was cooled 
down in a desiccator for 15-30 minutes.  
Amino acid derivatization and GC-MS analysis. For analysis of proteinogenic amino acids, 
cell mass was harvested by centrifugation (5000g, 10 minutes), washed twice with distilled water 
and stored at -20C until further analysis. Samples, in duplicates, were withdrawn from the 
cultivations at two time-points, corresponding to mid exponential and late exponential growth 
phase. The day before analysis the cell mass was dried in aliquots 16-20 h at 105C. For hydrolysis 
of total cell protein, approx. 5 mg of dry cell mass was resuspended in 800 l 6M HCl and 
hydrolyzed for 16-24h at 105C. Next the hydrolyzate was divided into 200 l aliquots, dried at 
105C and used for amino acid derivatization. Amino acid derivatization and GC-MS analysis were 
performed as described previously (Christensen and Nielsen, 1999, 2000).  
Several ion clusters can be seen for each amino acid in the MS spectra, due to fragmentation of the 
derivatized amino acids during the ionization process. The labeling of each fragment was corrected 
for the natural labeling of the derivatization agent and for  natural labeling of oxygen, hydrogen and 
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nitrogen content of the amino acids  and the labeling patterns of the amino acid derived parts of the 
fragments were described in terms of summed fractional labeling, SFL (Christensen and Nielsen, 
1999, 2000), according to the formula: 
SFL (%) = 100
....
....10
10
10 


n
n
III
InII
 
where I0 is the intensity of the peak resulting from the unlabeled mass isotopomer, I1 is the intensity 
of the peak arising from the mass isotopomers with one 
13
C atom, and In is the intensity of the peak 
corresponding to the mass isotopomer where all carbon atoms are 
13
C. As the natural occurrence of 
13
C is 1.1%, the SFL of a naturally labeled fragment with n carbon atoms will be n.n%.  
Data analysis. The software Unscrambler version 7.6 (CAMO, Norway) was used for principal 
component analysis (PCA) modeling. SFL values for all amino acid fragments except those of 
threonine and serine were used as predictors (X matrix). All X-variables were centered and 
weighted to unit variance. Segmented cross validation was applied with samples from the same 
strain forming one block. PCA decomposes data into a structure part and a noise part in order to 
provide an interpretable overview of the main information of multivariate data (Wold et al., 1987). 
The algorithm reduces the number of variables and the information is projected onto a smaller 
number of significant variables, the so-called principal components (PCs). The PCs are linear 
combinations of the original variables and are selected so that the first PC covers as much of the 
variation in the data as possible. The second PC is orthogonal to the first and covers as much of the 
remaining variation as possible, and so forth. 
For hierarchical clustering the software MATLAB Version 7.0.4 (The MathWorks, Inc., Natrick, MA, 
USA) was applied. Group average linkage (also called UPGMA) was used as agglomerative method 
and Euclidean distance was used as similarity measure between samples. SFL values were 
normalized before analysis. Hierarchical clustering works by iteratively joining the two closest 
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clusters starting from singleton clusters (agglomerative methods) or iteratively partitioning 
clusters starting with the complete set (divisive methods) (Guenoche 1991). With the linkage 
method used in the present work, at each stage, two clusters are merged such that the newly 
formed cluster, on average, will have minimum pairwise distances between its points. Hierarchical 
clustering may be represented by a two dimensional diagram known as dendrogram which 
illustrates the fusions or divisions made at each successive stage of analysis.  
 
 
RESULTS 
In order to estimate the activity of different pathways in the central carbon metabolism in 
Actinobacteria, 13C-labeling experiments were performed and the positional labeling patterns of 
central metabolites determined for sixteen different strains.  The strains were selected from 
different groups of the phylum Actinobacteria, however, the majority were streptomycetes, as an 
active ED pathway recently was detected in a species belonging to this genus, namely 
Streptomyces tenebrarius [Borodina, 2005 #67]. Batch cultivations in minimal media with glucose 
as the sole carbon source was carried out as described above, with half of the glucose labeled in 
the first position. Cells were harvested at two time points in the exponential growth phase for 
each strain and the SFLs of the proteinogenic amino acid fragments were determined by GC-MS 
analysis (Table 1).  
EMP and ED. Glucose can hypothetically be catabolized to triose through the EMP, ED or PP 
pathways. The activity of each metabolic pathway can be estimated from the positional labeling of 
pyruvate. The oxidative part of PP and ED both result in unlabeled pyruvate-C3, whereas if glucose 
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is metabolized through EMP, 50% of the pyruvate will be labeled in position 3 when 100% [1]-13C-
glucose is used as substrate (Figure PYRlabel). The natural labeling of pyruvate-C1 is 1.1%. Strains 
having a significant higher labeling in this position of pyruvate have an active ED pathway as 
conversion of glucose to pyruvate through the ED pathway results in, that the labeling of [1]-13C-
glucose remains in the carbon in the first position. By combining the SFLs of alanine 158, alanine 
99/116 and valine 143, the fractional labeling for each C of pyruvate can be calculated. High 
labeling in pyruvate-C1, and consequently presence of ED pathway were observed for four strains 
out of the sixteen investigated; Sacc. erythrea, Am. orientalis, Str. tenebrarius and Am. balhimycina 
(Table 1). Sacc. erythrea and Am. orientalis almost exclusively used ED, whereas a combination of 
ED and EMP metabolism was seen for the other two strains, Str. tenebrarius and Am. balhimycina .  
PP pathway.  Amino acids originating from precursor metabolites in the lower part of EMP 
pathway, such as glycerol 3-phosphate (G3P) and pyruvate, have lower labeling for strains having a 
high PP activity as the carbon 13 from the C1 of glucose is lost as carbon dioxide in the oxidative 
part of PP.  SFL of alanine 158, corresponding to pyruvate C1-3, can be used to estimate the PP 
activity, the lower the SFL the higher the pentose phosphate pathway (PPP) flux. The SFL of the 
glucose fed to the cells in the present work was 55.55%, and the labeling of pyruvate C1-3 will 
then be 27.75% if PPP is inactive. The strains could be divided into three groups based on PPP 
activity. Str. sp PRL1642, Str. mediocidicus, Str. roseochromogenes and Str.tsusumacensis had SFLs 
of 27-28% indicating very low PP activity under the investigated conditions. Sacc. erythrea, Str. 
canescus, Str. avermitilis, Str. refuineus, Str. coelicolor, Str. lividans, Am. balhimycina, and Act. 
teichomyceticus had a low to moderate PP activity, whereas, high PP activity was observed for Str. 
alboniger, Str. tenebrarius, C. glutamicum and Am. orientalis.  
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TCA cycle and anaplerotic routes. C2 of asparatate, derived from oxaloacetate, is formed 
from C3 and C4 of -ketoglutarate. C3 of pyruvate (comes from glucose-C1 if the EMP pathway is 
active) corresponds to C4 in -ketoglutarate. A high SFL of asparatate115, which represents 
labeling of C2 in oxaloacetate, therefore corresponds to a high TCA flux. For the strains having an 
active ED pathway the labeling in asparatate 115 was low as expected, as pyruvate-C1 is lost as 
CO2 resulting in a low labeling of AcCoA. Thus, one cannot conclude anything about the TCA flux 
using the SFL of asparatate115 for strains having ED pathway activity.  
Investigation of the labeling in pyruvate and TCA-intermediates also provides information 
about the presence of anaplerotic routes.  If the labeling in TCA-intermediates is solely from 
pyruvate, the labeling per C of pyruvate should be similar to that of oxaloacetate and –
ketoglutarate. This was the case for the non-ED strains, and consequently, there was no (or low) 
flux through anaplerotic routes at the investigated conditions (Table 1). For the two strains with 
high ED activity, Am. orientalis and Sacc. erythrea, a higher labeling in TCA-intermediates than in 
pyruvate was observed. The labeling per carbon of AcCoA entering TCA was 2.8 and 2.3, whereas 
the TCA-intermediates had labelings of 4.0-4.1 and 4.0-4.3 per carbon, for Am. orientalis and Sacc. 
erythrea, respectively, indicating that carbon must enter the TCA through another route. PEP 
carboxylase and pyruvate carboxylase are both anaplerotic enzymes that have been found in 
Actinobacteria and have been thoroughly studied in Corynebacterium glutamicum (Shirai 2007 
AND Peters-Wendish 2001 AND Mukhopadhyay 2000). As the labeling per carbon in PEP was 1.6 
and 1.7, respectively, the presence of PEP carboxylase would not result in increased labeling in 
TCA-intermediates.  However, through the action of pyruvate carboxylase, catalysing the 
carboxylation of pyruvate to oxaloacetate, the labeling from pyruvate-C1 (which is high for strains 
with ED activity) will be transferred to oxaloacetate. 
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Malic enxyme. Malic enzyme  converts malate to pyruvate coupled with the production of 
NAD(P)H and has been found in C. glutamicum (Gourdon 2000), in Mycobacterium, (probable NAD 
enzyme found in Mycobacterium bovis and smegmatis BLAST), and in Str. coelicolor (Rodriguez 
2012). From the SFL of phenylalanine143 it could be seen that the labeling per carbon in PEP was 
close to the natural labeling for all strains (1.5-1.9). On the other hand, the labeling in pyruvate-
C1,C2 (valine143) for many of the strains was higher than the natural labeling. A higher labeling in 
pyruvate-C1 can be the result of an active ED pathway as discussed earlier, so instead the labeling 
in pyruvate-C2, calculated from alanine and valine fragments was assessed. An increased labeling 
(4.4-4.8) was observed for Str. sp PRL1642, Str. mediocidicus, Str. roseochromogenes and  Str. 
tsusumacensis, indicating activity of malic enzyme in those strains. 
Clustering of strains. In order to examine data structure and evaluate whether the grouping 
of strains based on central carbon metabolism activity follows phylogeny or not, PCA and 
hierarchical clustering were applied on the obtained SFLs for the different strains. PCA is a data 
reduction method, which from multivariate data defines a smaller variable set, so called principal 
components (PCs), that retains the amount of information present in the original data set (Wold 
1987). The two first principal components explained 89% of the variation and the strains formed 4 
clusters (Figure PCA). Three of the strains that have an active ED pathway, Sac. erythreae, Am. 
orientalis and Str. tenebrarius, formed a cluster, whereas the fourth strain with ED, Am. 
balhimycina, did not cluster with these three strains, but with cluster three, which consisted of C. 
glutamicum, Str. canescus and Str. alboniger. Cluster two comprised Act. teichomycetius, Str. 
lividans, Str. coelicolor, Str. avermitlitis.  Str. refuineus; Str mediocidicus, Str. PRL 1642, Str 
roseochromogenes and Str. tsusumacensis formed the last cluster. Comparing the score plot with 
the loading plot (data not shown) it could be seen that the direction of PC1 corresponded to the 
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labeling in pyruvate-C3. To verify the influence of an active ED pathway on the grouping of strains, 
the analysis was redone without the SFLs of valine143 and 186, glycine175, alanine158 and 
phenylalanine143 and 192. The same clustering as before could be observed, with the only 
difference that Am. balhimycina did not form a separate group any more in the score plot, but 
clustered with C. glutamicum, Str. canescus and Str. alboniger (data not shown). This indicates that 
clustering was based on total central carbon activity and not only on EMP and ED activities.  
The second unsupervised method applied, hierarchical clustering, uses dissimilarities or 
distances between the objects when forming clusters. Hierarchical Clustering is subdivided into 
bottom-up or agglomerative methods, which start with each object in a separate cluster and by 
series of fusions of the n objects combines them into groups, and top-down or divisive methods, 
which separate n objects successively into finer groupings.  We have used an agglomerative 
method, group average, where the distance between two clusters is calculated as the average 
distance between all pairs of objects in the two different clusters. The dendrogram plot of the 
clustering results suggested 4 clusters, the clusters being the same as for PCA (figure dendrogram). 
If the cut off was chosen to gain 5 clusters, Am. balhimycina formed a cluster by its own, and with 
4 clusters it grouped with C. glutamicum, Str. canescus and Str. alboniger, as for the PCA without 
SFLs for pyruvate derived amino acid fragments. 
The specific growth rate was determined for the different strains (data not shown). It could be 
argued that the effect of the growth rate would dominate the clustering results, though it was 
clear from the clustering that this was not the case, as there was a considerable variance of 
growth rates within each of the obtained clusters (data not shown). 
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DISCUSSION 
We have applied 13C-labeling methodology for mapping of central carbon metabolism in 
sixteen different Actinobacteria strains. The use of labeled glucose for analysis of network 
topology is an attractive method since it provides integrative information about the activity of 
different pathways and thereby about in vivo fluxes in the cells. Furthermore, in contrast to other 
methods applied in metabolic engineering, e.g. transcriptome and proteome analysis, 13C-labeling 
can be applied on micro-organisms for which there is only little knowledge available. 
PCA as well as hierarchical clustering based on the SFL data directly resulted in four to five 
clusters. To explore which common traits in physiology that made the strains cluster together, the 
level of activity of the ED, EMP, PP and TCA pathways were estimated for all the investigated 
strains based on SFL values as discussed earlier (Table 2). Characteristics of cluster one (Sac. 
erythreae, Am. orientalis and Str. tenebrarius) was in particular presence of an active ED pathway, 
furthermore, the strains had low EMP activity. The reason why Am. balhimycina clustered with 
cluster three might be due to the fact that this strain also has a higher EMP activity than the other 
strains having ED pathway activity. The strains in cluster three (C. glutamicum, Str. canescus and 
Str. alboniger) all displayed medium EMP activity and low TCA activity. Typical traits for strains in 
cluster two (Act. teichomycetius, Str. lividana, Str. coelicolor and Str. avermitilis.  Str. refuineus) 
were medium EMP activity, low PPP activity and medium/high TCA activity. Finally, the strains in 
cluster four (Str mediocidicus, Str. PRL 1642, Str roseochromogenes and Str. tsusumacensis) were 
those that showed the highest EMP and the lowest PPP activity among the strains tested.  
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We identified an active ED pathway in three strains for which the presence of this pathway 
has not been reported before; two glycopeptide producing strains (Am. balhimycina and Am. 
orientalis) and the erythromycin producer (Sac. erythreae). While this work was on-going, the 
genomic sequence of Sac. erythreae became available; in this sequence the two genes have been 
found and annotated (Olinyinyk 2007, and Licona -Cassani 2010), though so far no functional proof 
has been published. The presence of two genes with high similarity (Blastn alignment, Altschul 
1997) to eda and edd of Nonomuraea (GenBank accession number AJ6055554 and AJ6055555, 
respectively) indicates the presence of this pathway in a number of Actinobacteria, including the 
two Streptomycetes, Str. hygroscopicus subsp. jinggangensis and Str. cattleya, as well as Sac. 
Polyspora, which has been published, Am. Mediterranei which is a close relative of the two 
published Amycolatopsis spp., and M. smegmatis (see supplementary table 1). In the ED pathway 
glucose 6P is converted to 6-phosphogluconate instead of to fructose 6P as in the EMP pathway. 
6-phosphogluconate then goes to 2-keto-3-deoxy-6-phosphogluconate (KDPG) and subsequently 
KDGP is split into two C3 molecules. In summary from one mole glucose, 1 mole NADPH, 1 mole 
NADH and 1 mole ATP are produced when the ED pathway is used, whereas the EMP pathway 
yields 2 moles NADH and 2 moles ATP per mole glucose. Since the ED pathway is energetically less 
favorable, one may wonder what the rationale behind the usage of this pathway is? In E.coli, the 
ED pathway is believed to be central to utilization of gluconate and other sugar acids [Conway, 
1992 #40 / Peekhaus, 1998 #37 / Murray, 2005 #42]. Moreover, Eda synthesis has been seen to be 
induced by phosphate limitation and carbon starvation (Murray 2005). One could also speculate 
that the higher NADPH production during operation of the ED pathway compared to when the 
EMP pathway is employed would be beneficial for antibiotic production where NADPH often 
functions as an important cofactor. 
150 
 
Among the strains investigated in this study Str. tenebrarius was the only streptomycete 
found to express an active ED pathway. One could start to wonder if the tobramycin producer 
designated Str. tenebrarius really is a streptomycete.  Streptomycetes can be distinguished from 
other actinomycetes by their cell wall type (Type I) characterized by the presence of ll-
diaminopimelic acid and glycine (Lechevalier & Lechevalier, 1970). The cell wall of Str. tenebrarius 
has been found to contain meso-diaminopimelic acid (Tamura 2008), which indicates that it 
indeed is not a true streptomycete.  
 
The ED pathway is believed to evolutionary pre-date the EMP (Melendez-Hevia 1997; Romano 
and Conway 1996). We had expected to see a correlation between phylogeny and activity of 
central carbon metabolism. Surprisingly, no such trend could be detected. Even though the three 
strains discovered to have ED activity in the present study all belong to the Pseudonocardiaceae 
family; earlier known species expressing ED activity where widespread among different families: 
Str. tenebrarius of the family Streptomycetaceae, Nonomuraea sp. of the family 
Streptosporangiaceae and Mycobacterium smegmatis of the family Mycobacteriaceae. 
Furthermore, streptomycetes could be found in all clusters and neither were the closely related A. 
balhimycina and A. orientalis adjacent. The present findings indicate that activity in the central 
carbon metabolism is more connected to environmental niche than phylogenetic group, which 
could be explained by the considerable horizontal gene transfer within bacteria. A similar pattern 
has been observed for secondary metabolite genes. Metsä-Ketelä et al (2002) investigated the 
molecular evolution of aromatic polyketides in Actinobacteria. A phylogenetic analysis showed 
discrepancy between a polyketides sequences based clustering and a 16S based one, and they 
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concluded that horizontal transfer of polyketides genes was probably the reason for the 
disagreement.  
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Tables and Figures 
TABLE 2. Estimated activities of central carbon metabolism and growth rates of the investigated 
strains. 
Strain Family1 EMP ED PP TCA2 
Sacc. erythrea P (+) ++ +  
Am. orientalis P (+) ++ ++  
Str. tenebrarius S + + ++  
Am. balhimycina P ++ + +  
Str. canescus S ++ - + + 
Str. alboniger S ++ - ++ + 
C. glutamicum C ++ - ++ + 
Str. coelicolor S ++ - + +(+) 
Str. lividans S ++ - + + 
Act. teichomyceticus M ++ - + ++ 
Str. refuineus S ++ - + ++ 
Str. avermitilis S ++ - + ++ 
Str. PRL1642 S +++ - (+) ++ 
Str. mediocidicus S +++ - (+) ++ 
Str. roseochromogenes S +++ - (+) ++ 
Str. tsusumacensis S +++ - (+) ++ 
1 P: Pseudonocardiaceae, S: Streptomycetaceae, C: Corynebacteriaceae, M: 
Micromonosporaceae 
2 For the strains having ED activity the TCA activity can not be estimated with the applied method
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FIGURES 
 
Figure PYRlabel. Illustration of how conversion of glucose into pyruvate through different 
metabolic pathways result in different positional labeling of pyruvate.  
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Figure PCA. Biplot of PC1 and PC2 from principal component analysis on SFLs for the different 
strains. The SFLs for threonine and serine were excluded from the analysis due to high STDdev. 
The colors and shapes symbolize the group membership, as determined from a K-means clustering 
algorithm 
 
Figure Dendrogram. Dendrogram plot of a hierarchical clustering analysis of SFL data. The SFLs for 
threonine and serine were excluded from the analysis due to high STDdev. 
